PMID- 30744542
OWN - NLM
STAT- MEDLINE
DCOM- 20191125
LR  - 20191125
IS  - 1524-4628 (Electronic)
IS  - 0039-2499 (Linking)
VI  - 50
IP  - 3
DP  - 2019 Mar
TI  - Magnetic Resonance Imaging or Computed Tomography Before Treatment in Acute 
      Ischemic Stroke.
PG  - 659-664
LID - 10.1161/STROKEAHA.118.023882 [doi]
AB  - Background and Purpose- The acute management of stroke patients requires a fast 
      and efficient screening imaging modality. We compared workflow and functional 
      outcome in acute ischemic stroke patients screened by magnetic resonance imaging 
      (MRI) or computed tomography (CT) before treatment in the THRACE trial 
      (Thrombectomie des Artères Cérébrales), with the emphasis on the duration of the 
      imaging step. Methods- The THRACE randomized trial (June 2010 to February 2015) 
      evaluated the efficacy of mechanical thrombectomy after intravenous tPA 
      (tissue-type plasminogen activator) in ischemic stroke patients with proximal 
      occlusion. The choice of screening imaging modality was left to each enrolling 
      center. Differences between MRI and CT groups were assessed using univariable 
      analysis and the impact of imaging modality on favorable 3-month functional 
      outcome (modified Rankin Scale score of ≤2) was tested using multivariable 
      logistic regression. Results- Four hundred one patients were included (25 
      centers), comprising 299 MRI-selected and 102 CT-selected patients. Median 
      baseline National Institutes of Health Stroke Scale score was 18 in both groups. 
      MRI scan duration (median [interquartile range]) was longer than CT (MRI: 13 
      minutes [10-16]; CT: 9 minutes [7-12]; P<0.001). Stroke-onset-to-imaging time 
      (MRI: median 114 minutes [interquartile range, 89-138]; CT: 107 minutes [88-139]; 
      P=0.19), onset-to-intravenous tPA time (MRI: 150 minutes [124-179]; CT: 150 
      minutes [123-180]; P=0.38) and onset-to-angiography-suite time (MRI: 200 minutes 
      [170-250]; CT: 213 minutes [180-246]; P=0.57) did not differ between groups. 
      Imaging modality was not significantly associated with functional outcome in the 
      multivariable analysis. Conclusions- Although MRI scan duration is slightly 
      longer than CT, MRI-based selection for acute ischemic stroke patients is 
      accomplished within a timeframe similar to CT-based selection, without delaying 
      treatment or impacting functional outcome. This should help to promote wider use 
      of MRI, which has inherent imaging advantages over CT. Clinical Trial 
      Registration- URL: https://www.clinicaltrials.gov . Unique identifier: 
      NCT01062698.
FAU - Provost, Corentin
AU  - Provost C
AD  - From the Imaging Department, INSERM UMR S1266, Sainte-Anne Hospital, Paris 
      Descartes University, France (C.P., L.L., W.B.H., J.B., M.E., G.B., O.N., C.O.).
FAU - Soudant, Marc
AU  - Soudant M
AD  - INSERM CIC-1433 Clinical Epidemiology, Nancy Hospital, France (M.S., F.G.).
FAU - Legrand, Laurence
AU  - Legrand L
AD  - From the Imaging Department, INSERM UMR S1266, Sainte-Anne Hospital, Paris 
      Descartes University, France (C.P., L.L., W.B.H., J.B., M.E., G.B., O.N., C.O.).
FAU - Ben Hassen, Wagih
AU  - Ben Hassen W
AD  - From the Imaging Department, INSERM UMR S1266, Sainte-Anne Hospital, Paris 
      Descartes University, France (C.P., L.L., W.B.H., J.B., M.E., G.B., O.N., C.O.).
FAU - Xie, Yu
AU  - Xie Y
AD  - Department of Neuroradiology, INSERM U1254, Lorraine University, Nancy, France 
      (Y.X., S.B.).
FAU - Soize, Sébastien
AU  - Soize S
AD  - Department of Diagnostic and Interventional Neuroradiology, University Hospital 
      of Reims, France (S.S.).
FAU - Bourcier, Romain
AU  - Bourcier R
AD  - Department of Diagnostic and Interventional Neuroradiology, University Hospital 
      of Nantes, France (R.B.).
FAU - Benzakoun, Joseph
AU  - Benzakoun J
AD  - From the Imaging Department, INSERM UMR S1266, Sainte-Anne Hospital, Paris 
      Descartes University, France (C.P., L.L., W.B.H., J.B., M.E., G.B., O.N., C.O.).
FAU - Edjlali, Myriam
AU  - Edjlali M
AD  - From the Imaging Department, INSERM UMR S1266, Sainte-Anne Hospital, Paris 
      Descartes University, France (C.P., L.L., W.B.H., J.B., M.E., G.B., O.N., C.O.).
FAU - Boulouis, Grégoire
AU  - Boulouis G
AD  - From the Imaging Department, INSERM UMR S1266, Sainte-Anne Hospital, Paris 
      Descartes University, France (C.P., L.L., W.B.H., J.B., M.E., G.B., O.N., C.O.).
FAU - Raoult, Hélène
AU  - Raoult H
AD  - Department of Neuroradiology, University Hospital of Rennes, France (H.R.).
FAU - Guillemin, Francis
AU  - Guillemin F
AD  - INSERM CIC-1433 Clinical Epidemiology, Nancy Hospital, France (M.S., F.G.).
FAU - Naggara, Olivier
AU  - Naggara O
AD  - From the Imaging Department, INSERM UMR S1266, Sainte-Anne Hospital, Paris 
      Descartes University, France (C.P., L.L., W.B.H., J.B., M.E., G.B., O.N., C.O.).
FAU - Bracard, Serge
AU  - Bracard S
AD  - Department of Neuroradiology, INSERM U1254, Lorraine University, Nancy, France 
      (Y.X., S.B.).
FAU - Oppenheim, Catherine
AU  - Oppenheim C
AD  - From the Imaging Department, INSERM UMR S1266, Sainte-Anne Hospital, Paris 
      Descartes University, France (C.P., L.L., W.B.H., J.B., M.E., G.B., O.N., C.O.).
LA  - eng
SI  - ClinicalTrials.gov/NCT01062698
PT  - Comparative Study
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Stroke
JT  - Stroke
JID - 0235266
SB  - IM
MH  - Aged
MH  - Brain Ischemia/*diagnostic imaging/therapy
MH  - Female
MH  - Humans
MH  - Magnetic Resonance Imaging/*methods
MH  - Male
MH  - Middle Aged
MH  - Predictive Value of Tests
MH  - Risk Factors
MH  - Stroke/*diagnostic imaging/therapy
MH  - Thrombectomy
MH  - Thrombolytic Therapy
MH  - Time-to-Treatment
MH  - Tomography, X-Ray Computed/*methods
MH  - Treatment Outcome
MH  - Workflow
OTO - NOTNLM
OT  - brain ischemia
OT  - magnetic resonance imaging
OT  - thrombectomy
OT  - treatment outcome
OT  - workflow
EDAT- 2019/02/13 06:00
MHDA- 2019/11/26 06:00
CRDT- 2019/02/13 06:00
PHST- 2019/02/13 06:00 [pubmed]
PHST- 2019/11/26 06:00 [medline]
PHST- 2019/02/13 06:00 [entrez]
AID - 10.1161/STROKEAHA.118.023882 [doi]
PST - ppublish
SO  - Stroke. 2019 Mar;50(3):659-664. doi: 10.1161/STROKEAHA.118.023882.

PMID- 33612163
OWN - NLM
STAT- MEDLINE
DCOM- 20210729
LR  - 20210729
IS  - 1549-4713 (Electronic)
IS  - 0161-6420 (Linking)
VI  - 128
IP  - 3
DP  - 2021 Mar
TI  - Bisphosphonate-induced Posterior Scleritis.
PG  - 371
LID - S0161-6420(20)30966-0 [pii]
LID - 10.1016/j.ophtha.2020.09.041 [doi]
FAU - Provost, Corentin
AU  - Provost C
AD  - Department of Neuroradiology, Fondation Ophtalmologique A. Rothschild, Paris, 
      France.
FAU - Sené, Thomas
AU  - Sené T
AD  - Department of Internal Medicine, Fondation Ophtalmologique A. Rothschild, Paris, 
      France.
FAU - Lecler, Augustin
AU  - Lecler A
AD  - Department of Neuroradiology, Fondation Ophtalmologique A. Rothschild, Paris, 
      France.
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - Ophthalmology
JT  - Ophthalmology
JID - 7802443
RN  - 0 (Bone Density Conservation Agents)
RN  - 6XC1PAD3KF (Zoledronic Acid)
SB  - IM
MH  - Bone Density Conservation Agents/*adverse effects
MH  - Female
MH  - Humans
MH  - Magnetic Resonance Imaging
MH  - Middle Aged
MH  - Osteoporosis/drug therapy
MH  - Posterior Eye Segment/diagnostic imaging/*drug effects
MH  - Scleritis/*chemically induced/diagnostic imaging
MH  - Zoledronic Acid/*adverse effects
EDAT- 2021/02/23 06:00
MHDA- 2021/07/30 06:00
CRDT- 2021/02/22 05:44
PHST- 2020/09/23 00:00 [received]
PHST- 2020/09/28 00:00 [revised]
PHST- 2020/09/29 00:00 [accepted]
PHST- 2021/02/22 05:44 [entrez]
PHST- 2021/02/23 06:00 [pubmed]
PHST- 2021/07/30 06:00 [medline]
AID - S0161-6420(20)30966-0 [pii]
AID - 10.1016/j.ophtha.2020.09.041 [doi]
PST - ppublish
SO  - Ophthalmology. 2021 Mar;128(3):371. doi: 10.1016/j.ophtha.2020.09.041.

PMID- 35731277
OWN - NLM
STAT- MEDLINE
DCOM- 20220914
LR  - 20220920
IS  - 1432-1459 (Electronic)
IS  - 0340-5354 (Print)
IS  - 0340-5354 (Linking)
VI  - 269
IP  - 10
DP  - 2022 Oct
TI  - NMOSD typical brain lesions after COVID-19 mRNA vaccination.
PG  - 5213-5215
LID - 10.1007/s00415-022-11229-1 [doi]
FAU - Lévi-Strauss, Julie
AU  - Lévi-Strauss J
AUID- ORCID: 0000-0002-5827-5678
AD  - Department of Neurology, GHU Paris Psychiatrie et Neurosciences, Université Paris 
      Cité, Sainte-Anne Hospital, 1 rue Cabanis, 75014, Paris, France. 
      julie.levi.strauss@gmail.com.
AD  - INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, FHU NeuroVasc, 
      Paris, France. julie.levi.strauss@gmail.com.
FAU - Provost, Corentin
AU  - Provost C
AD  - INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, FHU NeuroVasc, 
      Paris, France.
AD  - Department of Neuroradiology, GHU Paris Psychiatrie et Neurosciences, Sainte-Anne 
      Hospital, Université Paris Cité, Paris, France.
FAU - Wane, Noémie
AU  - Wane N
AD  - Department of Neurology, GHU Paris Psychiatrie et Neurosciences, Université Paris 
      Cité, Sainte-Anne Hospital, 1 rue Cabanis, 75014, Paris, France.
AD  - INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, FHU NeuroVasc, 
      Paris, France.
FAU - Jacquemont, Thomas
AU  - Jacquemont T
AD  - Department of Neurology, GHU Paris Psychiatrie et Neurosciences, Université Paris 
      Cité, Sainte-Anne Hospital, 1 rue Cabanis, 75014, Paris, France.
AD  - INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, FHU NeuroVasc, 
      Paris, France.
FAU - Mélé, Nicolas
AU  - Mélé N
AD  - Department of Neurology, GHU Paris Psychiatrie et Neurosciences, Université Paris 
      Cité, Sainte-Anne Hospital, 1 rue Cabanis, 75014, Paris, France.
AD  - INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, FHU NeuroVasc, 
      Paris, France.
LA  - eng
PT  - Letter
DEP - 20220622
PL  - Germany
TA  - J Neurol
JT  - Journal of neurology
JID - 0423161
RN  - 0 (Aquaporin 4)
RN  - 0 (Autoantibodies)
RN  - 0 (RNA, Messenger)
SB  - IM
MH  - Aquaporin 4
MH  - Autoantibodies
MH  - Brain/diagnostic imaging/pathology
MH  - *COVID-19/prevention & control
MH  - Humans
MH  - *Nervous System Diseases/pathology
MH  - *Neuromyelitis Optica/pathology
MH  - RNA, Messenger
MH  - Vaccination
PMC - PMC9214460
COIS- The authors declare no potential conflicts of interest with respect to the 
      research, authorship and/or publication of this article.
EDAT- 2022/06/23 06:00
MHDA- 2022/09/15 06:00
CRDT- 2022/06/22 11:25
PHST- 2022/04/21 00:00 [received]
PHST- 2022/06/13 00:00 [accepted]
PHST- 2022/06/13 00:00 [revised]
PHST- 2022/06/23 06:00 [pubmed]
PHST- 2022/09/15 06:00 [medline]
PHST- 2022/06/22 11:25 [entrez]
AID - 10.1007/s00415-022-11229-1 [pii]
AID - 11229 [pii]
AID - 10.1007/s00415-022-11229-1 [doi]
PST - ppublish
SO  - J Neurol. 2022 Oct;269(10):5213-5215. doi: 10.1007/s00415-022-11229-1. Epub 2022 
      Jun 22.

PMID- 35966801
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220929
IS  - 1612-4758 (Print)
IS  - 1612-4766 (Electronic)
IS  - 1612-4758 (Linking)
VI  - 95
IP  - 4
DP  - 2022
TI  - Selecting aggressiveness to improve biological control agents efficiency.
PG  - 1589-1596
LID - 10.1007/s10340-022-01552-x [doi]
AB  - In agroecosystems, omnivorous predators are recognized as potential biological 
      control agents because of the numerous pest species they prey on. Nonetheless, it 
      could be possible to enhance their efficiency through artificial selection on 
      traits of economical or ecological relevance. Aggressiveness, which defines the 
      readiness of an individual to display agonistic actions toward other individuals, 
      is expected to be related to zoophagy, diet preferences and to a higher attack 
      rate. The study aimed to assess the aggressiveness degree of the damsel bug, 
      Nabis americoferus, and to estimate its heritability. We hypothesized that a high 
      aggressiveness degree can be selected, and that males are more aggressive than 
      females. Using artificial selection, we reared two separate populations, each 
      composed of nine genetically isolated lines characterized by their different 
      aggressiveness degree (aggressive, docile and non-selected). After three 
      generations, we had efficiently selected aggressive behavior. The realized 
      heritability was 0.16 and 0.27 for aggressiveness and docility in the first 
      population. It was 0.25 and 0.23 for the second population. Males were more 
      aggressive than females only for the second population. The potential of these 
      individuals as biological control agents and the ecological consequences of 
      aggressiveness are discussed.
CI  - © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of 
      Springer Nature 2022, Springer Nature or its licensor holds exclusive rights to 
      this article under a publishing agreement with the author(s) or other 
      rightsholder(s); author self-archiving of the accepted manuscript version of this 
      article is solely governed by the terms of such publishing agreement and 
      applicable law.
FAU - Royer, Pierre
AU  - Royer P
AD  - Laboratoire de Lutte Biologique, Département Des Sciences Biologiques, Université 
      du Québec À Montréal (UQAM), CP 8888, Succursale Centre-Ville, Montréal, QC H3C 
      3P8 Canada. GRID: grid.38678.32. ISNI: 0000 0001 2181 0211
AD  - Centre de Recherche Agroalimentaire de Mirabel - 9850, rue de Belle-Rivière, 
      Mirabel, QC J7N 2X8 Canada.
FAU - Dumont, François
AU  - Dumont F
AD  - Centre de Recherche Agroalimentaire de Mirabel - 9850, rue de Belle-Rivière, 
      Mirabel, QC J7N 2X8 Canada.
FAU - Provost, Caroline
AU  - Provost C
AD  - Centre de Recherche Agroalimentaire de Mirabel - 9850, rue de Belle-Rivière, 
      Mirabel, QC J7N 2X8 Canada.
FAU - Lucas, Eric
AU  - Lucas E
AD  - Laboratoire de Lutte Biologique, Département Des Sciences Biologiques, Université 
      du Québec À Montréal (UQAM), CP 8888, Succursale Centre-Ville, Montréal, QC H3C 
      3P8 Canada. GRID: grid.38678.32. ISNI: 0000 0001 2181 0211
LA  - eng
PT  - Journal Article
DEP - 20220808
PL  - Germany
TA  - J Pest Sci (2004)
JT  - Journal of pest science
JID - 101312656
PMC - PMC9358388
OTO - NOTNLM
OT  - Aggressiveness
OT  - Animal personality
OT  - Artificial selection
OT  - Intraspecific variation
OT  - Nabis americoferus
OT  - Realized heritability
COIS- Competing interestsThe authors declare no competing interests.Conflict of 
      interestAuthors declare no conflict of interest or competing interests.
EDAT- 2022/08/16 06:00
MHDA- 2022/08/16 06:01
CRDT- 2022/08/15 03:47
PHST- 2022/04/13 00:00 [received]
PHST- 2022/07/26 00:00 [revised]
PHST- 2022/07/29 00:00 [accepted]
PHST- 2022/08/16 06:00 [pubmed]
PHST- 2022/08/16 06:01 [medline]
PHST- 2022/08/15 03:47 [entrez]
AID - 1552 [pii]
AID - 10.1007/s10340-022-01552-x [doi]
PST - ppublish
SO  - J Pest Sci (2004). 2022;95(4):1589-1596. doi: 10.1007/s10340-022-01552-x. Epub 
      2022 Aug 8.

PMID- 32081775
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200706
IS  - 1878-3511 (Electronic)
IS  - 1201-9712 (Linking)
VI  - 93
DP  - 2020 Apr
TI  - Nasopharyngeal tuberculosis incidentally diagnosed on (18)F-FDG PET/CT.
PG  - 295-296
LID - S1201-9712(20)30068-0 [pii]
LID - 10.1016/j.ijid.2020.02.010 [doi]
FAU - Champion, Laurence
AU  - Champion L
AD  - Nuclear Medicine Department, Institut Curie 35 rue Dailly, 92210 Saint-Cloud, 
      France.
FAU - Provost, Claire
AU  - Provost C
AD  - Nuclear Medicine Department, Institut Curie 35 rue Dailly, 92210 Saint-Cloud, 
      France; Radiopharmacology Department, Institut Curie 35 rue Dailly, 92210 
      Saint-Cloud, France. Electronic address: claire.provost@curie.fr.
LA  - eng
PT  - Journal Article
DEP - 20200217
PL  - Canada
TA  - Int J Infect Dis
JT  - International journal of infectious diseases : IJID : official publication of the 
      International Society for Infectious Diseases
JID - 9610933
SB  - IM
EDAT- 2020/02/23 06:00
MHDA- 2020/02/23 06:01
CRDT- 2020/02/22 06:00
PHST- 2020/01/17 00:00 [received]
PHST- 2020/02/11 00:00 [revised]
PHST- 2020/02/11 00:00 [accepted]
PHST- 2020/02/23 06:00 [pubmed]
PHST- 2020/02/23 06:01 [medline]
PHST- 2020/02/22 06:00 [entrez]
AID - S1201-9712(20)30068-0 [pii]
AID - 10.1016/j.ijid.2020.02.010 [doi]
PST - ppublish
SO  - Int J Infect Dis. 2020 Apr;93:295-296. doi: 10.1016/j.ijid.2020.02.010. Epub 2020 
      Feb 17.

PMID- 35621777
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 2075-4450 (Print)
IS  - 2075-4450 (Electronic)
IS  - 2075-4450 (Linking)
VI  - 13
IP  - 5
DP  - 2022 May 7
TI  - Using Autumnal Trap Crops to Manage Tarnished Plant Bugs (Lygus lineolaris).
LID - 10.3390/insects13050441 [doi]
LID - 441
AB  - For insects, surviving winter depends on their capacity to store enough energy 
      and find proper hibernation sites. A common strategy is to minimize movement and 
      hibernate near autumn food sources. We investigated the efficiency of autumnal 
      hosts to act as trap crops where insects could be exposed to targeted repressive 
      treatments. This approach could reduce the local populations of insect pests in 
      the next production season, reducing the need for insecticides. First, we tested 
      the mullein plant's attractiveness as an autumn trap crop for Lygus lineolaris 
      (Hemiptera: Miridae) in strawberry fields by comparing peak population density 
      among mullein (Verbascum thapsus), strawberry plants (Fragaria × ananassa), 
      buckwheat (Fagopyrum esculentum), and mustard (Sinapis alba). Second, we tested 
      four treatments applied to the autumn trap crops to reduce L. lineolaris winter 
      survivorship: (1) hot water, (2) a pathogen (Beauveria bassiana), (3) insecticide 
      (cypermethrin), and (4) a control. The density of the L. lineolaris population on 
      mullein in autumn and on buckwheat in summer was higher than on strawberry and 
      mustard. Of the overwintering L. lineolaris, 0% survived the winter when treated 
      with the insecticide cypermethrin, while 38.3% survived in the control treatment 
      (without repressive treatment). The B. bassiana and hot water treatments did not 
      differ from the control. The mullein autumn trap crops combined with insecticide 
      treatments could contribute to reducing the overwintering population, hence 
      potentially reducing population during the following growing season.
FAU - Dumont, François
AU  - Dumont F
AUID- ORCID: 0000-0001-7587-072X
AD  - Centre de Recherche Agroalimentaire de Mirabel, 9850 Rue de Belle-Rivière, 
      Mirabel, QC J7N 2X8, Canada.
FAU - Provost, Caroline
AU  - Provost C
AD  - Centre de Recherche Agroalimentaire de Mirabel, 9850 Rue de Belle-Rivière, 
      Mirabel, QC J7N 2X8, Canada.
LA  - eng
GR  - #projet PAI-377/Agriculture and Agriculture-Food Canada/
PT  - Journal Article
DEP - 20220507
PL  - Switzerland
TA  - Insects
JT  - Insects
JID - 101574235
PMC - PMC9146492
OTO - NOTNLM
OT  - integrated pest management
OT  - landscape diversification
OT  - overwintering
OT  - trap cropping
COIS- The authors declare no conflict of interest.
EDAT- 2022/05/28 06:00
MHDA- 2022/05/28 06:01
CRDT- 2022/05/27 10:23
PHST- 2022/03/25 00:00 [received]
PHST- 2022/04/27 00:00 [revised]
PHST- 2022/05/05 00:00 [accepted]
PHST- 2022/05/27 10:23 [entrez]
PHST- 2022/05/28 06:00 [pubmed]
PHST- 2022/05/28 06:01 [medline]
AID - insects13050441 [pii]
AID - insects-13-00441 [pii]
AID - 10.3390/insects13050441 [doi]
PST - epublish
SO  - Insects. 2022 May 7;13(5):441. doi: 10.3390/insects13050441.

PMID- 33380752
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20210224
IS  - 0038-6308 (Print)
IS  - 1572-9672 (Electronic)
IS  - 0038-6308 (Linking)
VI  - 217
IP  - 1
DP  - 2021
TI  - The SuperCam Instrument Suite on the NASA Mars 2020 Rover: Body Unit and Combined 
      System Tests.
PG  - 4
LID - 10.1007/s11214-020-00777-5 [doi]
LID - 4
AB  - The SuperCam instrument suite provides the Mars 2020 rover, Perseverance, with a 
      number of versatile remote-sensing techniques that can be used at long distance 
      as well as within the robotic-arm workspace. These include laser-induced 
      breakdown spectroscopy (LIBS), remote time-resolved Raman and luminescence 
      spectroscopies, and visible and infrared (VISIR; separately referred to as VIS 
      and IR) reflectance spectroscopy. A remote micro-imager (RMI) provides 
      high-resolution color context imaging, and a microphone can be used as a 
      stand-alone tool for environmental studies or to determine physical properties of 
      rocks and soils from shock waves of laser-produced plasmas. SuperCam is built in 
      three parts: The mast unit (MU), consisting of the laser, telescope, RMI, IR 
      spectrometer, and associated electronics, is described in a companion paper. The 
      on-board calibration targets are described in another companion paper. Here we 
      describe SuperCam's body unit (BU) and testing of the integrated instrument. The 
      BU, mounted inside the rover body, receives light from the MU via a 5.8 m optical 
      fiber. The light is split into three wavelength bands by a demultiplexer, and is 
      routed via fiber bundles to three optical spectrometers, two of which (UV and 
      violet; 245-340 and 385-465 nm) are crossed Czerny-Turner reflection 
      spectrometers, nearly identical to their counterparts on ChemCam. The third is a 
      high-efficiency transmission spectrometer containing an optical intensifier 
      capable of gating exposures to 100 ns or longer, with variable delay times 
      relative to the laser pulse. This spectrometer covers 535-853 nm ( 105-7070 cm-1 
      Raman shift relative to the 532 nm green laser beam) with 12 cm-1 full-width at 
      half-maximum peak resolution in the Raman fingerprint region. The BU electronics 
      boards interface with the rover and control the instrument, returning data to the 
      rover. Thermal systems maintain a warm temperature during cruise to Mars to avoid 
      contamination on the optics, and cool the detectors during operations on Mars. 
      Results obtained with the integrated instrument demonstrate its capabilities for 
      LIBS, for which a library of 332 standards was developed. Examples of Raman and 
      VISIR spectroscopy are shown, demonstrating clear mineral identification with 
      both techniques. Luminescence spectra demonstrate the utility of having both 
      spectral and temporal dimensions. Finally, RMI and microphone tests on the rover 
      demonstrate the capabilities of these subsystems as well.
CI  - © The Author(s) 2020.
FAU - Wiens, Roger C
AU  - Wiens RC
AUID- ORCID: 0000-0002-3409-7344
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Maurice, Sylvestre
AU  - Maurice S
AD  - Institut de Recherche en Astrophysique et Planetologie (IRAP), Université de 
      Toulouse, UPS, CNRS, Toulouse, France. GRID: grid.15781.3a. ISNI: 0000 0001 0723 
      035X
FAU - Robinson, Scott H
AU  - Robinson SH
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Nelson, Anthony E
AU  - Nelson AE
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Cais, Philippe
AU  - Cais P
AD  - Laboratoire d'astrophysique de Bordeaux, Univ. Bordeaux, CNRS, Bordeaux, France. 
      GRID: grid.412041.2. ISNI: 0000 0001 2106 639X
FAU - Bernardi, Pernelle
AU  - Bernardi P
AD  - Laboratoire d'Etudes Spatiales et d'Instrumentation en Astrophysique, 
      Observatoire de Paris, Meudon, France. GRID: grid.4307.0. ISNI: 0000 0004 0475 
      642X
FAU - Newell, Raymond T
AU  - Newell RT
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Clegg, Sam
AU  - Clegg S
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Sharma, Shiv K
AU  - Sharma SK
AD  - University of Hawaii, Manoa, HI USA. GRID: grid.410445.0. ISNI: 0000 0001 2188 
      0957
FAU - Storms, Steven
AU  - Storms S
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Deming, Jonathan
AU  - Deming J
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Beckman, Darrel
AU  - Beckman D
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Ollila, Ann M
AU  - Ollila AM
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Gasnault, Olivier
AU  - Gasnault O
AD  - Institut de Recherche en Astrophysique et Planetologie (IRAP), Université de 
      Toulouse, UPS, CNRS, Toulouse, France. GRID: grid.15781.3a. ISNI: 0000 0001 0723 
      035X
FAU - Anderson, Ryan B
AU  - Anderson RB
AD  - U.S. Geological Survey Astrogeology Science Center, Flagstaff, AZ USA.
FAU - André, Yves
AU  - André Y
AD  - Centre National d'Etudes Spatiales, Toulouse, France. GRID: grid.13349.3c. ISNI: 
      0000 0001 2201 6490
FAU - Michael Angel, S
AU  - Michael Angel S
AD  - University of South Carolina, Columbia, SC USA. GRID: grid.254567.7. ISNI: 0000 
      0000 9075 106X
FAU - Arana, Gorka
AU  - Arana G
AD  - University of Basque Country, UPV/EHU, Bilbao, Spain. GRID: grid.11480.3c. ISNI: 
      0000000121671098
FAU - Auden, Elizabeth
AU  - Auden E
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Beck, Pierre
AU  - Beck P
AD  - Institut de Planétologie et d'Astrophysique de Grenoble, Université Grenoble 
      Alpes, Grenoble, France. GRID: grid.450308.a. ISNI: 0000 0004 0369 268X
FAU - Becker, Joseph
AU  - Becker J
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Benzerara, Karim
AU  - Benzerara K
AD  - Institut de Minéralogie, Physique des Matériaux et Cosmochimie, CNRS, Museum 
      National d'Histoire Naturelle, Sorbonne Université, Paris, France. GRID: 
      grid.462844.8. ISNI: 0000 0001 2308 1657
FAU - Bernard, Sylvain
AU  - Bernard S
AD  - Institut de Minéralogie, Physique des Matériaux et Cosmochimie, CNRS, Museum 
      National d'Histoire Naturelle, Sorbonne Université, Paris, France. GRID: 
      grid.462844.8. ISNI: 0000 0001 2308 1657
FAU - Beyssac, Olivier
AU  - Beyssac O
AD  - Institut de Minéralogie, Physique des Matériaux et Cosmochimie, CNRS, Museum 
      National d'Histoire Naturelle, Sorbonne Université, Paris, France. GRID: 
      grid.462844.8. ISNI: 0000 0001 2308 1657
FAU - Borges, Louis
AU  - Borges L
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Bousquet, Bruno
AU  - Bousquet B
AD  - Centre Lasers Intenses et Applications, University of Bordeaux, Bordeaux, France. 
      GRID: grid.412041.2. ISNI: 0000 0001 2106 639X
FAU - Boyd, Kerry
AU  - Boyd K
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Caffrey, Michael
AU  - Caffrey M
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Carlson, Jeffrey
AU  - Carlson J
AD  - Jet Propulsion Laboratory/Caltech, Pasadena, CA USA.
FAU - Castro, Kepa
AU  - Castro K
AD  - University of Basque Country, UPV/EHU, Bilbao, Spain. GRID: grid.11480.3c. ISNI: 
      0000000121671098
FAU - Celis, Jorden
AU  - Celis J
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Chide, Baptiste
AU  - Chide B
AD  - Institut Supérieur de l'Aéronautique et de l'Espace (ISAE), Toulouse, France.
AD  - Institut de Recherche en Astrophysique et Planetologie (IRAP), Université de 
      Toulouse, UPS, CNRS, Toulouse, France. GRID: grid.15781.3a. ISNI: 0000 0001 0723 
      035X
FAU - Clark, Kevin
AU  - Clark K
AD  - Jet Propulsion Laboratory/Caltech, Pasadena, CA USA.
FAU - Cloutis, Edward
AU  - Cloutis E
AD  - University of Winnipeg, Winnipeg, Canada. GRID: grid.267457.5. ISNI: 0000 0001 
      1703 4731
FAU - Cordoba, Elizabeth C
AU  - Cordoba EC
AD  - Jet Propulsion Laboratory/Caltech, Pasadena, CA USA.
FAU - Cousin, Agnes
AU  - Cousin A
AD  - Institut de Recherche en Astrophysique et Planetologie (IRAP), Université de 
      Toulouse, UPS, CNRS, Toulouse, France. GRID: grid.15781.3a. ISNI: 0000 0001 0723 
      035X
FAU - Dale, Magdalena
AU  - Dale M
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Deflores, Lauren
AU  - Deflores L
AD  - Jet Propulsion Laboratory/Caltech, Pasadena, CA USA.
FAU - Delapp, Dorothea
AU  - Delapp D
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Deleuze, Muriel
AU  - Deleuze M
AD  - Centre National d'Etudes Spatiales, Toulouse, France. GRID: grid.13349.3c. ISNI: 
      0000 0001 2201 6490
FAU - Dirmyer, Matthew
AU  - Dirmyer M
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Donny, Christophe
AU  - Donny C
AD  - Centre National d'Etudes Spatiales, Toulouse, France. GRID: grid.13349.3c. ISNI: 
      0000 0001 2201 6490
FAU - Dromart, Gilles
AU  - Dromart G
AD  - Univ Lyon, ENSL, Univ Lyon 1, CNRS, LGL-TPE, 69364 Lyon, France. GRID: 
      grid.25697.3f. ISNI: 0000 0001 2172 4233
FAU - George Duran, M
AU  - George Duran M
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Egan, Miles
AU  - Egan M
AD  - University of Hawaii, Manoa, HI USA. GRID: grid.410445.0. ISNI: 0000 0001 2188 
      0957
FAU - Ervin, Joan
AU  - Ervin J
AD  - Jet Propulsion Laboratory/Caltech, Pasadena, CA USA.
FAU - Fabre, Cecile
AU  - Fabre C
AD  - GeoRessources, Université de Lorraine, Nancy, France. GRID: grid.29172.3f. ISNI: 
      0000 0001 2194 6418
FAU - Fau, Amaury
AU  - Fau A
AD  - Institut de Minéralogie, Physique des Matériaux et Cosmochimie, CNRS, Museum 
      National d'Histoire Naturelle, Sorbonne Université, Paris, France. GRID: 
      grid.462844.8. ISNI: 0000 0001 2308 1657
FAU - Fischer, Woodward
AU  - Fischer W
AD  - California Institute of Technology, Pasadena, CA USA. GRID: grid.20861.3d. ISNI: 
      0000000107068890
FAU - Forni, Olivier
AU  - Forni O
AD  - Institut de Recherche en Astrophysique et Planetologie (IRAP), Université de 
      Toulouse, UPS, CNRS, Toulouse, France. GRID: grid.15781.3a. ISNI: 0000 0001 0723 
      035X
FAU - Fouchet, Thierry
AU  - Fouchet T
AD  - Laboratoire d'Etudes Spatiales et d'Instrumentation en Astrophysique, 
      Observatoire de Paris, Meudon, France. GRID: grid.4307.0. ISNI: 0000 0004 0475 
      642X
FAU - Fresquez, Reuben
AU  - Fresquez R
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Frydenvang, Jens
AU  - Frydenvang J
AD  - University of Copenhagen, Copenhagen, Denmark. GRID: grid.5254.6. ISNI: 0000 0001 
      0674 042X
FAU - Gasway, Denine
AU  - Gasway D
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Gontijo, Ivair
AU  - Gontijo I
AD  - Jet Propulsion Laboratory/Caltech, Pasadena, CA USA.
FAU - Grotzinger, John
AU  - Grotzinger J
AD  - California Institute of Technology, Pasadena, CA USA. GRID: grid.20861.3d. ISNI: 
      0000000107068890
FAU - Jacob, Xavier
AU  - Jacob X
AD  - Institut de mécanique des fluides de Toulouse (CNRS, INP, Univ. Toulouse), 
      Toulouse, France. GRID: grid.462001.1. ISNI: 0000 0004 0614 3424
FAU - Jacquinod, Sophie
AU  - Jacquinod S
AD  - Laboratoire d'Etudes Spatiales et d'Instrumentation en Astrophysique, 
      Observatoire de Paris, Meudon, France. GRID: grid.4307.0. ISNI: 0000 0004 0475 
      642X
FAU - Johnson, Jeffrey R
AU  - Johnson JR
AD  - Johns Hopkins University Applied Physics Laboratory, Laurel, MD USA. GRID: 
      grid.474430.0. ISNI: 0000 0004 0630 1170
FAU - Klisiewicz, Roberta A
AU  - Klisiewicz RA
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Lake, James
AU  - Lake J
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Lanza, Nina
AU  - Lanza N
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Laserna, Javier
AU  - Laserna J
AD  - Universidad de Malaga, Malaga, Spain. GRID: grid.10215.37. ISNI: 0000 0001 2298 
      7828
FAU - Lasue, Jeremie
AU  - Lasue J
AD  - Institut de Recherche en Astrophysique et Planetologie (IRAP), Université de 
      Toulouse, UPS, CNRS, Toulouse, France. GRID: grid.15781.3a. ISNI: 0000 0001 0723 
      035X
FAU - Le Mouélic, Stéphane
AU  - Le Mouélic S
AD  - Laboratoire de Planétologie et Géodynamique, Université de Nantes, Université 
      d'Angers, CNRS UMR 6112, Nantes, France. GRID: grid.4817.a
FAU - Legett, Carey 4th
AU  - Legett C 4th
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Leveille, Richard
AU  - Leveille R
AD  - McGill University, Montreal, Canada. GRID: grid.14709.3b. ISNI: 0000 0004 1936 
      8649
FAU - Lewin, Eric
AU  - Lewin E
AD  - Institut de Planétologie et d'Astrophysique de Grenoble, Université Grenoble 
      Alpes, Grenoble, France. GRID: grid.450308.a. ISNI: 0000 0004 0369 268X
FAU - Lopez-Reyes, Guillermo
AU  - Lopez-Reyes G
AD  - University of Valladolid, UVA, Valladolid, Spain. GRID: grid.5239.d. ISNI: 0000 
      0001 2286 5329
FAU - Lorenz, Ralph
AU  - Lorenz R
AD  - Johns Hopkins University Applied Physics Laboratory, Laurel, MD USA. GRID: 
      grid.474430.0. ISNI: 0000 0004 0630 1170
FAU - Lorigny, Eric
AU  - Lorigny E
AD  - Centre National d'Etudes Spatiales, Toulouse, France. GRID: grid.13349.3c. ISNI: 
      0000 0001 2201 6490
FAU - Love, Steven P
AU  - Love SP
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Lucero, Briana
AU  - Lucero B
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Madariaga, Juan Manuel
AU  - Madariaga JM
AD  - University of Basque Country, UPV/EHU, Bilbao, Spain. GRID: grid.11480.3c. ISNI: 
      0000000121671098
FAU - Madsen, Morten
AU  - Madsen M
AD  - University of Copenhagen, Copenhagen, Denmark. GRID: grid.5254.6. ISNI: 0000 0001 
      0674 042X
FAU - Madsen, Soren
AU  - Madsen S
AD  - Jet Propulsion Laboratory/Caltech, Pasadena, CA USA.
FAU - Mangold, Nicolas
AU  - Mangold N
AD  - Laboratoire de Planétologie et Géodynamique, Université de Nantes, Université 
      d'Angers, CNRS UMR 6112, Nantes, France. GRID: grid.4817.a
FAU - Manrique, Jose Antonio
AU  - Manrique JA
AD  - University of Valladolid, UVA, Valladolid, Spain. GRID: grid.5239.d. ISNI: 0000 
      0001 2286 5329
FAU - Martinez, J P
AU  - Martinez JP
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Martinez-Frias, Jesus
AU  - Martinez-Frias J
AD  - Agencia Estatal Consejo Superior de Investigaciones Cientificas, Madrid, Spain. 
      GRID: grid.4711.3. ISNI: 0000 0001 2183 4846
FAU - McCabe, Kevin P
AU  - McCabe KP
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - McConnochie, Timothy H
AU  - McConnochie TH
AD  - University of Maryland, College Park, MD USA. GRID: grid.164295.d. ISNI: 0000 
      0001 0941 7177
FAU - McGlown, Justin M
AU  - McGlown JM
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - McLennan, Scott M
AU  - McLennan SM
AD  - State University of New York, Stony Brook, NY USA. GRID: grid.36425.36. ISNI: 
      0000 0001 2216 9681
FAU - Melikechi, Noureddine
AU  - Melikechi N
AD  - University of Massachusetts, Lowell, MA USA. GRID: grid.225262.3. ISNI: 0000 0000 
      9620 1122
FAU - Meslin, Pierre-Yves
AU  - Meslin PY
AD  - Institut de Recherche en Astrophysique et Planetologie (IRAP), Université de 
      Toulouse, UPS, CNRS, Toulouse, France. GRID: grid.15781.3a. ISNI: 0000 0001 0723 
      035X
FAU - Michel, John M
AU  - Michel JM
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Mimoun, David
AU  - Mimoun D
AD  - Institut Supérieur de l'Aéronautique et de l'Espace (ISAE), Toulouse, France.
FAU - Misra, Anupam
AU  - Misra A
AD  - University of Hawaii, Manoa, HI USA. GRID: grid.410445.0. ISNI: 0000 0001 2188 
      0957
FAU - Montagnac, Gilles
AU  - Montagnac G
AD  - Univ Lyon, ENSL, Univ Lyon 1, CNRS, LGL-TPE, 69364 Lyon, France. GRID: 
      grid.25697.3f. ISNI: 0000 0001 2172 4233
FAU - Montmessin, Franck
AU  - Montmessin F
AD  - Laboratoire Atmosphères, Milieux, Observations Spatiales, Paris, France. GRID: 
      grid.494619.7
FAU - Mousset, Valerie
AU  - Mousset V
AD  - Centre National d'Etudes Spatiales, Toulouse, France. GRID: grid.13349.3c. ISNI: 
      0000 0001 2201 6490
FAU - Murdoch, Naomi
AU  - Murdoch N
AD  - Institut Supérieur de l'Aéronautique et de l'Espace (ISAE), Toulouse, France.
FAU - Newsom, Horton
AU  - Newsom H
AD  - University of New Mexico, Albuquerque, NM USA. GRID: grid.266832.b. ISNI: 0000 
      0001 2188 8502
FAU - Ott, Logan A
AU  - Ott LA
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Ousnamer, Zachary R
AU  - Ousnamer ZR
AD  - Jet Propulsion Laboratory/Caltech, Pasadena, CA USA.
FAU - Pares, Laurent
AU  - Pares L
AD  - Institut de Recherche en Astrophysique et Planetologie (IRAP), Université de 
      Toulouse, UPS, CNRS, Toulouse, France. GRID: grid.15781.3a. ISNI: 0000 0001 0723 
      035X
FAU - Parot, Yann
AU  - Parot Y
AD  - Institut de Recherche en Astrophysique et Planetologie (IRAP), Université de 
      Toulouse, UPS, CNRS, Toulouse, France. GRID: grid.15781.3a. ISNI: 0000 0001 0723 
      035X
FAU - Pawluczyk, Rafal
AU  - Pawluczyk R
AD  - FiberTech Optica, Kitchener, ON Canada. GRID: grid.450804.d
FAU - Glen Peterson, C
AU  - Glen Peterson C
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Pilleri, Paolo
AU  - Pilleri P
AD  - Institut de Recherche en Astrophysique et Planetologie (IRAP), Université de 
      Toulouse, UPS, CNRS, Toulouse, France. GRID: grid.15781.3a. ISNI: 0000 0001 0723 
      035X
FAU - Pinet, Patrick
AU  - Pinet P
AD  - Institut de Recherche en Astrophysique et Planetologie (IRAP), Université de 
      Toulouse, UPS, CNRS, Toulouse, France. GRID: grid.15781.3a. ISNI: 0000 0001 0723 
      035X
FAU - Pont, Gabriel
AU  - Pont G
AD  - Centre National d'Etudes Spatiales, Toulouse, France. GRID: grid.13349.3c. ISNI: 
      0000 0001 2201 6490
FAU - Poulet, Francois
AU  - Poulet F
AD  - Institut d'Astrophysique Spatiale (IAS), Orsay, France. GRID: grid.482888.6. 
      ISNI: 0000 0004 0614 9404
FAU - Provost, Cheryl
AU  - Provost C
AD  - FiberTech Optica, Kitchener, ON Canada. GRID: grid.450804.d
FAU - Quertier, Benjamin
AU  - Quertier B
AD  - Laboratoire d'astrophysique de Bordeaux, Univ. Bordeaux, CNRS, Bordeaux, France. 
      GRID: grid.412041.2. ISNI: 0000 0001 2106 639X
FAU - Quinn, Heather
AU  - Quinn H
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Rapin, William
AU  - Rapin W
AD  - Institut de Minéralogie, Physique des Matériaux et Cosmochimie, CNRS, Museum 
      National d'Histoire Naturelle, Sorbonne Université, Paris, France. GRID: 
      grid.462844.8. ISNI: 0000 0001 2308 1657
FAU - Reess, Jean-Michel
AU  - Reess JM
AD  - Laboratoire d'Etudes Spatiales et d'Instrumentation en Astrophysique, 
      Observatoire de Paris, Meudon, France. GRID: grid.4307.0. ISNI: 0000 0004 0475 
      642X
FAU - Regan, Amy H
AU  - Regan AH
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Reyes-Newell, Adriana L
AU  - Reyes-Newell AL
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Romano, Philip J
AU  - Romano PJ
AD  - Jet Propulsion Laboratory/Caltech, Pasadena, CA USA.
FAU - Royer, Clement
AU  - Royer C
AD  - Institut d'Astrophysique Spatiale (IAS), Orsay, France. GRID: grid.482888.6. 
      ISNI: 0000 0004 0614 9404
FAU - Rull, Fernando
AU  - Rull F
AD  - University of Valladolid, UVA, Valladolid, Spain. GRID: grid.5239.d. ISNI: 0000 
      0001 2286 5329
FAU - Sandoval, Benigno
AU  - Sandoval B
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Sarrao, Joseph H
AU  - Sarrao JH
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Sautter, Violaine
AU  - Sautter V
AD  - Institut de Minéralogie, Physique des Matériaux et Cosmochimie, CNRS, Museum 
      National d'Histoire Naturelle, Sorbonne Université, Paris, France. GRID: 
      grid.462844.8. ISNI: 0000 0001 2308 1657
FAU - Schoppers, Marcel J
AU  - Schoppers MJ
AD  - Jet Propulsion Laboratory/Caltech, Pasadena, CA USA.
FAU - Schröder, Susanne
AU  - Schröder S
AD  - Deutsches Zentrum für Luft- und Raumfahrt (DLR), Institute of Optical Sensor 
      Systems, Berlin, Germany. GRID: grid.7551.6. ISNI: 0000 0000 8983 7915
FAU - Seitz, Daniel
AU  - Seitz D
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Shepherd, Terra
AU  - Shepherd T
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Sobron, Pablo
AU  - Sobron P
AD  - SETI Institute, Mountain View, CA USA. GRID: grid.422128.f. ISNI: 0000 0001 2115 
      2810
FAU - Dubois, Bruno
AU  - Dubois B
AD  - Université de Toulouse; UPS-OMP, Toulouse, France. GRID: grid.508721.9
FAU - Sridhar, Vishnu
AU  - Sridhar V
AD  - Jet Propulsion Laboratory/Caltech, Pasadena, CA USA.
FAU - Toplis, Michael J
AU  - Toplis MJ
AD  - Institut de Recherche en Astrophysique et Planetologie (IRAP), Université de 
      Toulouse, UPS, CNRS, Toulouse, France. GRID: grid.15781.3a. ISNI: 0000 0001 0723 
      035X
FAU - Torre-Fdez, Imanol
AU  - Torre-Fdez I
AD  - University of Basque Country, UPV/EHU, Bilbao, Spain. GRID: grid.11480.3c. ISNI: 
      0000000121671098
FAU - Trettel, Ian A
AU  - Trettel IA
AD  - Jet Propulsion Laboratory/Caltech, Pasadena, CA USA.
FAU - Underwood, Mark
AU  - Underwood M
AD  - Jet Propulsion Laboratory/Caltech, Pasadena, CA USA.
FAU - Valdez, Andres
AU  - Valdez A
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Valdez, Jacob
AU  - Valdez J
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Venhaus, Dawn
AU  - Venhaus D
AD  - Los Alamos National Laboratory, Los Alamos, NM USA. GRID: grid.148313.c. ISNI: 
      0000 0004 0428 3079
FAU - Willis, Peter
AU  - Willis P
AD  - Jet Propulsion Laboratory/Caltech, Pasadena, CA USA.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20201221
PL  - Netherlands
TA  - Space Sci Rev
JT  - Space science reviews
JID - 100971458
PMC - PMC7752893
OTO - NOTNLM
OT  - Infrared spectroscopy
OT  - Jezero crater
OT  - LIBS
OT  - Mars
OT  - Microphone on Mars
OT  - Perseverance rover
OT  - Raman spectroscopy
OT  - SuperCam
COIS- Conflicts of interest/Competing interestsThe authors declare that there are no 
      conflicts of interest or competing interests.
EDAT- 2021/01/01 06:00
MHDA- 2021/01/01 06:01
CRDT- 2020/12/31 05:23
PHST- 2020/05/16 00:00 [received]
PHST- 2020/11/27 00:00 [accepted]
PHST- 2020/12/31 05:23 [entrez]
PHST- 2021/01/01 06:00 [pubmed]
PHST- 2021/01/01 06:01 [medline]
AID - 777 [pii]
AID - 10.1007/s11214-020-00777-5 [doi]
PST - ppublish
SO  - Space Sci Rev. 2021;217(1):4. doi: 10.1007/s11214-020-00777-5. Epub 2020 Dec 21.

PMID- 33918702
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20210518
IS  - 2075-4418 (Print)
IS  - 2075-4418 (Electronic)
IS  - 2075-4418 (Linking)
VI  - 11
IP  - 4
DP  - 2021 Apr 9
TI  - Immune Response Visualized In Vivo by [18F]-FDG PET/CT after COVID-19 Vaccine.
LID - 10.3390/diagnostics11040676 [doi]
LID - 676
AB  - Worldwide deployment of COVID-19 vaccines is in progress. Recent immune 
      activation following vaccination can sometimes be seen in 
      fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography 
      ([18F]-FDG PET/CT). As previously evidenced, FDG-avid axillary lymph node(s) are 
      common in patients receiving vaccines against SARS-CoV-2, influenza virus, or 
      human papillomavirus, and reflect a regional immune response. In addition, these 
      findings may also be accompanied by an increased spleen glucose metabolism after 
      the COVID-19 vaccine, which captures a systemic immune response. Hence, we 
      provide here a clinical example demonstrating that immune response could be 
      associated with increased glucose metabolism in lymphoid organs such as lymph 
      nodes and the spleen, which are critical modulators of T cell immunity. We 
      believe that it is of paramount importance that nuclear physicians should be able 
      to recognize clinical and imaging features of such immune responses upon 
      vaccination for COVID-19 and beyond.
FAU - Seban, Romain-David
AU  - Seban RD
AD  - Department of Nuclear Medicine and Endocrine Oncology, Institut Curie, 92210 
      Saint-Cloud, France.
AD  - Laboratoire d'Imagerie Translationnelle en Oncologie, Inserm, Institut Curie, 
      91401 Orsay, France.
FAU - Champion, Laurence
AU  - Champion L
AD  - Department of Nuclear Medicine and Endocrine Oncology, Institut Curie, 92210 
      Saint-Cloud, France.
AD  - Laboratoire d'Imagerie Translationnelle en Oncologie, Inserm, Institut Curie, 
      91401 Orsay, France.
FAU - Deleval, Nicolas
AU  - Deleval N
AD  - Department of Nuclear Medicine and Endocrine Oncology, Institut Curie, 92210 
      Saint-Cloud, France.
FAU - Richard, Capucine
AU  - Richard C
AD  - Department of Nuclear Medicine and Endocrine Oncology, Institut Curie, 92210 
      Saint-Cloud, France.
FAU - Provost, Claire
AU  - Provost C
AUID- ORCID: 0000-0002-4390-4486
AD  - Laboratoire d'Imagerie Translationnelle en Oncologie, Inserm, Institut Curie, 
      91401 Orsay, France.
AD  - Department of Pharmacology, Institut Curie, 92210 Saint-Cloud, France.
LA  - eng
PT  - Journal Article
DEP - 20210409
PL  - Switzerland
TA  - Diagnostics (Basel)
JT  - Diagnostics (Basel, Switzerland)
JID - 101658402
PMC - PMC8069156
OTO - NOTNLM
OT  - COVID-19 vaccine
OT  - [18F]-FDG PET/CT
OT  - immune response
OT  - lymph nodes
OT  - spleen
COIS- The authors declare no conflict of interest.
EDAT- 2021/05/01 06:00
MHDA- 2021/05/01 06:01
CRDT- 2021/04/30 01:10
PHST- 2021/03/26 00:00 [received]
PHST- 2021/04/06 00:00 [revised]
PHST- 2021/04/08 00:00 [accepted]
PHST- 2021/04/30 01:10 [entrez]
PHST- 2021/05/01 06:00 [pubmed]
PHST- 2021/05/01 06:01 [medline]
AID - diagnostics11040676 [pii]
AID - diagnostics-11-00676 [pii]
AID - 10.3390/diagnostics11040676 [doi]
PST - epublish
SO  - Diagnostics (Basel). 2021 Apr 9;11(4):676. doi: 10.3390/diagnostics11040676.

PMID- 36066786
OWN - NLM
STAT- MEDLINE
DCOM- 20221102
LR  - 20221102
IS  - 1573-7373 (Electronic)
IS  - 0167-594X (Linking)
VI  - 160
IP  - 1
DP  - 2022 Oct
TI  - Meningioma in patients exposed to progestin drugs: results from a real-life 
      screening program.
PG  - 127-136
LID - 10.1007/s11060-022-04124-2 [doi]
AB  - PURPOSE: To report the results of systematic meningioma screening program 
      implemented by French authorities in patients exposed to progestin therapies 
      (cyproterone (CPA), nomegestrol (NA), and chlormadinone (CMA) acetate). METHODS: 
      We conducted a prospective monocentric study on patients who, between September 
      2018 and April 2021, underwent standardized MRI (injection of gadolinium, then a 
      T2 axial FLAIR and a 3D-T1 gradient-echo sequence) for meningioma screening. 
      RESULTS: Of the 210 included patients, 15 (7.1%) had at least one meningioma; 
      seven (7/15, 47%) had multiple meningiomas. Meningiomas were more frequent in 
      older patients and after exposure to CPA (13/103, 13%) compared to NA (1/22, 4%) 
      or CMA (1/85, 1%; P = 0.005). After CPA exposure, meningiomas were associated 
      with longer treatment duration (median = 20 vs 7 years, P = 0.001) and higher 
      cumulative dose (median = 91 g vs. 62 g, P = 0.014). Similarly, their 
      multiplicity was associated with higher dose of CPA (median = 244 g vs 
      61 g, P = 0.027). Most meningiomas were ≤ 1 cm(3) (44/58, 76%) and were convexity 
      meningiomas (36/58, 62%). At diagnosis, patients were non-symptomatic, and all 
      were managed conservatively. Among 14 patients with meningioma who stopped 
      progestin exposure, meningioma burden decreased in 11 (79%) cases with no case of 
      progression during MR follow-up. CONCLUSION: Systematic MR screening in 
      progestin-exposed patients uncovers small and multiple meningiomas, which can be 
      managed conservatively, decreasing in size after progestin discontinuation. The 
      high rate of meningiomas after CPA exposure reinforces the need for systematic 
      screening. For NA and CMA, further studies are needed to identify patients most 
      likely to benefit from screening.
CI  - © 2022. The Author(s), under exclusive licence to Springer Science+Business 
      Media, LLC, part of Springer Nature.
FAU - Samoyeau, Thomas
AU  - Samoyeau T
AUID- ORCID: 0000-0002-7259-7876
AD  - Institut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM U 1266, 
      IMA-BRAIN, Paris, France.
AD  - Université Paris Cité, Paris, France.
AD  - Service de Neuroradiologie, GHU Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte-Anne, Paris, France.
FAU - Provost, Corentin
AU  - Provost C
AUID- ORCID: 0000-0002-0200-4027
AD  - Institut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM U 1266, 
      IMA-BRAIN, Paris, France.
AD  - Université Paris Cité, Paris, France.
AD  - Service de Neuroradiologie, GHU Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte-Anne, Paris, France.
FAU - Roux, Alexandre
AU  - Roux A
AUID- ORCID: 0000-0002-9597-673X
AD  - Institut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM U 1266, 
      IMA-BRAIN, Paris, France.
AD  - Université Paris Cité, Paris, France.
AD  - Service de Neurochirurgie, GHU Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte-Anne, Paris, France.
FAU - Legrand, Laurence
AU  - Legrand L
AUID- ORCID: 0000-0003-3951-7405
AD  - Institut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM U 1266, 
      IMA-BRAIN, Paris, France.
AD  - Université Paris Cité, Paris, France.
AD  - Service de Neuroradiologie, GHU Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte-Anne, Paris, France.
FAU - Dezamis, Edouard
AU  - Dezamis E
AD  - Institut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM U 1266, 
      IMA-BRAIN, Paris, France.
AD  - Université Paris Cité, Paris, France.
AD  - Service de Neurochirurgie, GHU Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte-Anne, Paris, France.
FAU - Plu-Bureau, Geneviève
AU  - Plu-Bureau G
AUID- ORCID: 0000-0002-1020-8142
AD  - Université Paris Cité, Paris, France.
AD  - Unité de gynécologie endocrinienne, Hôpital Cochin-Port-Royal, 123 Boulevard 
      Port-Royal, Paris, France.
AD  - Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, Centre for 
      Epidemiology and Statistics Sorbonne Paris Cité (CRESS), INSERM U1153, Paris, 
      France.
FAU - Pallud, Johan
AU  - Pallud J
AUID- ORCID: 0000-0002-1652-9844
AD  - Institut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM U 1266, 
      IMA-BRAIN, Paris, France.
AD  - Université Paris Cité, Paris, France.
AD  - Service de Neurochirurgie, GHU Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte-Anne, Paris, France.
FAU - Oppenheim, Catherine
AU  - Oppenheim C
AUID- ORCID: 0000-0003-3410-0862
AD  - Institut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM U 1266, 
      IMA-BRAIN, Paris, France.
AD  - Université Paris Cité, Paris, France.
AD  - Service de Neuroradiologie, GHU Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte-Anne, Paris, France.
FAU - Benzakoun, Joseph
AU  - Benzakoun J
AUID- ORCID: 0000-0002-0733-0104
AD  - Institut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM U 1266, 
      IMA-BRAIN, Paris, France. j.benzakoun@ghu-paris.fr.
AD  - Service de Neuroradiologie, GHU Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte-Anne, Paris, France. j.benzakoun@ghu-paris.fr.
LA  - eng
PT  - Journal Article
DEP - 20220906
PL  - United States
TA  - J Neurooncol
JT  - Journal of neuro-oncology
JID - 8309335
RN  - 0 (Progestins)
SB  - IM
MH  - Humans
MH  - Aged
MH  - *Meningioma/chemically induced/epidemiology
MH  - Progestins/adverse effects
MH  - Prospective Studies
MH  - Magnetic Resonance Imaging
MH  - *Meningeal Neoplasms/chemically induced/diagnostic imaging/epidemiology
OTO - NOTNLM
OT  - Chlormadinone acetate
OT  - Cyproterone acetate
OT  - Mass screening
OT  - Meningioma
OT  - Nomegestrol acetate
EDAT- 2022/09/07 06:00
MHDA- 2022/11/03 06:00
CRDT- 2022/09/06 11:20
PHST- 2022/08/04 00:00 [received]
PHST- 2022/08/26 00:00 [accepted]
PHST- 2022/09/07 06:00 [pubmed]
PHST- 2022/11/03 06:00 [medline]
PHST- 2022/09/06 11:20 [entrez]
AID - 10.1007/s11060-022-04124-2 [pii]
AID - 10.1007/s11060-022-04124-2 [doi]
PST - ppublish
SO  - J Neurooncol. 2022 Oct;160(1):127-136. doi: 10.1007/s11060-022-04124-2. Epub 2022 
      Sep 6.

PMID- 35502259
OWN - NLM
STAT- MEDLINE
DCOM- 20220504
LR  - 20220802
IS  - 0008-5286 (Print)
IS  - 0008-5286 (Linking)
VI  - 63
IP  - 5
DP  - 2022 May
TI  - Quebec: Avian pathogens identification and genomic characterization: 2021 annual 
      review of the Molecular Diagnostic Laboratory, Université de Montréal.
PG  - 486-490
FAU - Gagnon, Carl A
AU  - Gagnon CA
AD  - Swine and Poultry Infectious Diseases Research Center (CRIPA-FRQ) (Gagnon); 
      Molecular Diagnostic Laboratory (MDL) of Centre de diagnostic vétérinaire de 
      l'Université de Montréal (CDVUM) (Gagnon, Bournival, Koszegi, Nantel-Fortier, 
      St-Sauveur, Provost); Centre québécois sur la santé des animaux sauvages 
      (CQSAS)/Canadian Wildlife Health Cooperative (Lair); Faculté de médecine 
      vétérinaire (FMV), Université de Montréal, St-Hyacinthe, Québec, Canada.
FAU - Bournival, Véronique
AU  - Bournival V
AD  - Swine and Poultry Infectious Diseases Research Center (CRIPA-FRQ) (Gagnon); 
      Molecular Diagnostic Laboratory (MDL) of Centre de diagnostic vétérinaire de 
      l'Université de Montréal (CDVUM) (Gagnon, Bournival, Koszegi, Nantel-Fortier, 
      St-Sauveur, Provost); Centre québécois sur la santé des animaux sauvages 
      (CQSAS)/Canadian Wildlife Health Cooperative (Lair); Faculté de médecine 
      vétérinaire (FMV), Université de Montréal, St-Hyacinthe, Québec, Canada.
FAU - Koszegi, Marika
AU  - Koszegi M
AD  - Swine and Poultry Infectious Diseases Research Center (CRIPA-FRQ) (Gagnon); 
      Molecular Diagnostic Laboratory (MDL) of Centre de diagnostic vétérinaire de 
      l'Université de Montréal (CDVUM) (Gagnon, Bournival, Koszegi, Nantel-Fortier, 
      St-Sauveur, Provost); Centre québécois sur la santé des animaux sauvages 
      (CQSAS)/Canadian Wildlife Health Cooperative (Lair); Faculté de médecine 
      vétérinaire (FMV), Université de Montréal, St-Hyacinthe, Québec, Canada.
FAU - Nantel-Fortier, Nicolas
AU  - Nantel-Fortier N
AD  - Swine and Poultry Infectious Diseases Research Center (CRIPA-FRQ) (Gagnon); 
      Molecular Diagnostic Laboratory (MDL) of Centre de diagnostic vétérinaire de 
      l'Université de Montréal (CDVUM) (Gagnon, Bournival, Koszegi, Nantel-Fortier, 
      St-Sauveur, Provost); Centre québécois sur la santé des animaux sauvages 
      (CQSAS)/Canadian Wildlife Health Cooperative (Lair); Faculté de médecine 
      vétérinaire (FMV), Université de Montréal, St-Hyacinthe, Québec, Canada.
FAU - St-Sauveur, Valérie Grenier
AU  - St-Sauveur VG
AD  - Swine and Poultry Infectious Diseases Research Center (CRIPA-FRQ) (Gagnon); 
      Molecular Diagnostic Laboratory (MDL) of Centre de diagnostic vétérinaire de 
      l'Université de Montréal (CDVUM) (Gagnon, Bournival, Koszegi, Nantel-Fortier, 
      St-Sauveur, Provost); Centre québécois sur la santé des animaux sauvages 
      (CQSAS)/Canadian Wildlife Health Cooperative (Lair); Faculté de médecine 
      vétérinaire (FMV), Université de Montréal, St-Hyacinthe, Québec, Canada.
FAU - Provost, Chantale
AU  - Provost C
AD  - Swine and Poultry Infectious Diseases Research Center (CRIPA-FRQ) (Gagnon); 
      Molecular Diagnostic Laboratory (MDL) of Centre de diagnostic vétérinaire de 
      l'Université de Montréal (CDVUM) (Gagnon, Bournival, Koszegi, Nantel-Fortier, 
      St-Sauveur, Provost); Centre québécois sur la santé des animaux sauvages 
      (CQSAS)/Canadian Wildlife Health Cooperative (Lair); Faculté de médecine 
      vétérinaire (FMV), Université de Montréal, St-Hyacinthe, Québec, Canada.
FAU - Lair, Stéphane
AU  - Lair S
AD  - Swine and Poultry Infectious Diseases Research Center (CRIPA-FRQ) (Gagnon); 
      Molecular Diagnostic Laboratory (MDL) of Centre de diagnostic vétérinaire de 
      l'Université de Montréal (CDVUM) (Gagnon, Bournival, Koszegi, Nantel-Fortier, 
      St-Sauveur, Provost); Centre québécois sur la santé des animaux sauvages 
      (CQSAS)/Canadian Wildlife Health Cooperative (Lair); Faculté de médecine 
      vétérinaire (FMV), Université de Montréal, St-Hyacinthe, Québec, Canada.
LA  - eng
PT  - Journal Article
PL  - Canada
TA  - Can Vet J
JT  - The Canadian veterinary journal = La revue veterinaire canadienne
JID - 0004653
SB  - IM
MH  - Animals
MH  - *Genomics
MH  - Laboratories
MH  - *Pathology, Molecular
MH  - Quebec
PMC - PMC9009753
EDAT- 2022/05/04 06:00
MHDA- 2022/05/06 06:00
CRDT- 2022/05/03 02:06
PHST- 2022/05/03 02:06 [entrez]
PHST- 2022/05/04 06:00 [pubmed]
PHST- 2022/05/06 06:00 [medline]
AID - cvj_05_486 [pii]
PST - ppublish
SO  - Can Vet J. 2022 May;63(5):486-490.

PMID- 35297683
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220423
IS  - 2576-098X (Electronic)
IS  - 2576-098X (Linking)
VI  - 11
IP  - 4
DP  - 2022 Apr 21
TI  - Coding-Complete Genome Sequence of a Falcon aviadenovirus A Strain Associated 
      with Necrotizing Hepatitis in an American Kestrel (Falco sparverius).
PG  - e0000922
LID - 10.1128/mra.00009-22 [doi]
LID - e00009-22
AB  - A necropsy was performed on an American kestrel (Falco sparverius) with 
      necrotizing hepatitis associated with inclusion bodies, suggesting an adenovirus 
      infection. A next-generation sequencing assay was conducted on the liver, and the 
      coding-complete genome sequence of a Falcon aviadenovirus A strain was revealed.
FAU - Gagnon, Carl A
AU  - Gagnon CA
AUID- ORCID: 0000-0003-4528-541X
AD  - Swine and Poultry Infectious Diseases Research Center, Faculté de Médecine 
      Vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada.
AD  - Centre de Diagnostic Vétérinaire de l'Université de Montréal, Faculté de Médecine 
      Vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada.
FAU - Provost, Chantale
AU  - Provost C
AUID- ORCID: 0000-0002-6674-1157
AD  - Centre de Diagnostic Vétérinaire de l'Université de Montréal, Faculté de Médecine 
      Vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada.
FAU - Lair, Stéphane
AU  - Lair S
AD  - Centre de Diagnostic Vétérinaire de l'Université de Montréal, Faculté de Médecine 
      Vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada.
AD  - Centre Québécois sur la Santé des Animaux Sauvages-Canadian Wildlife Health 
      Cooperative, Faculté de Médecine Vétérinaire, Université de Montréal, 
      Saint-Hyacinthe, Québec, Canada.
LA  - eng
PT  - Journal Article
DEP - 20220317
PL  - United States
TA  - Microbiol Resour Announc
JT  - Microbiology resource announcements
JID - 101728794
PMC - PMC9022515
COIS- The authors declare no conflict of interest.
EDAT- 2022/03/18 06:00
MHDA- 2022/03/18 06:01
CRDT- 2022/03/17 12:12
PHST- 2022/03/18 06:00 [pubmed]
PHST- 2022/03/18 06:01 [medline]
PHST- 2022/03/17 12:12 [entrez]
AID - MRA00009-22 [pii]
AID - mra.00009-22 [pii]
AID - 10.1128/mra.00009-22 [doi]
PST - ppublish
SO  - Microbiol Resour Announc. 2022 Apr 21;11(4):e0000922. doi: 10.1128/mra.00009-22. 
      Epub 2022 Mar 17.

PMID- 34427399
OWN - NLM
STAT- MEDLINE
DCOM- 20220929
LR  - 20221006
IS  - 1865-1682 (Electronic)
IS  - 1865-1674 (Print)
IS  - 1865-1674 (Linking)
VI  - 69
IP  - 5
DP  - 2022 Sep
TI  - First report and genomic characterization of a bovine-like coronavirus causing 
      enteric infection in an odd-toed non-ruminant species (Indonesian tapir, 
      Acrocodia indica) during an outbreak of winter dysentery in a zoo.
PG  - 3056-3065
LID - 10.1111/tbed.14300 [doi]
AB  - Bovine coronavirus (BCoV) is associated with three distinct clinical syndromes in 
      cattle that is, neonatal diarrhoea, haemorrhagic diarrhoea in adults (the 
      so-called winter dysentery syndrome, WD) and respiratory infections in cattle of 
      different ages. In addition, bovine-like CoVs have been detected in various 
      species including domestic and wild ruminants. However, bovine-like CoVs have not 
      been reported so far in odd-toed ungulates. We describe an outbreak of WD 
      associated with a bovine-like CoV affecting several captive wild ungulates, 
      including Indonesian tapirs (Acrocodia indica) an odd-toed ungulate species 
      (Perissodactyla) which, with even-toed ungulates species (Artiodactyla) form the 
      clade Euungulata. Genomic characterization of the CoV revealed that it was 
      closely related to BCoVs previously reported in America. This case illustrates 
      the adaptability of bovine-like CoVs to new species and the necessity of 
      continued surveillance of bovine-like CoVs in various species.
CI  - © 2021 Wiley-VCH GmbH.
FAU - Savard, Christian
AU  - Savard C
AD  - Biovet Inc., Saint-Hyacinthe, Québec, Canada.
FAU - Provost, Chantale
AU  - Provost C
AD  - Molecular diagnostic laboratory, Centre de diagnostic vétérinaire de l'Université 
      de Montréal (CDVUM), Faculté de médecine vétérinaire, Université de Montréal, 
      Saint-Hyacinthe, Québec, Canada.
FAU - Ariel, Olivier
AU  - Ariel O
AD  - Biovet Inc., Saint-Hyacinthe, Québec, Canada.
FAU - Morin, Samuel
AU  - Morin S
AD  - Bureau vétérinaire Iberville, Saint-Jean-sur-Richelieu, Québec, Canada.
FAU - Fredrickson, Richard
AU  - Fredrickson R
AD  - Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of 
      Illinois, Urbana, Illinois, USA.
FAU - Gagnon, Carl A
AU  - Gagnon CA
AD  - Molecular diagnostic laboratory, Centre de diagnostic vétérinaire de l'Université 
      de Montréal (CDVUM), Faculté de médecine vétérinaire, Université de Montréal, 
      Saint-Hyacinthe, Québec, Canada.
FAU - Broes, André
AU  - Broes A
AD  - Biovet Inc., Saint-Hyacinthe, Québec, Canada.
FAU - Wang, Leyi
AU  - Wang L
AUID- ORCID: 0000-0001-5813-9505
AD  - Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of 
      Illinois, Urbana, Illinois, USA.
LA  - eng
GR  - U18 FD006673/FD/FDA HHS/United States
GR  - U18 FD006866/FD/FDA HHS/United States
GR  - 1U18FD006866-01/FD/FDA HHS/United States
GR  - 1U18FD006673-01/FD/FDA HHS/United States
GR  - 1U18FD006673-01/FD/FDA HHS/United States
GR  - 1U18FD006866-01/FD/FDA HHS/United States
PT  - Journal Article
DEP - 20210831
PL  - Germany
TA  - Transbound Emerg Dis
JT  - Transboundary and emerging diseases
JID - 101319538
SB  - IM
MH  - Animals
MH  - Cattle
MH  - *Cattle Diseases/epidemiology
MH  - *Coronavirus/genetics
MH  - *Coronavirus Infections/epidemiology/veterinary
MH  - *Coronavirus, Bovine/genetics
MH  - Diarrhea/epidemiology/veterinary
MH  - Disease Outbreaks/veterinary
MH  - *Dysentery/epidemiology/veterinary
MH  - Genomics
MH  - Indonesia/epidemiology
MH  - Perissodactyla
MH  - Phylogeny
MH  - Ruminants
PMC - PMC8943714
MID - NIHMS1788929
OTO - NOTNLM
OT  - bovine-like CoV
OT  - diarrhoea
OT  - genomic characterization
OT  - tapir
COIS- CONFLICT OF INTEREST The authors declare no conflicts of interest.
EDAT- 2021/08/25 06:00
MHDA- 2022/09/30 06:00
CRDT- 2021/08/24 09:33
PHST- 2021/08/16 00:00 [revised]
PHST- 2021/05/20 00:00 [received]
PHST- 2021/08/22 00:00 [accepted]
PHST- 2021/08/25 06:00 [pubmed]
PHST- 2022/09/30 06:00 [medline]
PHST- 2021/08/24 09:33 [entrez]
AID - 10.1111/tbed.14300 [doi]
PST - ppublish
SO  - Transbound Emerg Dis. 2022 Sep;69(5):3056-3065. doi: 10.1111/tbed.14300. Epub 
      2021 Aug 31.

PMID- 35977653
OWN - NLM
STAT- MEDLINE
DCOM- 20220920
LR  - 20221015
IS  - 1567-7257 (Electronic)
IS  - 1567-1348 (Linking)
VI  - 104
DP  - 2022 Oct
TI  - Comparative full genome sequence analysis of wild-type and chicken embryo origin 
      vaccine-like infectious laryngotracheitis virus field isolates from Canada.
PG  - 105350
LID - S1567-1348(22)00147-2 [pii]
LID - 10.1016/j.meegid.2022.105350 [doi]
AB  - Infectious laryngotracheitis (ILT), caused by infectious laryngotracheitis virus 
      (ILTV), occurs sporadically in poultry flocks in Canada. Live attenuated chicken 
      embryo origin (CEO) vaccines are being used routinely to prevent and control ILTV 
      infections. However, ILT outbreaks still occur since vaccine strains could revert 
      to virulence in the field. In this study, 7 Canadian ILTV isolates linked to ILT 
      outbreaks across different time in Eastern Canada (Ontario; ON and Quebec; QC) 
      were whole genome sequenced. Phylogenetic analysis confirmed the close 
      relationship between the ON isolates and the CEO vaccines, whereas the QC 
      isolates clustered with strains previously known as CEO revertant and wild-type 
      ILTVs. Recombination network analysis of ILTV sequences revealed clear evidence 
      of historical recombination between ILTV strains circulating in Canada and other 
      geographical regions. The comparison of ON CEO clustered and QC CEO revertant 
      clustered isolates with the LT Blen® CEO vaccine reference sequence showed amino 
      acid differences in 5 and 12 open reading frames (ORFs), respectively. Similar 
      analysis revealed amino acid differences in 32 ORFs in QC wild-type isolates. 
      Compared to all CEO vaccine strains in the public domain, the QC wild-type 
      isolates showed 15 unique mutational sites leading to amino acid changes in 13 
      ORFs. Our outcomes add to the knowledge of the molecular mechanisms behind ILTV 
      genetic variance and provide genetic markers between wild-type and vaccine 
      strains.
CI  - Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
FAU - Elshafiee, Esraa A
AU  - Elshafiee EA
AD  - Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, 
      University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada; 
      Department of Zoonoses, Faculty of Veterinary Medicine, Cairo University, Giza 
      12211, Egypt.
FAU - Hassan, Mohamed S H
AU  - Hassan MSH
AD  - Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, 
      University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada; 
      Department of Poultry Diseases, Faculty of Veterinary Medicine, Assiut 
      University, Assiut 71515, Egypt.
FAU - Provost, Chantale
AU  - Provost C
AD  - Swine and Poultry Infectious Diseases Research Center (CRIPA - Fonds de Recherche 
      du Québec), Faculté de Médecine Vétérinaire, Université de Montréal, 3200 rue 
      Sicotte, Saint-Hyacinthe, QC J2S 2M2, Canada.
FAU - Gagnon, Carl A
AU  - Gagnon CA
AD  - Swine and Poultry Infectious Diseases Research Center (CRIPA - Fonds de Recherche 
      du Québec), Faculté de Médecine Vétérinaire, Université de Montréal, 3200 rue 
      Sicotte, Saint-Hyacinthe, QC J2S 2M2, Canada.
FAU - Ojkic, Davor
AU  - Ojkic D
AD  - Animal Health Laboratory, University of Guelph, Guelph, ON N1G 2W1, Canada.
FAU - Abdul-Careem, Mohamed Faizal
AU  - Abdul-Careem MF
AD  - Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, 
      University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada. 
      Electronic address: faizal.abdulcareem@ucalgary.ca.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20220814
PL  - Netherlands
TA  - Infect Genet Evol
JT  - Infection, genetics and evolution : journal of molecular epidemiology and 
      evolutionary genetics in infectious diseases
JID - 101084138
RN  - 0 (Amino Acids)
RN  - 0 (Genetic Markers)
RN  - 0 (Vaccines, Attenuated)
RN  - 0 (Viral Vaccines)
SB  - IM
MH  - Amino Acids/genetics
MH  - Animals
MH  - Chick Embryo
MH  - Chickens
MH  - Genetic Markers
MH  - *Herpesviridae Infections/epidemiology/veterinary
MH  - *Herpesvirus 1, Gallid/genetics
MH  - Ontario
MH  - Phylogeny
MH  - *Poultry Diseases
MH  - Sequence Analysis, DNA
MH  - Vaccines, Attenuated/genetics
MH  - *Viral Vaccines/genetics
OTO - NOTNLM
OT  - ILT CEO vaccine
OT  - Infectious laryngotracheitis virus (ILTV)
OT  - Phylogenetic analysis
OT  - Recombination
OT  - Whole genome sequencing
OT  - Wild-type ILTV
COIS- Declaration of Competing Interest The authors declare no conflict of interest.
EDAT- 2022/08/18 06:00
MHDA- 2022/09/21 06:00
CRDT- 2022/08/17 19:24
PHST- 2022/06/16 00:00 [received]
PHST- 2022/07/30 00:00 [revised]
PHST- 2022/08/09 00:00 [accepted]
PHST- 2022/08/18 06:00 [pubmed]
PHST- 2022/09/21 06:00 [medline]
PHST- 2022/08/17 19:24 [entrez]
AID - S1567-1348(22)00147-2 [pii]
AID - 10.1016/j.meegid.2022.105350 [doi]
PST - ppublish
SO  - Infect Genet Evol. 2022 Oct;104:105350. doi: 10.1016/j.meegid.2022.105350. Epub 
      2022 Aug 14.

PMID- 34487876
OWN - NLM
STAT- MEDLINE
DCOM- 20220201
LR  - 20220201
IS  - 2666-9919 (Electronic)
IS  - 2666-9919 (Linking)
VI  - 52
IP  - 1
DP  - 2022 Feb
TI  - Prevention and control of highly antibiotic-resistant bacteria in a Pacific 
      territory: Feedback from New Caledonia between 2004 and 2020.
PG  - 7-12
LID - S2666-9919(21)00489-9 [pii]
LID - 10.1016/j.idnow.2021.08.005 [doi]
AB  - OBJECTIVE: Carbapenemase-producing Enterobacteriaceae (CRE) and Enterococcus 
      faecium resistant to vancomycin (VRE) constitute major threats to public health 
      worldwide. The Pacific area is concerned and has implemented strategies to 
      control antimicrobial resistance (AMR). However, accurate epidemiological data 
      are rarely reported. Our study aimed to present the strategies applied to prevent 
      and control the spread of highly resistant bacteria in the Pacific territory of 
      New Caledonia. PATIENTS AND METHODS: Cohort prospective study of all cases of 
      highly resistant bacteria (HRB) isolated in New Caledonia from September 2004 to 
      December 2020. Evaluation of the impact of the infection control measures 
      implemented in healthcare settings: screening strategy, cohorting unit, IT tools 
      and control of antibiotic prescriptions. RESULTS: A total of 346 patients with 
      HRB were identified. Most of them (63.0%) were infected or colonized by VRE 
      (n=218) and 128 by CRE. While the number of CREs significantly increased from 
      2013 to 2020 (P<0.0001), control procedures have limited their dissemination. 
      Most patients were colonized by IMP-4-CRE (n=124/128). The incidence density of 
      VRE significantly decreased from 38.52 for 100,000 hospitalisation-days in 2015 
      to 4.19 for 100,000 hospitalisation-days in 2019 due to systematic screening of 
      patients before sanitary repatriation from Australia and cohorting 
      implementation. The risk of VRE diffusion is now well under control. CONCLUSIONS: 
      Our study confirms that it is possible to control the spread of AMR in a 
      circumscribed territory by means of a global control strategy involving 
      screening, cohorting unit, IT tools and antibiotic prescription controls.
CI  - Copyright © 2021. Published by Elsevier Masson SAS.
FAU - Colot, Julien
AU  - Colot J
AD  - Microbiology Laboratory, Centre Hospitalier Territorial, Gaston Bourret, BP J5 
      98849 Nouméa, New Caledonia; Institut Pasteur de Nouvelle-Calédonie, Nouméa, New 
      Caledonia. Electronic address: Julien.colot@cht.nc.
FAU - Fouquet, Claire
AU  - Fouquet C
AD  - Infection control unit, Centre Hospitalier Territorial, Nouméa, New Caledonia.
FAU - Ducrocq, Frédérique
AU  - Ducrocq F
AD  - New Caledonian Health authorities, Direction des affaires sanitaires et sociales 
      (DASS-NC), Nouméa, New Caledonia.
FAU - Chevalier, Sylvie
AU  - Chevalier S
AD  - Infection control unit, Centre Hospitalier Territorial, Nouméa, New Caledonia.
FAU - Le Provost, Christine
AU  - Le Provost C
AD  - Infection control unit, Centre Hospitalier Territorial, Nouméa, New Caledonia.
FAU - Cazorla, Cécile
AU  - Cazorla C
AD  - Infectious diseases Unit, Centre Hospitalier Territorial, Nouméa, New Caledonia.
FAU - Cheval, Camille
AU  - Cheval C
AD  - Pharmacy Unit, Centre Hospitalier Territorial, Nouméa, New Caledonia.
FAU - Fijalkowski, Caroline
AU  - Fijalkowski C
AD  - Pharmacy Unit, Centre Hospitalier Territorial, Nouméa, New Caledonia.
FAU - Gourinat, Ann-Claire
AU  - Gourinat AC
AD  - Microbiology Laboratory, Centre Hospitalier Territorial, Gaston Bourret, BP J5 
      98849 Nouméa, New Caledonia.
FAU - Biron, Antoine
AU  - Biron A
AD  - Microbiology Laboratory, Centre Hospitalier Territorial, Gaston Bourret, BP J5 
      98849 Nouméa, New Caledonia.
FAU - Goarant, Cyrille
AU  - Goarant C
AD  - Institut Pasteur de Nouvelle-Calédonie, Nouméa, New Caledonia.
FAU - Bourles, Alexandre
AU  - Bourles A
AD  - Institut Pasteur de Nouvelle-Calédonie, Nouméa, New Caledonia.
FAU - Marot, Benoît
AU  - Marot B
AD  - Intensive Care Unit, Centre Hospitalier Territorial, Nouméa, New Caledonia.
FAU - Saliou, Philippe
AU  - Saliou P
AD  - Institut Pasteur de Nouvelle-Calédonie, Nouméa, New Caledonia; Univ Brest, 
      Inserm, EFS, UMR 1078, GGB, 29200 Brest, France; Infection control unit, CHU de 
      Brest, 29200 Brest, France.
LA  - eng
PT  - Journal Article
DEP - 20210904
PL  - France
TA  - Infect Dis Now
JT  - Infectious diseases now
JID - 101775152
RN  - 0 (Anti-Bacterial Agents)
SB  - IM
MH  - *Anti-Bacterial Agents/therapeutic use
MH  - *Enterococcus faecium
MH  - Feedback
MH  - Humans
MH  - New Caledonia
MH  - Prospective Studies
OTO - NOTNLM
OT  - Carbapenem-resistant Enterobacteriaceae
OT  - Multi-drug-resistant bacteria
OT  - New Caledonia
OT  - Outbreak
OT  - Prevention
OT  - Vancomycin-resistant Enterococcus
EDAT- 2021/09/07 06:00
MHDA- 2022/02/02 06:00
CRDT- 2021/09/06 20:13
PHST- 2021/04/27 00:00 [received]
PHST- 2021/07/11 00:00 [revised]
PHST- 2021/08/27 00:00 [accepted]
PHST- 2021/09/07 06:00 [pubmed]
PHST- 2022/02/02 06:00 [medline]
PHST- 2021/09/06 20:13 [entrez]
AID - S2666-9919(21)00489-9 [pii]
AID - 10.1016/j.idnow.2021.08.005 [doi]
PST - ppublish
SO  - Infect Dis Now. 2022 Feb;52(1):7-12. doi: 10.1016/j.idnow.2021.08.005. Epub 2021 
      Sep 4.

PMID- 35230486
OWN - NLM
STAT- MEDLINE
DCOM- 20220414
LR  - 20220531
IS  - 1437-1596 (Electronic)
IS  - 0937-9827 (Linking)
VI  - 136
IP  - 3
DP  - 2022 May
TI  - Validation of a post-mortem computed tomography method for age estimation based 
      on the 4th rib in a French population.
PG  - 833-839
LID - 10.1007/s00414-022-02798-x [doi]
AB  - Age estimation is a key factor for identification procedure in forensic context. 
      Based on anthropological findings, degenerative changes of the sternal extremity 
      of the 4th rib are currently used for age estimation. These have been adapted to 
      post-mortem computed tomography (PMCT). The aim of this study was to validate a 
      post-mortem computed tomography method based on a revision of the Iscan's method 
      on a French sample. A total of 250 PMCT (aged from 18-98 years (IQR 36-68 years, 
      median 51 years); 68 (27%) females) from the Medicolegal Institute of Paris 
      (MLIP) were analyzed by two radiologists. The sternal extremity of 4th right rib 
      was scored using method adapted from Iscan et al. Weighted κ was used to evaluate 
      intra- and inter-observer reliability and Spearman correlation was performed to 
      evaluate relationship between age and score. Confidence intervals for individual 
      prediction of age based on 4th rib score and sex were computed with 
      bootstrapping. The intra-observer reliability and inter-observer reliability were 
      almost perfect (weighted κ = 0.85 [95%CI: 0.78-0.93] and 0.82 [95%CI 0.70-0.96] 
      respectively). We confirmed a high correlation between the 4th rib score and 
      subject age (rho = 0.72, p < 0.001), although the confidence intervals for 
      individual age prediction were large, spanning over several decades. This study 
      confirms the high reliability of Iscan method applied to PMCT for age estimation, 
      although future multimodal age prediction techniques may help reducing the span 
      of confidence intervals for individual age estimation.Trial registration: INDS 
      0,509,211,020, October 2020, retrospectively registered.
CI  - © 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, 
      part of Springer Nature.
FAU - Richard, Marie-Edith
AU  - Richard ME
AD  - Université de Paris, Paris, France.
AD  - Service de Neuroradiologie, GHU Paris Psychiatrie et Neurosciences, 1, Rue 
      Cabanis, 75014, Paris, France.
FAU - Delabarde, Tania
AU  - Delabarde T
AD  - Université de Paris, UMR8045 BABEL, CNRS, Paris, France.
AD  - Institut Médico-Légal de Paris, Paris, France.
AD  - Pôle Universitaire d'imagerie Post-Mortem, Université de Paris, Paris, France.
FAU - Hmeydia, Ghazi
AU  - Hmeydia G
AD  - Service de Neuroradiologie, GHU Paris Psychiatrie et Neurosciences, 1, Rue 
      Cabanis, 75014, Paris, France.
AD  - Institut de Psychiatrie et de Neurosciences de Paris, INSERM UMR 1266, IMA-BRAIN, 
      Paris, France.
FAU - Provost, Corentin
AU  - Provost C
AD  - Université de Paris, Paris, France.
AD  - Service de Neuroradiologie, GHU Paris Psychiatrie et Neurosciences, 1, Rue 
      Cabanis, 75014, Paris, France.
AD  - Institut de Psychiatrie et de Neurosciences de Paris, INSERM UMR 1266, IMA-BRAIN, 
      Paris, France.
FAU - de Jong, Laura
AU  - de Jong L
AD  - Service de Neuroradiologie, GHU Paris Psychiatrie et Neurosciences, 1, Rue 
      Cabanis, 75014, Paris, France.
AD  - Institut de Psychiatrie et de Neurosciences de Paris, INSERM UMR 1266, IMA-BRAIN, 
      Paris, France.
FAU - Hamza, Lilia
AU  - Hamza L
AD  - Institut Médico-Légal de Paris, Paris, France.
AD  - Pôle Universitaire d'imagerie Post-Mortem, Université de Paris, Paris, France.
FAU - Meder, Jean-François
AU  - Meder JF
AD  - Université de Paris, Paris, France.
AD  - Service de Neuroradiologie, GHU Paris Psychiatrie et Neurosciences, 1, Rue 
      Cabanis, 75014, Paris, France.
AD  - Institut de Psychiatrie et de Neurosciences de Paris, INSERM UMR 1266, IMA-BRAIN, 
      Paris, France.
FAU - Oppenheim, Catherine
AU  - Oppenheim C
AD  - Université de Paris, Paris, France.
AD  - Service de Neuroradiologie, GHU Paris Psychiatrie et Neurosciences, 1, Rue 
      Cabanis, 75014, Paris, France.
AD  - Institut de Psychiatrie et de Neurosciences de Paris, INSERM UMR 1266, IMA-BRAIN, 
      Paris, France.
FAU - Ludes, Bertrand
AU  - Ludes B
AD  - Université de Paris, UMR8045 BABEL, CNRS, Paris, France.
AD  - Institut Médico-Légal de Paris, Paris, France.
AD  - Pôle Universitaire d'imagerie Post-Mortem, Université de Paris, Paris, France.
FAU - Benzakoun, Joseph
AU  - Benzakoun J
AUID- ORCID: 0000-0002-0733-0104
AD  - Université de Paris, Paris, France. j.benzakoun@ghu-paris.fr.
AD  - Service de Neuroradiologie, GHU Paris Psychiatrie et Neurosciences, 1, Rue 
      Cabanis, 75014, Paris, France. j.benzakoun@ghu-paris.fr.
AD  - Institut de Psychiatrie et de Neurosciences de Paris, INSERM UMR 1266, IMA-BRAIN, 
      Paris, France. j.benzakoun@ghu-paris.fr.
LA  - eng
PT  - Journal Article
DEP - 20220301
PL  - Germany
TA  - Int J Legal Med
JT  - International journal of legal medicine
JID - 9101456
SB  - IM
MH  - *Age Determination by Skeleton/methods
MH  - Female
MH  - Humans
MH  - Reproducibility of Results
MH  - *Ribs/diagnostic imaging
MH  - Tomography
OTO - NOTNLM
OT  - Age estimation
OT  - Computed tomography
OT  - Forensic anthropology
OT  - Sternal rib
EDAT- 2022/03/02 06:00
MHDA- 2022/04/15 06:00
CRDT- 2022/03/01 12:17
PHST- 2021/08/18 00:00 [received]
PHST- 2022/02/09 00:00 [accepted]
PHST- 2022/03/02 06:00 [pubmed]
PHST- 2022/04/15 06:00 [medline]
PHST- 2022/03/01 12:17 [entrez]
AID - 10.1007/s00414-022-02798-x [pii]
AID - 10.1007/s00414-022-02798-x [doi]
PST - ppublish
SO  - Int J Legal Med. 2022 May;136(3):833-839. doi: 10.1007/s00414-022-02798-x. Epub 
      2022 Mar 1.

PMID- 34859737
OWN - NLM
STAT- MEDLINE
DCOM- 20220429
LR  - 20220626
IS  - 1540-7586 (Electronic)
IS  - 0734-7332 (Linking)
VI  - 40
IP  - 3
DP  - 2022
TI  - Articulating viewpoints to better define and respond to the needs of adolescents 
      and young adult survivors of pediatric brain tumors.
PG  - 347-365
LID - 10.1080/07347332.2021.2004291 [doi]
AB  - PURPOSE: Adolescents and young adult survivors of pediatric brain tumors 
      (AYA-PBTS) often experience difficulties with social skills, pursuit of studies 
      and employment. This study explored pediatric long-term survivors' perspective on 
      their post-treatment needs and ways to improve resources and interventions. 
      METHODS: We used an original method of three sequential focus group interviews by 
      adding the perspectives of survivors (15-22 years), parents and health 
      professionals (total N = 22). Participants were recruited using purposive 
      sampling from the long-term follow-up clinic at a Canadian tertiary hospital. We 
      used computer-assisted analysis to draw themes from each group and compare 
      thematic content across groups. RESULTS: Categorization of participants' 
      responses resulted in three domains: personal life, education and work. 
      Participants mentioned the improvement of communication tools to facilitate 
      access to timely information, the organization of counseling to improve 
      employment integration, and tailoring interventions to optimize the return to 
      daily activities in aftercare. Subsequent inductive analysis revealed three 
      overarching trends among groups: multipurpose social networking, 
      AYA-PBTS-specific information websites and transition tools and procedures. 
      CONCLUSION AND IMPLICATIONS FOR PSYCHOSOCIAL PROVIDERS: This study identified 
      solutions for AYA-PBTS' specific needs in aftercare. This population needs 
      up-to-date post-treatment information and refined outreach procedures. Future 
      research should define and prioritize these suggested solutions.
FAU - Bonanno, Marco
AU  - Bonanno M
AUID- ORCID: 0000-0002-5816-0301
AD  - Hematology-Oncology Department, Sainte-Justine University Hospital Center, 
      Montreal, Canada.
AD  - Psycho-Oncology Center (CPO), Sainte-Justine University Hospital Research Center, 
      Montreal, Canada.
FAU - Bourque, Claude Julie
AU  - Bourque CJ
AD  - Psycho-Oncology Center (CPO), Sainte-Justine University Hospital Research Center, 
      Montreal, Canada.
AD  - Department of Pediatrics, Université de Montréal, Montreal, Canada.
FAU - Aramideh, Jennifer
AU  - Aramideh J
AD  - Psycho-Oncology Center (CPO), Sainte-Justine University Hospital Research Center, 
      Montreal, Canada.
AD  - Department of Psychology, Université de Montréal, Montreal, Canada.
FAU - Cloutier, Nancy
AU  - Cloutier N
AD  - Hematology-Oncology Department, Sainte-Justine University Hospital Center, 
      Montreal, Canada.
FAU - Dumont, Émilie
AU  - Dumont É
AD  - Psycho-Oncology Center (CPO), Sainte-Justine University Hospital Research Center, 
      Montreal, Canada.
FAU - Gomez-Tyo, Mathias
AU  - Gomez-Tyo M
AD  - Leucan - The Association for children with cancer, Montréal, Canada.
FAU - Julien-Lacoste, Ariane
AU  - Julien-Lacoste A
AD  - Psycho-Oncology Center (CPO), Sainte-Justine University Hospital Research Center, 
      Montreal, Canada.
FAU - Košir, Urška
AU  - Košir U
AUID- ORCID: 0000-0003-2132-4090
AD  - Department of Experimental Psychology, University of Oxford, Oxford, United 
      Kingdom.
FAU - Provost, Carole
AU  - Provost C
AD  - Hematology-Oncology Department, Sainte-Justine University Hospital Center, 
      Montreal, Canada.
FAU - Laverdière, Caroline
AU  - Laverdière C
AD  - Hematology-Oncology Department, Sainte-Justine University Hospital Center, 
      Montreal, Canada.
AD  - Department of Pediatrics, Université de Montréal, Montreal, Canada.
FAU - Sultan, Serge
AU  - Sultan S
AUID- ORCID: 0000-0002-7520-1734
AD  - Psycho-Oncology Center (CPO), Sainte-Justine University Hospital Research Center, 
      Montreal, Canada.
AD  - Department of Psychology, Université de Montréal, Montreal, Canada.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20211203
PL  - United States
TA  - J Psychosoc Oncol
JT  - Journal of psychosocial oncology
JID - 8309337
SB  - IM
MH  - Adolescent
MH  - Aftercare/psychology
MH  - *Brain Neoplasms/psychology/therapy
MH  - Canada
MH  - *Cancer Survivors/psychology
MH  - Child
MH  - Humans
MH  - *Neoplasms/psychology
MH  - Survivors
MH  - Young Adult
OTO - NOTNLM
OT  - adolescent/young adult
OT  - brain tumor
OT  - health-care provider
OT  - qualitative research
OT  - survivorship
OT  - unmet needs
EDAT- 2021/12/04 06:00
MHDA- 2022/04/30 06:00
CRDT- 2021/12/03 08:42
PHST- 2021/12/04 06:00 [pubmed]
PHST- 2022/04/30 06:00 [medline]
PHST- 2021/12/03 08:42 [entrez]
AID - 10.1080/07347332.2021.2004291 [doi]
PST - ppublish
SO  - J Psychosoc Oncol. 2022;40(3):347-365. doi: 10.1080/07347332.2021.2004291. Epub 
      2021 Dec 3.

PMID- 35759152
OWN - NLM
STAT- MEDLINE
DCOM- 20220830
LR  - 20220830
IS  - 1573-7373 (Electronic)
IS  - 0167-594X (Linking)
VI  - 159
IP  - 2
DP  - 2022 Sep
TI  - Accuracy and safety of 101 consecutives neurosurgical procedures for newly 
      diagnosed central nervous system lymphomas: a single-institution experience.
PG  - 347-358
LID - 10.1007/s11060-022-04069-6 [doi]
AB  - INTRODUCTION: Brain surgery is required to ascertain the diagnosis of central 
      nervous system lymphoma. We assessed the diagnostic yield and safety of the 
      surgical procedures, the predictors of postoperative morbidity, and of overall 
      survival. METHODS: Observational single-institution retrospective cohort study 
      (1992-2020) of 101 consecutive adult patients who underwent stereotactic biopsy, 
      open biopsy, or resection for a newly diagnosed central nervous system lymphoma. 
      RESULTS: The diagnostic yield was 100% despite preoperative steroid 
      administration in 48/101 cases (47.5%). A preoperative Karnofsky Performance 
      Status score less than 70 (p = 0.006) was an independent predictor of a new 
      postoperative focal neurological deficit (7/101 cases, 6.9%). A previous history 
      of hematological malignancy (p = 0.049), age 65 years or more (p = 0.031), and 
      new postoperative neurological deficit (p < 0.001) were independent predictors of 
      a Karnofsky Performance Status score decrease 20 points or more postoperatively 
      (13/101 cases, 12.9%). A previous history of hematological malignancy 
      (p = 0.034), and preoperative Karnofsky Performance Status score less than 70 
      (p = 0.024) were independent predictors of postoperative hemorrhage (13/101 
      cases, 12.9%). A preoperative Karnofsky Performance Status score less than 70 
      (p = 0.019), and a previous history of hematological malignancy (p = 0.014) were 
      independent predictors of death during hospital stay (8/101 cases, 7.9%). In the 
      82 immunocompetent patients harboring a primary central nervous system lymphoma, 
      age 65 years or more (p = 0.044), and time to hematological treatment more than 
      21 days (p = 0.008), were independent predictors of a shorter overall survival. A 
      dedicated hematological treatment (p < 0.001) was an independent predictor of a 
      longer overall survival. CONCLUSION: Brain biopsy is feasible with low morbidity 
      for central nervous system lymphomas. Postoperatively, patients should be 
      promptly referred for hematological treatment initiation.
CI  - © 2022. The Author(s), under exclusive licence to Springer Science+Business 
      Media, LLC, part of Springer Nature.
FAU - Aliouat, Ilyes
AU  - Aliouat I
AD  - Department of Neurosurgery, GHU-Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte Anne, 1 rue Cabanis, 75014, Paris Cedex 14, France.
AD  - Institute of Psychiatry and Neuroscience of Paris, IMABRAIN, INSERM U1266, 
      Université de Paris, F-75014, Paris, France.
FAU - Moiraghi, Alessandro
AU  - Moiraghi A
AD  - Department of Neurosurgery, GHU-Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte Anne, 1 rue Cabanis, 75014, Paris Cedex 14, France.
AD  - Institute of Psychiatry and Neuroscience of Paris, IMABRAIN, INSERM U1266, 
      Université de Paris, F-75014, Paris, France.
FAU - Simboli, Giorgia Antonia
AU  - Simboli GA
AD  - Department of Neurosurgery, GHU-Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte Anne, 1 rue Cabanis, 75014, Paris Cedex 14, France.
AD  - Institute of Psychiatry and Neuroscience of Paris, IMABRAIN, INSERM U1266, 
      Université de Paris, F-75014, Paris, France.
FAU - Birsen, Rudy
AU  - Birsen R
AD  - Hematology Department, Cochin Hospital, Assistance Publique-Hôpitaux de Paris 
      (AP-HP), Paris, France.
FAU - Elia, Angela
AU  - Elia A
AD  - Department of Neurosurgery, GHU-Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte Anne, 1 rue Cabanis, 75014, Paris Cedex 14, France.
AD  - Institute of Psychiatry and Neuroscience of Paris, IMABRAIN, INSERM U1266, 
      Université de Paris, F-75014, Paris, France.
AD  - Neurosurgery Unit, Department of Surgical Sciences, Fondazione IRCCS Policlinico 
      San Matteo, Pavia, Italy.
FAU - Roux, Alexandre
AU  - Roux A
AD  - Department of Neurosurgery, GHU-Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte Anne, 1 rue Cabanis, 75014, Paris Cedex 14, France.
AD  - Institute of Psychiatry and Neuroscience of Paris, IMABRAIN, INSERM U1266, 
      Université de Paris, F-75014, Paris, France.
FAU - Tamburini, Jérôme
AU  - Tamburini J
AD  - Hematology Department, Cochin Hospital, Assistance Publique-Hôpitaux de Paris 
      (AP-HP), Paris, France.
FAU - Dezamis, Edouard
AU  - Dezamis E
AD  - Department of Neurosurgery, GHU-Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte Anne, 1 rue Cabanis, 75014, Paris Cedex 14, France.
FAU - Parraga, Eduardo
AU  - Parraga E
AD  - Department of Neurosurgery, GHU-Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte Anne, 1 rue Cabanis, 75014, Paris Cedex 14, France.
FAU - Benevello, Chiara
AU  - Benevello C
AD  - Department of Neurosurgery, GHU-Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte Anne, 1 rue Cabanis, 75014, Paris Cedex 14, France.
AD  - Institute of Psychiatry and Neuroscience of Paris, IMABRAIN, INSERM U1266, 
      Université de Paris, F-75014, Paris, France.
FAU - Damotte, Diane
AU  - Damotte D
AD  - Pathology Department, Cochin Hospital, Assistance Publique-Hôpitaux de Paris 
      (AP-HP), Paris, France.
FAU - Provost, Corentin
AU  - Provost C
AD  - Institute of Psychiatry and Neuroscience of Paris, IMABRAIN, INSERM U1266, 
      Université de Paris, F-75014, Paris, France.
AD  - Department of Neuroradiology, GHU-Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte Anne, 75014, Paris, France.
FAU - Oppenheim, Catherine
AU  - Oppenheim C
AD  - Institute of Psychiatry and Neuroscience of Paris, IMABRAIN, INSERM U1266, 
      Université de Paris, F-75014, Paris, France.
AD  - Department of Neuroradiology, GHU-Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte Anne, 75014, Paris, France.
FAU - Bouscary, Didier
AU  - Bouscary D
AD  - Hematology Department, Cochin Hospital, Assistance Publique-Hôpitaux de Paris 
      (AP-HP), Paris, France.
FAU - Chretien, Fabrice
AU  - Chretien F
AD  - Department of Neuropathology, GHU-Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte Anne, 75014, Paris, France.
FAU - Zanello, Marc
AU  - Zanello M
AD  - Department of Neurosurgery, GHU-Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte Anne, 1 rue Cabanis, 75014, Paris Cedex 14, France.
AD  - Institute of Psychiatry and Neuroscience of Paris, IMABRAIN, INSERM U1266, 
      Université de Paris, F-75014, Paris, France.
FAU - Pallud, Johan
AU  - Pallud J
AD  - Department of Neurosurgery, GHU-Paris Psychiatrie et Neurosciences, Hôpital 
      Sainte Anne, 1 rue Cabanis, 75014, Paris Cedex 14, France. 
      johanpallud@hotmail.com.
AD  - Institute of Psychiatry and Neuroscience of Paris, IMABRAIN, INSERM U1266, 
      Université de Paris, F-75014, Paris, France. johanpallud@hotmail.com.
LA  - eng
PT  - Journal Article
PT  - Observational Study
DEP - 20220627
PL  - United States
TA  - J Neurooncol
JT  - Journal of neuro-oncology
JID - 8309335
SB  - IM
MH  - Adult
MH  - Aged
MH  - *Brain Neoplasms
MH  - Central Nervous System
MH  - *Hematologic Neoplasms
MH  - Humans
MH  - *Lymphoma
MH  - Neurosurgical Procedures
MH  - Retrospective Studies
MH  - Treatment Outcome
OTO - NOTNLM
OT  - Biopsy
OT  - Efficacy
OT  - Lymphoma
OT  - Safety
OT  - Steroid
OT  - Surgery
EDAT- 2022/06/28 06:00
MHDA- 2022/08/31 06:00
CRDT- 2022/06/27 11:23
PHST- 2022/05/04 00:00 [received]
PHST- 2022/06/13 00:00 [accepted]
PHST- 2022/06/28 06:00 [pubmed]
PHST- 2022/08/31 06:00 [medline]
PHST- 2022/06/27 11:23 [entrez]
AID - 10.1007/s11060-022-04069-6 [pii]
AID - 10.1007/s11060-022-04069-6 [doi]
PST - ppublish
SO  - J Neurooncol. 2022 Sep;159(2):347-358. doi: 10.1007/s11060-022-04069-6. Epub 2022 
      Jun 27.

PMID- 35189413
OWN - NLM
STAT- MEDLINE
DCOM- 20220308
LR  - 20220308
IS  - 1873-3573 (Electronic)
IS  - 0039-9140 (Linking)
VI  - 242
DP  - 2022 May 15
TI  - Untargeted and targeted metabolomics reveal that adenosine nucleotides released 
      in Actinobacillus pleuropneumoniae supernatant inhibit porcine reproductive and 
      respiratory syndrome virus replication.
PG  - 123315
LID - S0039-9140(22)00111-4 [pii]
LID - 10.1016/j.talanta.2022.123315 [doi]
AB  - Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the most 
      devastating viruses in the swine industry and causes major economic losses. To 
      date, there has not been an effective antiviral treatment for the disease. We 
      have shown in previous studies that culture supernatant of Actinobacillus 
      pleuropneumoniae (App), the causative agent of porcine pleuropneumonia, possesses 
      antiviral activity in vitro against PRRSV, and we have clearly established that 
      the antiviral activity was mediated by small molecular weight (i.e., <1 kDa), 
      heat resistant metabolites present in the App supernatant ultrafiltrates. 
      However, the identity of those metabolites remains unknown. The objective of the 
      current study was to identify the active metabolites using untargeted and 
      targeted mass spectrometry-based metabolomics and test their respective antiviral 
      activity against PRRSV in the Jude Porcine Lung Epithelial Cell Line (SJPL). The 
      results presented reveal very significant antiviral activity of App supernatant 
      ultrafiltrates against PRRSV in SJPL cells. Consequently, we identified and 
      quantified several adenosine nucleotide metabolites present in App supernatant 
      ultrafiltrates using mass spectrometry-based metabolomics, and the concentrations 
      detected were very high. SJPL cells infected with PRRSV and treated with 
      2'-adenosine monophosphate (2-AMP), 3'-adenosine monophosphate (3-AMP) or 
      5'-adenosine monophosphate (5-AMP) significantly reduced PRRSV infection. 
      Interestingly, many antiviral drugs or prodrugs are adenosine analogs, and the 
      mechanism of action was previously elucidated. Currently marketed nucleoside 
      analog drugs could potentially be used to treat PRRSV infection.
CI  - Copyright © 2022 Elsevier B.V. All rights reserved.
FAU - Salmin, Abdulrahman Fuad
AU  - Salmin AF
AD  - Centre de Recherche en Infectiologie Porcine et Avicole (CRIPA-FRQ), Faculté de 
      Médecine Vétérinaire, Université de Montréal, Canada; Département de Biomédecine 
      Vétérinaire Faculté de Médecine Vétérinaire, Université de Montréal, Canada.
FAU - Pesant, Marie-Jeanne
AU  - Pesant MJ
AD  - Centre de Recherche en Infectiologie Porcine et Avicole (CRIPA-FRQ), Faculté de 
      Médecine Vétérinaire, Université de Montréal, Canada.
FAU - Burgher, Yaima
AU  - Burgher Y
AD  - Centre de Recherche en Infectiologie Porcine et Avicole (CRIPA-FRQ), Faculté de 
      Médecine Vétérinaire, Université de Montréal, Canada.
FAU - Provost, Chantale
AU  - Provost C
AD  - Centre de Recherche en Infectiologie Porcine et Avicole (CRIPA-FRQ), Faculté de 
      Médecine Vétérinaire, Université de Montréal, Canada; Molecular diagnostic 
      laboratory, Centre de diagnostic vétérinaire de l'Université de Montréal, Canada.
FAU - Labrie, Josée
AU  - Labrie J
AD  - Groupe de Recherche sur Les Maladies Infectieuses en Production Animale (GREMIP), 
      Faculté de Médecine Vétérinaire, Université de Montréal, Canada.
FAU - Jacques, Mario
AU  - Jacques M
AD  - Groupe de Recherche sur Les Maladies Infectieuses en Production Animale (GREMIP), 
      Faculté de Médecine Vétérinaire, Université de Montréal, Canada.
FAU - Gagnon, Carl A
AU  - Gagnon CA
AD  - Centre de Recherche en Infectiologie Porcine et Avicole (CRIPA-FRQ), Faculté de 
      Médecine Vétérinaire, Université de Montréal, Canada; Molecular diagnostic 
      laboratory, Centre de diagnostic vétérinaire de l'Université de Montréal, Canada.
FAU - Beaudry, Francis
AU  - Beaudry F
AD  - Centre de Recherche en Infectiologie Porcine et Avicole (CRIPA-FRQ), Faculté de 
      Médecine Vétérinaire, Université de Montréal, Canada; Département de Biomédecine 
      Vétérinaire Faculté de Médecine Vétérinaire, Université de Montréal, Canada; 
      Centre de Recherche sur le Cerveau et L'apprentissage (CIRCA), Université de 
      Montréal, Montréal, QC, Canada. Electronic address: francis.beaudry@umontreal.ca.
LA  - eng
PT  - Journal Article
DEP - 20220212
PL  - Netherlands
TA  - Talanta
JT  - Talanta
JID - 2984816R
RN  - 0 (Antiviral Agents)
RN  - 0 (Nucleotides)
RN  - K72T3FS567 (Adenosine)
SB  - IM
MH  - *Actinobacillus pleuropneumoniae/metabolism
MH  - Adenosine/pharmacology
MH  - Animals
MH  - Antiviral Agents/pharmacology
MH  - Metabolomics
MH  - Nucleotides
MH  - *Porcine respiratory and reproductive syndrome virus/metabolism
MH  - Swine
MH  - Virus Replication
OTO - NOTNLM
OT  - Actinobacillus pleuropneumoniae (App)
OT  - Adenosine nucleosides
OT  - Antiviral
OT  - High-performance liquid chromatography
OT  - Mass spectrometry
OT  - Metabolomics
OT  - Porcine reproductive and respiratory syndrome virus (PRRSV)
OT  - St. jude porcine lung epithelial cell line (SJPL)
EDAT- 2022/02/22 06:00
MHDA- 2022/03/09 06:00
CRDT- 2022/02/21 20:11
PHST- 2021/09/27 00:00 [received]
PHST- 2022/02/04 00:00 [revised]
PHST- 2022/02/06 00:00 [accepted]
PHST- 2022/02/22 06:00 [pubmed]
PHST- 2022/03/09 06:00 [medline]
PHST- 2022/02/21 20:11 [entrez]
AID - S0039-9140(22)00111-4 [pii]
AID - 10.1016/j.talanta.2022.123315 [doi]
PST - ppublish
SO  - Talanta. 2022 May 15;242:123315. doi: 10.1016/j.talanta.2022.123315. Epub 2022 
      Feb 12.

PMID- 35104340
OWN - NLM
STAT- MEDLINE
DCOM- 20220428
LR  - 20220611
IS  - 1943-3700 (Electronic)
IS  - 0090-3558 (Linking)
VI  - 58
IP  - 2
DP  - 2022 Apr 1
TI  - IN SITU HYBRIDIZATION AND VIRUS CHARACTERIZATION OF SKUNK ADENOVIRUS IN NORTH 
      AMERICAN WILDLIFE REVEALS MULTISYSTEMIC INFECTIONS IN A BROAD RANGE OF HOSTS.
PG  - 356-367
LID - 10.7589/JWD-D-21-00099 [doi]
AB  - Skunk adenovirus-1 (SkAdV-1) has been reported infecting several North American 
      wildlife species; however, lesions associated with disease have not yet been 
      completely characterized, particularly in porcupines. We describe and 
      characterize the tissue distribution and lesions associated with SkAdV-1 
      infection in 24 wildlife diagnostic cases submitted between 2015 and 2020, 
      including 16 North American porcupines (Erethizon dorsatum), three striped skunks 
      (Mephitis mephitis), and five raccoons (Procyon lotor), which constitute a new 
      host species. The most common lesion in all species was severe necrotizing 
      bronchopneumonia with (n=12) or without (n=10) interstitial involvement. 
      Intranuclear inclusion bodies were common in respiratory epithelium (n=21) and 
      less often in renal tubular (n=6) and biliary epithelium (n=1). Several cases 
      (n=4) had secondary bacterial infections, including Bordetella bronchiseptica, 
      Pasteurella multocida, and Streptococcus zooepidemicus. In situ hybridization in 
      porcupine (n=6), raccoon (n=1), and skunk (n=1) revealed SkAdV-1 DNA in multiple 
      tissue types, including lung, trachea, turbinates, liver, kidney, lymph node, and 
      brain, and multiple cell types including epithelial, endothelial, and mesothelial 
      cells. These findings were consistent across species. Comparison of viral genomes 
      from a porcupine and a raccoon with that originally isolated from a skunk 
      demonstrated DNA point mutations affecting several viral genes, including the 
      fiber protein gene. Our findings show the spectrum of disease associated with 
      SkAdV-1 infection in a broad host range of wildlife species.
CI  - © Wildlife Disease Association 2022.
FAU - Bourque, Laura
AU  - Bourque L
AD  - Canadian Wildlife Health Cooperative-Atlantic Region, University of Prince Edward 
      Island, 550 University Avenue, Charlottetown, Prince Edward Island C1A4P3, 
      Canada.
FAU - Nielsen, Ole
AU  - Nielsen O
AD  - Department of Fisheries and Oceans Canada, 501 University Crescent, Winnipeg, 
      Manitoba R3T 2N6, Canada.
FAU - Jager, Mason
AU  - Jager M
AD  - Department of Biomedical Sciences, Cornell University, 930 Campus Road, Ithaca, 
      New York 14853, USA.
FAU - Ojkic, Davor
AU  - Ojkic D
AD  - Animal Health Laboratory, 419 Gordon Street, Guelph, Ontario N1G 2W1, Canada.
FAU - Provost, Chantale
AU  - Provost C
AD  - Swine and Poultry Infectious Diseases Research Center and the Molecular 
      Diagnostic Laboratory, Faculté de médecine vétérinaire, Université de Montréal, 
      3200 Sicotte, Saint-Hyacinthe, Quebec J2S 2M2, Canada.
FAU - Gagnon, Carl A
AU  - Gagnon CA
AD  - Swine and Poultry Infectious Diseases Research Center and the Molecular 
      Diagnostic Laboratory, Faculté de médecine vétérinaire, Université de Montréal, 
      3200 Sicotte, Saint-Hyacinthe, Quebec J2S 2M2, Canada.
FAU - Lockerbie, Betty
AU  - Lockerbie B
AD  - Western College of Veterinary Medicine, 52 Campus Drive, Saskatoon, Saskatchewan 
      S7N 5B4, Canada.
FAU - Snyman, Hein
AU  - Snyman H
AD  - Animal Health Laboratory, 79 Shearer Street, Kemptville, Ontario K0G 1J0, Canada.
FAU - Stevens, Brian
AU  - Stevens B
AD  - Canadian Wildlife Health Cooperative-Ontario/Nunavut, University of Guelph, 50 
      Stone Road E, Guelph, Ontario N1G 2W1, Canada.
FAU - Needle, David
AU  - Needle D
AD  - New Hampshire Veterinary Diagnostic Laboratory, University of New Hampshire, 21 
      Botanical Lane, Durham, New Hampshire 03824-3590, USA.
FAU - Nakagun, Shotaro
AU  - Nakagun S
AD  - Department of Biomedical Sciences, Cornell University, 930 Campus Road, Ithaca, 
      New York 14853, USA.
FAU - Cox, Sherri
AU  - Cox S
AD  - Integrative Biology Department, College of Biological Science, University of 
      Guelph, 50 Stone Road E, Guelph, Ontario N1G 2W1, Canada.
FAU - Khodadad, Jessica
AU  - Khodadad J
AD  - Alberta Institute of Wildlife Conservation, Township Road 282 and Range Road 30, 
      Madden, Alberta T0M 1L0, Canada.
FAU - Jones, Megan E B
AU  - Jones MEB
AD  - Canadian Wildlife Health Cooperative-Atlantic Region, University of Prince Edward 
      Island, 550 University Avenue, Charlottetown, Prince Edward Island C1A4P3, 
      Canada.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Wildl Dis
JT  - Journal of wildlife diseases
JID - 0244160
SB  - IM
MH  - Adenoviridae
MH  - *Adenoviridae Infections/epidemiology/veterinary
MH  - Animals
MH  - Animals, Wild
MH  - In Situ Hybridization/veterinary
MH  - Mephitidae
MH  - North America
MH  - *Porcupines
MH  - Raccoons
MH  - *Rodent Diseases
OTO - NOTNLM
OT  - Adenovirus
OT  - North American porcupine
OT  - broad host range
OT  - bronchointerstitial pneumonia
OT  - in situ hybridization
OT  - pathology
OT  - wildlife rehabilitation
EDAT- 2022/02/02 06:00
MHDA- 2022/04/29 06:00
CRDT- 2022/02/01 17:10
PHST- 2021/06/08 00:00 [received]
PHST- 2021/11/08 00:00 [accepted]
PHST- 2022/02/02 06:00 [pubmed]
PHST- 2022/04/29 06:00 [medline]
PHST- 2022/02/01 17:10 [entrez]
AID - 477259 [pii]
AID - 10.7589/JWD-D-21-00099 [doi]
PST - ppublish
SO  - J Wildl Dis. 2022 Apr 1;58(2):356-367. doi: 10.7589/JWD-D-21-00099.

PMID- 34857663
OWN - NLM
STAT- MEDLINE
DCOM- 20220803
LR  - 20220826
IS  - 1535-5667 (Electronic)
IS  - 0161-5505 (Print)
IS  - 0161-5505 (Linking)
VI  - 63
IP  - 8
DP  - 2022 Aug
TI  - Absolute Lymphocyte Count After COVID-19 Vaccination Is Associated with 
      Vaccine-Induced Hypermetabolic Lymph Nodes on (18)F-FDG PET/CT: A Focus in Breast 
      Cancer Care.
PG  - 1231-1238
LID - 10.2967/jnumed.121.263082 [doi]
AB  - We aimed to predict the presence of vaccine-induced hypermetabolic lymph nodes 
      (v-HLNs) on (18)F-FDG PET/CT after coronavirus disease 2019 (COVID-19) 
      vaccination and determine their association with lymphocyte counts. Methods: In 
      this retrospective single-center study, we included consecutive patients who 
      underwent (18)F-FDG PET/CT imaging after messenger RNA- or viral vector-based 
      COVID-19 vaccination between early March and late April 2021. Demographics, 
      clinical parameters, and absolute lymphocyte count (ALC) were collected, and 
      their association with the presence of v-HLNs in the draining territory was 
      studied by logistic regression. Results: In total, 260 patients were eligible, 
      including 209 (80%) women and 145 (56%) with breast cancer. The median age was 50 
      y (range, 23-96 y). The messenger RNA vaccine had been given to 233 (90%). Ninety 
      (35%) patients had v-HLNs, with a median SUV(max) of 3.7 (range, 2.0-26.3), and 
      74 (44%) displayed lymphopenia, with a median ALC of 1.4 × 10(9)/L (range, 
      0.3-18.3 × 10(9)/L). An age of no more than 50 y (odds ratio [OR], 2.2; 95% CI, 
      1.0-4.5), the absence of lymphopenia (OR, 2.2; 95% CI, 1.1-4.3), and less than a 
      30-d interval from the last vaccine injection to the (18)F-FDG PET/CT (OR, 2.6; 
      95% CI, 1.3-5.6) were independent factors for v-HLNs on multivariate analysis. In 
      breast cancer patients, the absence of lymphopenia was the only independent 
      factor significantly associated with v-HLNs (OR, 2.9; 95% CI, 1.2-7.4). 
      Conclusion: Patients with a normal ALC after COVID-19 vaccination were more 
      likely to have v-HLNs on (18)F-FDG PET/CT, both of which might be associated with 
      a stronger immune response to vaccination.
CI  - © 2022 by the Society of Nuclear Medicine and Molecular Imaging.
FAU - Seban, Romain-David
AU  - Seban RD
AD  - Department of Nuclear Medicine and Endocrine Oncology, Institut Curie, 
      Saint-Cloud, France; romain.seban@gmail.com.
AD  - Laboratoire d'Imagerie Translationnelle en Oncologie, InsermU1288, PSL Research 
      University, Institut Curie, Orsay, France.
FAU - Richard, Capucine
AU  - Richard C
AD  - Department of Nuclear Medicine and Endocrine Oncology, Institut Curie, 
      Saint-Cloud, France.
FAU - Nascimento-Leite, Camila
AU  - Nascimento-Leite C
AD  - Department of Nuclear Medicine and Endocrine Oncology, Institut Curie, 
      Saint-Cloud, France.
FAU - Ghidaglia, Jerome
AU  - Ghidaglia J
AD  - Department of Nuclear Medicine and Endocrine Oncology, Institut Curie, 
      Saint-Cloud, France.
FAU - Provost, Claire
AU  - Provost C
AD  - Laboratoire d'Imagerie Translationnelle en Oncologie, InsermU1288, PSL Research 
      University, Institut Curie, Orsay, France.
AD  - Department of Radio-Pharmacology, Institut Curie, Saint-Cloud, France.
FAU - Gonin, Julie
AU  - Gonin J
AD  - Department of Pathology, Institut Curie, Saint-Cloud, France.
FAU - Tourneau, Christophe Le
AU  - Tourneau CL
AD  - Department of Drug Development and Innovation (D3i), Institut Curie, Paris, 
      France.
AD  - INSERM U900 Research team, Paris Saclay University, Saint-Cloud, France.
FAU - Romano, Emanuela
AU  - Romano E
AD  - Department of Medical Oncology, Center for Cancer Immunotherapy, Institut Curie, 
      Paris, France; and.
AD  - INSERM U932, PSL Research University, Institut Curie, Paris, France.
FAU - Deleval, Nicolas
AU  - Deleval N
AD  - Department of Nuclear Medicine and Endocrine Oncology, Institut Curie, 
      Saint-Cloud, France.
FAU - Champion, Laurence
AU  - Champion L
AD  - Department of Nuclear Medicine and Endocrine Oncology, Institut Curie, 
      Saint-Cloud, France.
AD  - Laboratoire d'Imagerie Translationnelle en Oncologie, InsermU1288, PSL Research 
      University, Institut Curie, Orsay, France.
LA  - eng
PT  - Journal Article
DEP - 20211202
PL  - United States
TA  - J Nucl Med
JT  - Journal of nuclear medicine : official publication, Society of Nuclear Medicine
JID - 0217410
RN  - 0 (COVID-19 Vaccines)
RN  - 0 (mRNA Vaccines)
RN  - 0Z5B2CJX4D (Fluorodeoxyglucose F18)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - *Breast Neoplasms/diagnostic imaging/pathology/therapy
MH  - *COVID-19/prevention & control
MH  - *COVID-19 Vaccines/adverse effects
MH  - Female
MH  - Fluorodeoxyglucose F18
MH  - Humans
MH  - *Lymph Nodes/diagnostic imaging/pathology
MH  - Lymphocyte Count
MH  - *Lymphopenia
MH  - Male
MH  - Middle Aged
MH  - Positron Emission Tomography Computed Tomography/methods
MH  - Retrospective Studies
MH  - Vaccination/adverse effects
MH  - Young Adult
MH  - mRNA Vaccines/adverse effects
PMC - PMC9364344
OTO - NOTNLM
OT  - 18F-FDG PET/CT
OT  - COVID-19 vaccination
OT  - absolute lymphocyte count
OT  - hypermetabolic lymph nodes
OT  - immune response
EDAT- 2021/12/04 06:00
MHDA- 2022/08/04 06:00
CRDT- 2021/12/03 06:12
PHST- 2021/08/20 00:00 [received]
PHST- 2021/11/09 00:00 [accepted]
PHST- 2021/12/04 06:00 [pubmed]
PHST- 2022/08/04 06:00 [medline]
PHST- 2021/12/03 06:12 [entrez]
AID - jnumed.121.263082 [pii]
AID - 263082 [pii]
AID - 10.2967/jnumed.121.263082 [doi]
PST - ppublish
SO  - J Nucl Med. 2022 Aug;63(8):1231-1238. doi: 10.2967/jnumed.121.263082. Epub 2021 
      Dec 2.

PMID- 35092770
OWN - NLM
STAT- MEDLINE
DCOM- 20220316
LR  - 20220316
IS  - 1879-1026 (Electronic)
IS  - 0048-9697 (Linking)
VI  - 821
DP  - 2022 May 15
TI  - The biological sink of atmospheric H(2) is more sensitive to spatial variation of 
      microbial diversity than N(2)O and CO(2) emissions in a winter cover crop field 
      trial.
PG  - 153420
LID - S0048-9697(22)00512-5 [pii]
LID - 10.1016/j.scitotenv.2022.153420 [doi]
AB  - The integration of winter cover crop (WCC) in culture rotations promotes multiple 
      ecosystem services, but concomitant microbial diversity and functioning responses 
      in soil have received less attention. A field trial was established to test the 
      hypothesis that enhanced crop diversity with the integration of WCC in a 
      conventional maize-soy rotation promotes microbial diversity and the biological 
      sink of H(2) in soil, while reducing N(2)O emissions to the atmosphere. Vicia 
      villosa (hairy vetch), Avena sativa (oat), and Raphanus sativus (Daikon radish) 
      were cultivated alone or in combinations and flux measurements were performed 
      throughout two subsequent growing seasons. Soil acted as a net sink for H(2) and 
      as a net source for CO(2) and N(2)O. CO(2) flux was the most sensitive to WCC 
      whereas a significant spatial variation was observed for H(2) flux with soil 
      uptake rates observed in the most productive area two-fold greater than the 
      baseline level. Sequencing and quantification of taxonomic and functional genes 
      were integrated to explain variation in trace gas fluxes with compositional 
      changes in soil microbial communities. Fungal communities were the most sensitive 
      to WCC, but neither community abundance nor beta diversity were found to be 
      indicative of fluxes. The alpha diversity of taxonomic and functional genes, 
      expressed as the number of effective species, was integrated into composite 
      variables extracted from multivariate analyses. Only the composite variable 
      computed with the inverse Simpson's index displayed a reproducible pattern 
      throughout both growing seasons, with functional genes and bacterial 16S rRNA 
      gene defining the two most contrasting gradients. The composite variable was 
      decoupled from WCC treatment and explained 19-20% spatial variation of H(2) 
      fluxes. The coupling of composite alpha diversity metrics derived from multiple 
      genes with soil processes warrants further investigations to implement novel 
      indicators of soil health in response to changing management practices at the 
      local scale.
CI  - Copyright © 2022 Elsevier B.V. All rights reserved.
FAU - Baril, Xavier
AU  - Baril X
AD  - Institut national de la recherche scientifique, Centre Armand-Frappier Santé 
      Biotechnologie, 531 boulevard des Prairies, Laval, Québec H7V 1B7, Canada.
FAU - Durand, Audrey-Anne
AU  - Durand AA
AD  - Institut national de la recherche scientifique, Centre Armand-Frappier Santé 
      Biotechnologie, 531 boulevard des Prairies, Laval, Québec H7V 1B7, Canada.
FAU - Srei, Narin
AU  - Srei N
AD  - Institut national de la recherche scientifique, Centre Armand-Frappier Santé 
      Biotechnologie, 531 boulevard des Prairies, Laval, Québec H7V 1B7, Canada.
FAU - Lamothe, Steve
AU  - Lamothe S
AD  - Centre de recherche agroalimentaire de Mirabel, 9850, rue de Belle-Rivière, 
      Mirabel, Québec J7N 2X8, Canada.
FAU - Provost, Caroline
AU  - Provost C
AD  - Centre de recherche agroalimentaire de Mirabel, 9850, rue de Belle-Rivière, 
      Mirabel, Québec J7N 2X8, Canada.
FAU - Martineau, Christine
AU  - Martineau C
AD  - Natural Resources Canada, Canadian Forest Service, Laurentian Forestry Centre, 
      Sainte-Foy, Québec G1V 4C7, Canada.
FAU - Dunfield, Kari
AU  - Dunfield K
AD  - School of Environmental Sciences, University of Guelph, Guelph, Ontario N1G 2W1, 
      Canada.
FAU - Constant, Philippe
AU  - Constant P
AD  - Institut national de la recherche scientifique, Centre Armand-Frappier Santé 
      Biotechnologie, 531 boulevard des Prairies, Laval, Québec H7V 1B7, Canada. 
      Electronic address: philippe.constant@inrs.ca.
LA  - eng
PT  - Journal Article
DEP - 20220129
PL  - Netherlands
TA  - Sci Total Environ
JT  - The Science of the total environment
JID - 0330500
RN  - 0 (RNA, Ribosomal, 16S)
RN  - 0 (Soil)
RN  - 142M471B3J (Carbon Dioxide)
RN  - K50XQU1029 (Nitrous Oxide)
SB  - IM
MH  - *Carbon Dioxide/analysis
MH  - *Microbiota
MH  - Nitrous Oxide/analysis
MH  - RNA, Ribosomal, 16S
MH  - Seasons
MH  - Soil
OTO - NOTNLM
OT  - Cover crop
OT  - Gaseous exchanges
OT  - Microbial ecology
OT  - Soil
OT  - Trace gases
COIS- Declaration of competing interest The authors declare that they have no known 
      competing financial interests or personal relationships that could have appeared 
      to influence the work reported in this paper.
EDAT- 2022/01/30 06:00
MHDA- 2022/03/17 06:00
CRDT- 2022/01/29 20:05
PHST- 2021/11/26 00:00 [received]
PHST- 2022/01/21 00:00 [revised]
PHST- 2022/01/21 00:00 [accepted]
PHST- 2022/01/30 06:00 [pubmed]
PHST- 2022/03/17 06:00 [medline]
PHST- 2022/01/29 20:05 [entrez]
AID - S0048-9697(22)00512-5 [pii]
AID - 10.1016/j.scitotenv.2022.153420 [doi]
PST - ppublish
SO  - Sci Total Environ. 2022 May 15;821:153420. doi: 10.1016/j.scitotenv.2022.153420. 
      Epub 2022 Jan 29.

PMID- 34248267
OWN - NLM
STAT- MEDLINE
DCOM- 20211027
LR  - 20220102
IS  - 1928-9022 (Electronic)
IS  - 0830-9000 (Print)
IS  - 0830-9000 (Linking)
VI  - 85
IP  - 3
DP  - 2021 Jul
TI  - Whole genome sequencing of methicillin-resistant and methicillin-sensitive 
      Staphylococcus aureus isolated from 4 horses in a veterinary teaching hospital 
      and its ambulatory service.
PG  - 218-223
AB  - Genomic characterization was conducted on 2 methicillin-resistant Staphylococcus 
      aureus (MRSA) strains isolated from 2 horses hospitalized during an overlapping 
      period of time and 2 methicillin-sensitive S. aureus (MSSA) strains isolated from 
      2 distinct horses. Phylogenetic proximity was traced and the genotypic and 
      phenotypic characteristics of the antimicrobial resistance of the strains were 
      compared. Whole genome sequencing of MRSA strains for this report was similar but 
      differed from whole genome sequencing of MSSA strains. The MRSA strains were 
      closely related, belonging to sequence type (ST) 612, spa type t1257, and SCCmec 
      type IVd2B. The MSSA strains were also closely related, belonging to ST1660, spa 
      type t3043, and having no detectable staphylococcal cassette chromosome mec 
      elements. All MSRA and MSSA strains were Panton-Valentine leukocidin negative. 
      There were discrepancies in the genotypic analysis and the antimicrobial 
      susceptibility testing (phenotypic analysis) of MRSA strains for rifampin, 
      trimethoprim-sulfamethoxazole, gentamicin, amikacin, and enrofloxacin.
CI  - Copyright and/or publishing rights held by the Canadian Veterinary Medical 
      Association.
FAU - Morice, Paloma
AU  - Morice P
AD  - Département de sciences cliniques (Morice, Allano, Sauvé) and Centre de recherche 
      en infectiologie porcine et avicole (Provost, Gagnon), Faculté de médecine 
      vétérinaire, Université de Montréal, 3200 Sicotte, Saint-Hyacinthe, Quebec J2S 
      2M2; Bacteriology Diagnostic Laboratory, Complexe de diagnostic et 
      d'épidémiosurveillance vétérinaires du Québec, Ministère de l'Agriculture, des 
      Pêcheries et de l'Alimentation du Québec and Faculté de médecine vétérinaire, 
      Université de Montréal, 3200 Sicotte, Saint-Hyacinthe, Quebec J2S 2M2 
      (Fairbrother).
FAU - Allano, Marion
AU  - Allano M
AD  - Département de sciences cliniques (Morice, Allano, Sauvé) and Centre de recherche 
      en infectiologie porcine et avicole (Provost, Gagnon), Faculté de médecine 
      vétérinaire, Université de Montréal, 3200 Sicotte, Saint-Hyacinthe, Quebec J2S 
      2M2; Bacteriology Diagnostic Laboratory, Complexe de diagnostic et 
      d'épidémiosurveillance vétérinaires du Québec, Ministère de l'Agriculture, des 
      Pêcheries et de l'Alimentation du Québec and Faculté de médecine vétérinaire, 
      Université de Montréal, 3200 Sicotte, Saint-Hyacinthe, Quebec J2S 2M2 
      (Fairbrother).
FAU - Provost, Chantale
AU  - Provost C
AD  - Département de sciences cliniques (Morice, Allano, Sauvé) and Centre de recherche 
      en infectiologie porcine et avicole (Provost, Gagnon), Faculté de médecine 
      vétérinaire, Université de Montréal, 3200 Sicotte, Saint-Hyacinthe, Quebec J2S 
      2M2; Bacteriology Diagnostic Laboratory, Complexe de diagnostic et 
      d'épidémiosurveillance vétérinaires du Québec, Ministère de l'Agriculture, des 
      Pêcheries et de l'Alimentation du Québec and Faculté de médecine vétérinaire, 
      Université de Montréal, 3200 Sicotte, Saint-Hyacinthe, Quebec J2S 2M2 
      (Fairbrother).
FAU - Fairbrother, Julie-Hélène
AU  - Fairbrother JH
AD  - Département de sciences cliniques (Morice, Allano, Sauvé) and Centre de recherche 
      en infectiologie porcine et avicole (Provost, Gagnon), Faculté de médecine 
      vétérinaire, Université de Montréal, 3200 Sicotte, Saint-Hyacinthe, Quebec J2S 
      2M2; Bacteriology Diagnostic Laboratory, Complexe de diagnostic et 
      d'épidémiosurveillance vétérinaires du Québec, Ministère de l'Agriculture, des 
      Pêcheries et de l'Alimentation du Québec and Faculté de médecine vétérinaire, 
      Université de Montréal, 3200 Sicotte, Saint-Hyacinthe, Quebec J2S 2M2 
      (Fairbrother).
FAU - Gagnon, Carl A
AU  - Gagnon CA
AD  - Département de sciences cliniques (Morice, Allano, Sauvé) and Centre de recherche 
      en infectiologie porcine et avicole (Provost, Gagnon), Faculté de médecine 
      vétérinaire, Université de Montréal, 3200 Sicotte, Saint-Hyacinthe, Quebec J2S 
      2M2; Bacteriology Diagnostic Laboratory, Complexe de diagnostic et 
      d'épidémiosurveillance vétérinaires du Québec, Ministère de l'Agriculture, des 
      Pêcheries et de l'Alimentation du Québec and Faculté de médecine vétérinaire, 
      Université de Montréal, 3200 Sicotte, Saint-Hyacinthe, Quebec J2S 2M2 
      (Fairbrother).
FAU - Sauvé, Frédéric
AU  - Sauvé F
AD  - Département de sciences cliniques (Morice, Allano, Sauvé) and Centre de recherche 
      en infectiologie porcine et avicole (Provost, Gagnon), Faculté de médecine 
      vétérinaire, Université de Montréal, 3200 Sicotte, Saint-Hyacinthe, Quebec J2S 
      2M2; Bacteriology Diagnostic Laboratory, Complexe de diagnostic et 
      d'épidémiosurveillance vétérinaires du Québec, Ministère de l'Agriculture, des 
      Pêcheries et de l'Alimentation du Québec and Faculté de médecine vétérinaire, 
      Université de Montréal, 3200 Sicotte, Saint-Hyacinthe, Quebec J2S 2M2 
      (Fairbrother).
LA  - eng
PT  - Journal Article
PL  - Canada
TA  - Can J Vet Res
JT  - Canadian journal of veterinary research = Revue canadienne de recherche 
      veterinaire
JID - 8607793
RN  - 0 (Anti-Bacterial Agents)
RN  - 0 (Virulence Factors)
RN  - Q91FH1328A (Methicillin)
SB  - IM
MH  - Animals
MH  - Anti-Bacterial Agents/pharmacology
MH  - Horse Diseases/*microbiology
MH  - Horses
MH  - *Hospitals, Animal
MH  - Methicillin/pharmacology
MH  - Methicillin Resistance
MH  - Methicillin-Resistant Staphylococcus aureus/*genetics/metabolism
MH  - Phylogeny
MH  - Staphylococcal Infections/microbiology/veterinary
MH  - Staphylococcus aureus/*drug effects/*genetics/metabolism
MH  - Virulence Factors/genetics/metabolism
MH  - Whole Genome Sequencing
PMC - PMC8243796
EDAT- 2021/07/13 06:00
MHDA- 2021/10/28 06:00
CRDT- 2021/07/12 05:41
PHST- 2020/09/09 00:00 [received]
PHST- 2021/02/08 00:00 [accepted]
PHST- 2021/07/12 05:41 [entrez]
PHST- 2021/07/13 06:00 [pubmed]
PHST- 2021/10/28 06:00 [medline]
AID - cjvr_03_218 [pii]
PST - ppublish
SO  - Can J Vet Res. 2021 Jul;85(3):218-223.

PMID- 32960688
OWN - NLM
STAT- MEDLINE
DCOM- 20210728
LR  - 20210923
IS  - 1559-7016 (Electronic)
IS  - 0271-678X (Print)
IS  - 0271-678X (Linking)
VI  - 41
IP  - 2
DP  - 2021 Feb
TI  - Tissue no-reflow despite full recanalization following thrombectomy for anterior 
      circulation stroke with proximal occlusion: A clinical study.
PG  - 253-266
LID - 10.1177/0271678X20954929 [doi]
AB  - Despite early thrombectomy, a sizeable fraction of acute stroke patients with 
      large vessel occlusion have poor outcome. The no-reflow phenomenon, i.e. impaired 
      microvascular reperfusion despite complete recanalization, may contribute to such 
      "futile recanalizations". Although well reported in animal models, no-reflow is 
      still poorly characterized in man. From a large prospective thrombectomy 
      database, we included all patients with intracranial proximal occlusion, complete 
      recanalization (modified thrombolysis in cerebral infarction score 2c-3), and 
      availability of both baseline and 24 h follow-up MRI including arterial spin 
      labeling perfusion mapping. No-reflow was operationally defined as i) 
      hypoperfusion ≥40% relative to contralateral homologous region, assessed with 
      both visual (two independent investigators) and automatic image analysis, and ii) 
      infarction on follow-up MRI. Thirty-three patients were eligible (median age: 70 
      years, NIHSS: 18, and stroke onset-to-recanalization delay: 208 min). The 
      operational criteria were met in one patient only, consistently with the visual 
      and automatic analyses. This patient recanalized 160 min after stroke onset and 
      had excellent functional outcome. In our cohort of patients with complete and 
      stable recanalization following thrombectomy for intracranial proximal occlusion, 
      severe ipsilateral hypoperfusion on follow-up imaging associated with newly 
      developed infarction was a rare occurrence. Thus, no-reflow may be infrequent in 
      human stroke and may not substantially contribute to futile recanalizations.
FAU - Ter Schiphorst, Adrien
AU  - Ter Schiphorst A
AD  - INSERM U1266, Institut de Psychiatrie et Neurosciences de Paris, Université de 
      Paris, Paris, France.
AD  - Department of Neurology, CHU Montpellier, University of Montpellier, Montpellier, 
      France.
FAU - Charron, Sylvain
AU  - Charron S
AD  - INSERM U1266, Institut de Psychiatrie et Neurosciences de Paris, Université de 
      Paris, Paris, France.
AD  - Department of Neuroradiology, Hôpital Sainte-Anne, Université de Paris, Paris, 
      France.
FAU - Hassen, Wagih Ben
AU  - Hassen WB
AUID- ORCID: 0000-0003-4858-3623
AD  - INSERM U1266, Institut de Psychiatrie et Neurosciences de Paris, Université de 
      Paris, Paris, France.
AD  - Department of Neuroradiology, Hôpital Sainte-Anne, Université de Paris, Paris, 
      France.
FAU - Provost, Corentin
AU  - Provost C
AD  - INSERM U1266, Institut de Psychiatrie et Neurosciences de Paris, Université de 
      Paris, Paris, France.
AD  - Department of Neuroradiology, Hôpital Sainte-Anne, Université de Paris, Paris, 
      France.
FAU - Naggara, Olivier
AU  - Naggara O
AD  - INSERM U1266, Institut de Psychiatrie et Neurosciences de Paris, Université de 
      Paris, Paris, France.
AD  - Department of Neuroradiology, Hôpital Sainte-Anne, Université de Paris, Paris, 
      France.
FAU - Benzakoun, Joseph
AU  - Benzakoun J
AD  - INSERM U1266, Institut de Psychiatrie et Neurosciences de Paris, Université de 
      Paris, Paris, France.
AD  - Department of Neuroradiology, Hôpital Sainte-Anne, Université de Paris, Paris, 
      France.
FAU - Seners, Pierre
AU  - Seners P
AD  - INSERM U1266, Institut de Psychiatrie et Neurosciences de Paris, Université de 
      Paris, Paris, France.
AD  - Department of Neurology, Hôpital Sainte-Anne, Université de Paris, Paris, France.
FAU - Turc, Guillaume
AU  - Turc G
AD  - INSERM U1266, Institut de Psychiatrie et Neurosciences de Paris, Université de 
      Paris, Paris, France.
AD  - Department of Neurology, Hôpital Sainte-Anne, Université de Paris, Paris, France.
FAU - Baron, Jean-Claude
AU  - Baron JC
AD  - INSERM U1266, Institut de Psychiatrie et Neurosciences de Paris, Université de 
      Paris, Paris, France.
AD  - Department of Neurology, Hôpital Sainte-Anne, Université de Paris, Paris, France.
FAU - Oppenheim, Catherine
AU  - Oppenheim C
AD  - INSERM U1266, Institut de Psychiatrie et Neurosciences de Paris, Université de 
      Paris, Paris, France.
AD  - Department of Neuroradiology, Hôpital Sainte-Anne, Université de Paris, Paris, 
      France.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20200922
PL  - United States
TA  - J Cereb Blood Flow Metab
JT  - Journal of cerebral blood flow and metabolism : official journal of the 
      International Society of Cerebral Blood Flow and Metabolism
JID - 8112566
SB  - IM
MH  - Aged
MH  - Cerebrovascular Circulation/*physiology
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Retrospective Studies
MH  - Stroke/*surgery
MH  - Thrombectomy/*methods
MH  - Treatment Outcome
PMC - PMC8370008
OTO - NOTNLM
OT  - Perfusion
OT  - arterial spin labeling
OT  - cerebral blood flow
OT  - cerebral infarction diaschisis
OT  - large vessel occlusion
COIS- Declaration of conflicting interests: The author(s) declared no potential 
      conflicts of interest with respect to the research, authorship, and/or 
      publication of this article.
EDAT- 2020/09/23 06:00
MHDA- 2021/07/29 06:00
CRDT- 2020/09/22 17:11
PHST- 2020/09/23 06:00 [pubmed]
PHST- 2021/07/29 06:00 [medline]
PHST- 2020/09/22 17:11 [entrez]
AID - 10.1177_0271678X20954929 [pii]
AID - 10.1177/0271678X20954929 [doi]
PST - ppublish
SO  - J Cereb Blood Flow Metab. 2021 Feb;41(2):253-266. doi: 10.1177/0271678X20954929. 
      Epub 2020 Sep 22.

PMID- 30700334
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200225
IS  - 1756-6606 (Electronic)
IS  - 1756-6606 (Linking)
VI  - 12
IP  - 1
DP  - 2019 Jan 30
TI  - Correction to: The effect of Neuroligin-2 absence on sleep architecture and 
      electroencephalographic activity in mice.
PG  - 9
LID - 10.1186/s13041-019-0425-8 [doi]
LID - 9
AB  - Correction to: Molecular Brain (2018) 11:52 
      https://doi.org/10.1186/s13041-018-0394-3Following publication of the original 
      article [1], the authors reported that the article was mistakenly submitted with 
      the omission of two authors: Feng Cao and Zhengping Jia. The authors declare that 
      this was an error made in good faith. The corrected author list and list of 
      affiliations are used in this Correction. The changes made to the author list and 
      list of affiliations are also listed below, as well as the revised 
      'Acknowledgements' section and 'Authors' contributions' section.
FAU - Seok, Bong Soo
AU  - Seok BS
AD  - Research Center and Center for Advanced Research in Sleep Medicine, Hôpital du 
      Sacré-Cœur de Montréal (CIUSSS-NIM), 5400 Gouin West blvd, Montréal, QC H4J 1C5, 
      Canada.
AD  - Department of Neuroscience, Université de Montréal, 2960 chemin de la Tour, 
      Montreal, QC H3T 1J4, Canada.
FAU - Cao, Feng
AU  - Cao F
AD  - Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, M5G 
      1X8, Canada.
AD  - Department of Physiology, University of Toronto, Toronto, ON, M5S 1A8, Canada.
FAU - Bélanger-Nelson, Erika
AU  - Bélanger-Nelson E
AD  - Research Center and Center for Advanced Research in Sleep Medicine, Hôpital du 
      Sacré-Cœur de Montréal (CIUSSS-NIM), 5400 Gouin West blvd, Montréal, QC H4J 1C5, 
      Canada.
FAU - Provost, Chloé
AU  - Provost C
AD  - Research Center and Center for Advanced Research in Sleep Medicine, Hôpital du 
      Sacré-Cœur de Montréal (CIUSSS-NIM), 5400 Gouin West blvd, Montréal, QC H4J 1C5, 
      Canada.
FAU - Gibbs, Steve
AU  - Gibbs S
AD  - Research Center and Center for Advanced Research in Sleep Medicine, Hôpital du 
      Sacré-Cœur de Montréal (CIUSSS-NIM), 5400 Gouin West blvd, Montréal, QC H4J 1C5, 
      Canada.
AD  - Department of Neuroscience, Université de Montréal, 2960 chemin de la Tour, 
      Montreal, QC H3T 1J4, Canada.
FAU - Jia, Zhengping
AU  - Jia Z
AD  - Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, M5G 
      1X8, Canada.
AD  - Department of Physiology, University of Toronto, Toronto, ON, M5S 1A8, Canada.
FAU - Mongrain, Valérie
AU  - Mongrain V
AD  - Research Center and Center for Advanced Research in Sleep Medicine, Hôpital du 
      Sacré-Cœur de Montréal (CIUSSS-NIM), 5400 Gouin West blvd, Montréal, QC H4J 1C5, 
      Canada. valerie.mongrain@umontreal.ca.
AD  - Department of Neuroscience, Université de Montréal, 2960 chemin de la Tour, 
      Montreal, QC H3T 1J4, Canada. valerie.mongrain@umontreal.ca.
LA  - eng
PT  - Journal Article
PT  - Published Erratum
DEP - 20190130
PL  - England
TA  - Mol Brain
JT  - Molecular brain
JID - 101468876
EFR - Mol Brain. 2018 Sep 19;11(1):52. PMID: 30231918
PMC - PMC6352436
EDAT- 2019/02/01 06:00
MHDA- 2019/02/01 06:01
CRDT- 2019/02/01 06:00
PHST- 2018/11/07 00:00 [received]
PHST- 2018/12/07 00:00 [accepted]
PHST- 2019/02/01 06:00 [entrez]
PHST- 2019/02/01 06:00 [pubmed]
PHST- 2019/02/01 06:01 [medline]
AID - 10.1186/s13041-019-0425-8 [pii]
AID - 425 [pii]
AID - 10.1186/s13041-019-0425-8 [doi]
PST - epublish
SO  - Mol Brain. 2019 Jan 30;12(1):9. doi: 10.1186/s13041-019-0425-8.

PMID- 30231918
OWN - NLM
STAT- MEDLINE
DCOM- 20190107
LR  - 20190201
IS  - 1756-6606 (Electronic)
IS  - 1756-6606 (Linking)
VI  - 11
IP  - 1
DP  - 2018 Sep 19
TI  - The effect of Neuroligin-2 absence on sleep architecture and 
      electroencephalographic activity in mice.
PG  - 52
LID - 10.1186/s13041-018-0394-3 [doi]
LID - 52
AB  - Sleep disorders are comorbid with most psychiatric disorders, but the link 
      between these is not well understood. Neuroligin-2 (NLGN2) is a cell adhesion 
      molecule that plays roles in synapse formation and neurotransmission. Moreover, 
      NLGN2 has been associated with psychiatric disorders, but its implication in 
      sleep remains underexplored. In the present study, the effect of Nlgn2 knockout 
      (Nlgn2(-/-)) on sleep architecture and electroencephalographic (EEG) activity in 
      mice has been investigated. The EEG and electromyogram (EMG) were recorded in 
      Nlgn2(-/-) mice and littermates for 24 h from which three vigilance states (i.e., 
      wakefulness, rapid eye movement [REM] sleep, non-REM [NREM] sleep) were visually 
      identified. Spectral analysis of the EEG was performed for the three states. 
      Nlgn2(-/-) mice showed more wakefulness and less NREM and REM sleep compared to 
      wild-type (Nlgn2(+/+)) mice, especially during the dark period. This was 
      accompanied by changes in the number and duration of individual episodes of 
      wakefulness and sleep, indexing changes in state consolidation, as well as 
      widespread changes in EEG spectral activity in all states. Abnormal 
      'hypersynchronized' EEG events have also been observed predominantly in 
      Nlgn2(-/-) mice. These events were mainly observed during wakefulness and REM 
      sleep. In addition, Nlgn2(-/-) mice showed alterations in the daily time course 
      of NREM sleep delta (1-4 Hz) activity, pointing to modifications in the dynamics 
      of sleep homeostasis. These data suggest that NLGN2 participates in the 
      regulation of sleep duration as well as EEG activity during wakefulness and 
      sleep.
FAU - Seok, Bong Soo
AU  - Seok BS
AD  - Research Center and Center for Advanced Research in Sleep Medicine, Hôpital du 
      Sacré-Cœur de Montréal (CIUSSS-NIM), 5400 Gouin West blvd, Montréal, QC, H4J 1C5, 
      Canada.
AD  - Department of Neuroscience, Université de Montréal, 2960 chemin de la Tour, 
      Montreal, QC, H3T 1J4, Canada.
FAU - Cao, Feng
AU  - Cao F
FAU - Bélanger-Nelson, Erika
AU  - Bélanger-Nelson E
AD  - Research Center and Center for Advanced Research in Sleep Medicine, Hôpital du 
      Sacré-Cœur de Montréal (CIUSSS-NIM), 5400 Gouin West blvd, Montréal, QC, H4J 1C5, 
      Canada.
FAU - Provost, Chloé
AU  - Provost C
AD  - Research Center and Center for Advanced Research in Sleep Medicine, Hôpital du 
      Sacré-Cœur de Montréal (CIUSSS-NIM), 5400 Gouin West blvd, Montréal, QC, H4J 1C5, 
      Canada.
FAU - Gibbs, Steve
AU  - Gibbs S
AD  - Research Center and Center for Advanced Research in Sleep Medicine, Hôpital du 
      Sacré-Cœur de Montréal (CIUSSS-NIM), 5400 Gouin West blvd, Montréal, QC, H4J 1C5, 
      Canada.
AD  - Department of Neuroscience, Université de Montréal, 2960 chemin de la Tour, 
      Montreal, QC, H3T 1J4, Canada.
FAU - Jia, Zhengping
AU  - Jia Z
FAU - Mongrain, Valérie
AU  - Mongrain V
AUID- ORCID: 0000-0002-6242-9166
AD  - Research Center and Center for Advanced Research in Sleep Medicine, Hôpital du 
      Sacré-Cœur de Montréal (CIUSSS-NIM), 5400 Gouin West blvd, Montréal, QC, H4J 1C5, 
      Canada. valerie.mongrain@umontreal.ca.
AD  - Department of Neuroscience, Université de Montréal, 2960 chemin de la Tour, 
      Montreal, QC, H3T 1J4, Canada. valerie.mongrain@umontreal.ca.
LA  - eng
GR  - Sleep Molecular Physiology/Canada Research Chairs/International
GR  - Bourse de recrutement maitrise/Université de Montréal/International
GR  - 340196-126252/CIHR/Canada
GR  - 30831/Fonds de Recherche du Québec - Santé/International
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20180919
PL  - England
TA  - Mol Brain
JT  - Molecular brain
JID - 101468876
RN  - 0 (Cell Adhesion Molecules, Neuronal)
RN  - 0 (Nerve Tissue Proteins)
RN  - 0 (neuroligin 2)
SB  - IM
EIN - Mol Brain. 2019 Jan 30;12(1):9. Cao, Feng [added]; Jia, Zhengping [added]. PMID: 
      30700334
MH  - Animals
MH  - Cell Adhesion Molecules, Neuronal/deficiency/*metabolism
MH  - Delta Rhythm/physiology
MH  - *Electroencephalography
MH  - Mice
MH  - Nerve Tissue Proteins/deficiency/*metabolism
MH  - Sleep/*physiology
MH  - Sleep, REM/physiology
MH  - Time Factors
MH  - Wakefulness
PMC - PMC6146600
OTO - NOTNLM
OT  - Cell adhesion molecule
OT  - Delta activity
OT  - Electroencephalography
OT  - Knockout mice
OT  - Neuroligin
OT  - Sleep regulation
OT  - Wakefulness
COIS- ETHICS APPROVAL: All of the protocols and experimental procedures were performed 
      according to the guidelines of the Canadian Council on Animal Care and approved 
      by the Ethical Committee for Animal Experimentation of the Hôpital du Sacré-Coeur 
      de Montréal. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The 
      authors declare that they have no competing interest. PUBLISHER’S NOTE: Springer 
      Nature remains neutral with regard to jurisdictional claims in published maps and 
      institutional affiliations.
EDAT- 2018/09/21 06:00
MHDA- 2019/01/08 06:00
CRDT- 2018/09/21 06:00
PHST- 2018/06/13 00:00 [received]
PHST- 2018/09/06 00:00 [accepted]
PHST- 2018/09/21 06:00 [entrez]
PHST- 2018/09/21 06:00 [pubmed]
PHST- 2019/01/08 06:00 [medline]
AID - 10.1186/s13041-018-0394-3 [pii]
AID - 394 [pii]
AID - 10.1186/s13041-018-0394-3 [doi]
PST - epublish
SO  - Mol Brain. 2018 Sep 19;11(1):52. doi: 10.1186/s13041-018-0394-3.

PMID- 29313871
OWN - NLM
STAT- MEDLINE
DCOM- 20180514
LR  - 20181202
IS  - 1651-2081 (Electronic)
IS  - 1650-1977 (Linking)
VI  - 50
IP  - 3
DP  - 2018 Feb 28
TI  - Standing postural reaction to visual and proprioceptive stimulation in chronic 
      acquired demyelinating polyneuropathy.
PG  - 278-284
LID - 10.2340/16501977-2314 [doi]
AB  - OBJECTIVE: To investigate the weight of visual and proprioceptive inputs, 
      measured indirectly in standing position control, in patients with chronic 
      acquired demyelinating polyneuropathy (CADP). DESIGN: Prospective case study. 
      SUBJECTS: Twenty-five patients with CADP and 25 healthy controls. METHODS: 
      Posture was recorded on a double force platform. Stimulations were optokinetic 
      (60°/s) for visual input and vibration (50 Hz) for proprioceptive input. Visual 
      stimulation involved 4 tests (upward, downward, rightward and leftward) and 
      proprioceptive stimulation 2 tests (triceps surae and tibialis anterior). A 
      composite score, previously published and slightly modified, was used for the 
      recorded postural signals from the different stimulations. RESULTS: Despite their 
      sensitivity deficits, patients with CADP were more sensitive to proprioceptive 
      stimuli than were healthy controls (mean composite score 13.9 ((standard 
      deviation; SD) 4.8) vs 18.4 (SD 4.8), p = 0.002). As expected, they were also 
      more sensitive to visual stimuli (mean composite score 10.5 (SD 8.7) vs 22.9 (SD 
      7.5), p <0.0001). CONCLUSION: These results encourage balance rehabilitation of 
      patients with CADP, aimed at promoting the use of proprioceptive information, 
      thereby reducing too-early development of visual compensation while 
      proprioception is still available.
FAU - Provost, Clement P
AU  - Provost CP
AD  - PRM Department, GH St Louis Lariboisière F. Widal, AP-HP, Paris Diderot 
      University, 75010 Paris, France. clementprovost@yahoo.fr.
FAU - Tasseel-Ponche, Sophie
AU  - Tasseel-Ponche S
FAU - Lozeron, Pierre
AU  - Lozeron P
FAU - Piccinini, Giulia
AU  - Piccinini G
FAU - Quintaine, Victorine
AU  - Quintaine V
FAU - Arnulf, Bertrand
AU  - Arnulf B
FAU - Kubis, Nathalie
AU  - Kubis N
FAU - Yelnik, Alain P
AU  - Yelnik AP
LA  - eng
PT  - Journal Article
PL  - Sweden
TA  - J Rehabil Med
JT  - Journal of rehabilitation medicine
JID - 101088169
SB  - IM
MH  - Case-Control Studies
MH  - Chronic Disease
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Photic Stimulation/*methods
MH  - Polyneuropathies/*complications
MH  - Postural Balance/*physiology
MH  - Posture/*physiology
MH  - Proprioception/physiology
MH  - Prospective Studies
EDAT- 2018/01/10 06:00
MHDA- 2018/05/15 06:00
CRDT- 2018/01/10 06:00
PHST- 2018/01/10 06:00 [pubmed]
PHST- 2018/05/15 06:00 [medline]
PHST- 2018/01/10 06:00 [entrez]
AID - 10.2340/16501977-2314 [doi]
PST - ppublish
SO  - J Rehabil Med. 2018 Feb 28;50(3):278-284. doi: 10.2340/16501977-2314.

PMID- 31693621
OWN - NLM
STAT- MEDLINE
DCOM- 20200220
LR  - 20210204
IS  - 1536-0229 (Electronic)
IS  - 0363-9762 (Linking)
VI  - 45
IP  - 1
DP  - 2020 Jan
TI  - Pharmacokinetic Analysis of [18F]FAZA Dynamic PET Imaging Acquisitions for 
      Highlighting Sacrum Tumor Profiles.
PG  - e36-e38
LID - 10.1097/RLU.0000000000002813 [doi]
AB  - A patient enrolled in a clinical trial (NCT02802969) with suspicion of chordoma 
      underwent an [F]FAZA PET/CT, a radiolabeled nitroimidazole analog of hypoxia PET 
      imaging. The patient's images showed a different tumor profile compared to those 
      observed in other hypoxic or nonhypoxic chordoma patients. The motivation for 
      using [F]FAZA pharmacokinetic imaging was to compare this profile with 
      histologically confirmed cases of chordoma. Through visual imaging and 
      quantification of blood and tumor time-activity curves, we excluded the 
      hypothesis that it was a chordoma, diagnosing a paraganglioma.
FAU - Provost, Claire
AU  - Provost C
FAU - Mammar, Hamid
AU  - Mammar H
AD  - Department of Radio-therapy, Institut Curie, Orsay, France.
FAU - Belly-Poinsignon, Anne
AU  - Belly-Poinsignon A
AD  - From the Department of Medical Imaging, Nuclear Medicine, Institut Curie, 
      Saint-Cloud.
FAU - Madar, Olivier
AU  - Madar O
AD  - Department of Radio-pharmacology, Institut Curie, Saint-Cloud.
FAU - Champion, Laurence
AU  - Champion L
AD  - From the Department of Medical Imaging, Nuclear Medicine, Institut Curie, 
      Saint-Cloud.
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - Clin Nucl Med
JT  - Clinical nuclear medicine
JID - 7611109
RN  - 0 (Nitroimidazoles)
RN  - 1QR3UU6P48 (fluoroazomycin arabinoside)
SB  - IM
MH  - Clinical Trials as Topic
MH  - Female
MH  - Humans
MH  - *Image Processing, Computer-Assisted
MH  - Male
MH  - Nitroimidazoles/*pharmacokinetics
MH  - *Positron Emission Tomography Computed Tomography
MH  - Sacrum/*diagnostic imaging
MH  - Spinal Neoplasms/*diagnostic imaging/*metabolism
EDAT- 2019/11/07 06:00
MHDA- 2020/02/23 06:00
CRDT- 2019/11/07 06:00
PHST- 2019/11/07 06:00 [pubmed]
PHST- 2020/02/23 06:00 [medline]
PHST- 2019/11/07 06:00 [entrez]
AID - 00003072-202001000-00033 [pii]
AID - 10.1097/RLU.0000000000002813 [doi]
PST - ppublish
SO  - Clin Nucl Med. 2020 Jan;45(1):e36-e38. doi: 10.1097/RLU.0000000000002813.

PMID- 36424320
OWN - NLM
STAT- MEDLINE
DCOM- 20221220
LR  - 20221222
IS  - 1525-3198 (Electronic)
IS  - 0022-0302 (Linking)
VI  - 106
IP  - 1
DP  - 2023 Jan
TI  - Single-step production of autologous bovine platelet concentrate for clinical 
      applications in cattle.
PG  - 565-575
LID - S0022-0302(22)00673-7 [pii]
LID - 10.3168/jds.2021-21108 [doi]
AB  - Platelet concentrate (PC) is an alternative therapy to treat mastitis in dairy 
      cattle and is an alternative treatment for reproduction problems such as 
      endometritis. Unfortunately, double-centrifugation processing methods described 
      are time-consuming, require specialized laboratory equipment, and are usually 
      done in a heterologous way, which risks herd health. To overcome this limitation, 
      we evaluated single-step bovine PC processing methods readily applicable to a 
      farm setting using an autologous conditioned plasma (ACP) production system. We 
      investigated the hematologic findings, cytokines, and growth factors of the 
      obtained PC samples. Autologous conditioned plasma was prepared using whole blood 
      (WB) from 4 cows (group 1) using single-step centrifugation and 16 different 
      processing methods. The 2 protocols that yielded the highest ratio of platelet to 
      white blood cell (WBC) concentration were ACP-1 [720 × g (2,200 rpm), 5 min] and 
      ACP-2 [929 × g (2,500 rpm), 3 min]. They were subsequently reproduced and 
      compared using WB from 8 cows (group 2). Hematologic findings were quantified, 
      IL-1β (cytokine) and growth factors [platelet-derived growth factor (PDGF), 
      transforming growth factor (TGF)-β, bovine fibroblast growth factor (b-FGF)] were 
      measured, and enrichment factors were compared between samples and processing 
      methods. Hematological characteristics and platelet enrichment varied markedly 
      among tested protocols and all were statistically different from WB. Protocol 
      ACP-2 resulted in significantly greater platelet enrichment (mean 169% of WB) 
      than ACP-1 (125% of WB). We found no significant difference between the 2 ACP 
      preparation protocols with regard to leukocyte reduction (7.53-9.75% WBC compared 
      with WB) or growth factor enrichment (124-125% PDGF, 95-100% TGF-β, 102-104% 
      b-FGF, and 56-74% IL-1β compared with WB). In conclusion, both ACP protocols 
      yielded a platelet concentration shown to promote healing for clinical 
      applications in cattle, and the ACP-2 protocol resulted in a greater degree of 
      platelet enrichment. Therefore, this protocol could be used for ACP production 
      for clinical applications in cattle.
CI  - The Authors. Published by Elsevier Inc. and Fass Inc. on behalf of the American 
      Dairy Science Association®. This is an open access article under the CC BY 
      license (http://creativecommons.org/licenses/by/4.0/).
FAU - Constant, C
AU  - Constant C
AD  - Department of Clinical Sciences, Université de Montréal, St-Hyacinthe, Québec J2S 
      2M2, Canada; AO Research Institute Davos, 7270 Davos Platz, Switzerland. 
      Electronic address: caroline.constant@aofoundation.org.
FAU - Desrochers, A
AU  - Desrochers A
AD  - Department of Clinical Sciences, Université de Montréal, St-Hyacinthe, Québec J2S 
      2M2, Canada.
FAU - Gagnon, C A
AU  - Gagnon CA
AD  - Service de diagnostic et Centre de recherche en infectiologie porcine et avicole 
      (CRIPA), University of Montréal, St-Hyacinthe, J2S 2M2 Québec, Canada.
FAU - Provost, C
AU  - Provost C
AD  - Service de diagnostic et Centre de recherche en infectiologie porcine et avicole 
      (CRIPA), University of Montréal, St-Hyacinthe, J2S 2M2 Québec, Canada.
FAU - Nichols, S
AU  - Nichols S
AD  - Department of Clinical Sciences, Université de Montréal, St-Hyacinthe, Québec J2S 
      2M2, Canada.
FAU - Marchionatti, E
AU  - Marchionatti E
AD  - Department of Clinical Sciences, Université de Montréal, St-Hyacinthe, Québec J2S 
      2M2, Canada; Vetsuisse-Faculty Bern, University of Bern, 3012 Bern, Switzerland.
FAU - Gara-Boivin, C
AU  - Gara-Boivin C
AD  - Department of Pathology and Microbiology, University of Montréal, 
      Saint-Hyacinthe, Québec J2S 2M2, Canada.
LA  - eng
PT  - Journal Article
DEP - 20221121
PL  - United States
TA  - J Dairy Sci
JT  - Journal of dairy science
JID - 2985126R
RN  - 0 (Intercellular Signaling Peptides and Proteins)
RN  - 0 (Cytokines)
RN  - 62031-54-3 (Fibroblast Growth Factors)
SB  - IM
MH  - Female
MH  - Cattle
MH  - Animals
MH  - *Platelet-Rich Plasma/metabolism
MH  - Intercellular Signaling Peptides and Proteins
MH  - Cytokines/metabolism
MH  - Blood Platelets/metabolism
MH  - Leukocytes/metabolism
MH  - Fibroblast Growth Factors
OTO - NOTNLM
OT  - autologous conditioned plasma (ACP)
OT  - bovine
OT  - platelet concentrate (PC)
OT  - platelet-rich plasma (PRP)
OT  - regenerative medicine
EDAT- 2022/11/25 06:00
MHDA- 2022/12/21 06:00
CRDT- 2022/11/24 22:14
PHST- 2021/08/03 00:00 [received]
PHST- 2022/08/22 00:00 [accepted]
PHST- 2022/11/25 06:00 [pubmed]
PHST- 2022/12/21 06:00 [medline]
PHST- 2022/11/24 22:14 [entrez]
AID - S0022-0302(22)00673-7 [pii]
AID - 10.3168/jds.2021-21108 [doi]
PST - ppublish
SO  - J Dairy Sci. 2023 Jan;106(1):565-575. doi: 10.3168/jds.2021-21108. Epub 2022 Nov 
      21.

PMID- 36521962
OWN - NLM
STAT- MEDLINE
DCOM- 20230113
LR  - 20230211
IS  - 1936-959X (Electronic)
IS  - 0195-6108 (Print)
IS  - 0195-6108 (Linking)
VI  - 44
IP  - 1
DP  - 2023 Jan
TI  - FLAIR Vascular Hyperintensities as a Surrogate of Collaterals in Acute Stroke: 
      DWI Matters.
PG  - 26-32
LID - 10.3174/ajnr.A7733 [doi]
AB  - BACKGROUND AND PURPOSE: FLAIR vascular hyperintensities are thought to represent 
      leptomeningeal collaterals in acute ischemic stroke. However, whether all-FLAIR 
      vascular hyperintensities or FLAIR vascular hyperintensities-DWI mismatch, ie, 
      FLAIR vascular hyperintensities beyond the DWI lesion, best reflects collaterals 
      remains debated. We aimed to compare the value of FLAIR vascular 
      hyperintensities-DWI mismatch versus all-FLAIR vascular hyperintensities for 
      collateral assessment using PWI-derived collateral flow maps as a reference. 
      MATERIALS AND METHODS: We retrospectively reviewed the registries of 6 large 
      stroke centers and included all patients with acute stroke with anterior 
      circulation large-vessel occlusion who underwent MR imaging with PWI before 
      thrombectomy. Collateral status was graded from 1 to 4 on PWI-derived collateral 
      flow maps and dichotomized into good (grades 3-4) and poor (grades 1-2). The 
      extent of all-FLAIR vascular hyperintensities and FLAIR vascular 
      hyperintensities-DWI mismatch was assessed on the 7 cortical ASPECTS regions, 
      ranging from 0 (absence) to 7 (extensive), and associations with good collaterals 
      were compared using receiver operating characteristic curves. RESULTS: Of the 209 
      included patients, 133 (64%) and 76 (36%) had good and poor collaterals, 
      respectively. All-FLAIR vascular hyperintensity extent was similar between 
      collateral groups (P = .76). Conversely, FLAIR vascular hyperintensities-DWI 
      mismatch extent was significantly higher in patients with good compared with poor 
      collaterals (P < .001). The area under the curve was 0.80 (95% CI, 0.74-0.87) for 
      FLAIR vascular hyperintensities-DWI mismatch and 0.52 (95% CI, 0.44-0.60) for 
      all-FLAIR vascular hyperintensities (P < .001 for the comparison), to predict 
      good collaterals. Variables independently associated with good collaterals were 
      smaller DWI lesion volume (P < .001) and larger FLAIR vascular 
      hyperintensities-DWI mismatch (P = .02). CONCLUSIONS: In acute ischemic stroke 
      with large-vessel occlusion, the extent of FLAIR vascular hyperintensities does 
      not reliably reflect collateral status unless one accounts for DWI.
CI  - © 2023 by American Journal of Neuroradiology.
FAU - Legrand, L
AU  - Legrand L
AUID- ORCID: 0000-0003-3951-7405
AD  - From the Institute of Psychiatry and Neuroscience of Paris (L.L., A.L.B., J.B., 
      W.B.H., C.P., O.N., J.-C.B., G.T., C. Oppenheim), Université Paris Cité, Institut 
      National de la Santé et de la Recherche Médicale U1266, Federation 
      Hospitalo-Universitaire NeuroVasc, Paris, France l.legrand@ghu-paris.fr.
AD  - Departments of Neuroradiology (L.L., A.L.B., J.B., W.B.H., C.P., O.N., C. 
      Oppenheim).
FAU - Le Berre, A
AU  - Le Berre A
AUID- ORCID: 0000-0002-9328-6698
AD  - From the Institute of Psychiatry and Neuroscience of Paris (L.L., A.L.B., J.B., 
      W.B.H., C.P., O.N., J.-C.B., G.T., C. Oppenheim), Université Paris Cité, Institut 
      National de la Santé et de la Recherche Médicale U1266, Federation 
      Hospitalo-Universitaire NeuroVasc, Paris, France.
AD  - Departments of Neuroradiology (L.L., A.L.B., J.B., W.B.H., C.P., O.N., C. 
      Oppenheim).
FAU - Seners, P
AU  - Seners P
AUID- ORCID: 0000-0002-2134-0691
AD  - Department of Neurology (P.S.), Hôpital Fondation Rothschild, Paris, France.
FAU - Benzakoun, J
AU  - Benzakoun J
AUID- ORCID: 0000-0002-0733-0104
AD  - From the Institute of Psychiatry and Neuroscience of Paris (L.L., A.L.B., J.B., 
      W.B.H., C.P., O.N., J.-C.B., G.T., C. Oppenheim), Université Paris Cité, Institut 
      National de la Santé et de la Recherche Médicale U1266, Federation 
      Hospitalo-Universitaire NeuroVasc, Paris, France.
AD  - Departments of Neuroradiology (L.L., A.L.B., J.B., W.B.H., C.P., O.N., C. 
      Oppenheim).
FAU - Ben Hassen, W
AU  - Ben Hassen W
AUID- ORCID: 0000-0003-4858-3623
AD  - From the Institute of Psychiatry and Neuroscience of Paris (L.L., A.L.B., J.B., 
      W.B.H., C.P., O.N., J.-C.B., G.T., C. Oppenheim), Université Paris Cité, Institut 
      National de la Santé et de la Recherche Médicale U1266, Federation 
      Hospitalo-Universitaire NeuroVasc, Paris, France.
AD  - Departments of Neuroradiology (L.L., A.L.B., J.B., W.B.H., C.P., O.N., C. 
      Oppenheim).
FAU - Lion, S
AU  - Lion S
AD  - Edmus Services (S.L.), Fondation Edmus, Lyon, France.
FAU - Boulouis, G
AU  - Boulouis G
AUID- ORCID: 0000-0001-8422-9205
AD  - Department of Diagnostic and Interventional Neuroradiology (G.B., J-.P.C.), 
      Bretonneau Hospital, University of Tours, Institut National de la Santé et de la 
      Recherche Médicale 1253 iBrain, Tours, France.
FAU - Cottier, J-P
AU  - Cottier JP
AUID- ORCID: 0000-0003-0618-4026
AD  - Department of Diagnostic and Interventional Neuroradiology (G.B., J-.P.C.), 
      Bretonneau Hospital, University of Tours, Institut National de la Santé et de la 
      Recherche Médicale 1253 iBrain, Tours, France.
FAU - Costalat, V
AU  - Costalat V
AUID- ORCID: 0000-0001-8428-9101
AD  - Department of Interventional Neuroradiology (V.C.), Centre Hospitalier Regional 
      Universitaire Gui de Chauliac, Montpellier, France.
FAU - Bracard, S
AU  - Bracard S
AUID- ORCID: 0000-0001-9423-6660
AD  - Department of Diagnostic and Interventional Neuroradiology (S.B.), University 
      Hospital of Nancy, Institut National de la Santé et de la Recherche Médicale 
      U947, Nancy, France.
FAU - Berthezene, Y
AU  - Berthezene Y
AUID- ORCID: 0000-0001-6725-7861
AD  - Department of Neuroradiology (Y.B.), Hospices Civils de Lyon, Lyon, France.
FAU - Ozsancak, C
AU  - Ozsancak C
AD  - Department of Neurology (C. Ozsancak), Orleans Hospital, Orleans, France.
FAU - Provost, C
AU  - Provost C
AUID- ORCID: 0000-0002-0200-4027
AD  - From the Institute of Psychiatry and Neuroscience of Paris (L.L., A.L.B., J.B., 
      W.B.H., C.P., O.N., J.-C.B., G.T., C. Oppenheim), Université Paris Cité, Institut 
      National de la Santé et de la Recherche Médicale U1266, Federation 
      Hospitalo-Universitaire NeuroVasc, Paris, France.
AD  - Departments of Neuroradiology (L.L., A.L.B., J.B., W.B.H., C.P., O.N., C. 
      Oppenheim).
FAU - Naggara, O
AU  - Naggara O
AUID- ORCID: 0000-0002-9544-379X
AD  - From the Institute of Psychiatry and Neuroscience of Paris (L.L., A.L.B., J.B., 
      W.B.H., C.P., O.N., J.-C.B., G.T., C. Oppenheim), Université Paris Cité, Institut 
      National de la Santé et de la Recherche Médicale U1266, Federation 
      Hospitalo-Universitaire NeuroVasc, Paris, France.
AD  - Departments of Neuroradiology (L.L., A.L.B., J.B., W.B.H., C.P., O.N., C. 
      Oppenheim).
FAU - Baron, J-C
AU  - Baron JC
AUID- ORCID: 0000-0002-5264-2588
AD  - From the Institute of Psychiatry and Neuroscience of Paris (L.L., A.L.B., J.B., 
      W.B.H., C.P., O.N., J.-C.B., G.T., C. Oppenheim), Université Paris Cité, Institut 
      National de la Santé et de la Recherche Médicale U1266, Federation 
      Hospitalo-Universitaire NeuroVasc, Paris, France.
AD  - Neurology (J.-C.B., G.T.), Groupe Hospitalier Universitaire-Paris Psychiatrie et 
      Neurosciences, Sainte-Anne Hospital, Paris, France.
FAU - Turc, G
AU  - Turc G
AUID- ORCID: 0000-0001-5059-4095
AD  - From the Institute of Psychiatry and Neuroscience of Paris (L.L., A.L.B., J.B., 
      W.B.H., C.P., O.N., J.-C.B., G.T., C. Oppenheim), Université Paris Cité, Institut 
      National de la Santé et de la Recherche Médicale U1266, Federation 
      Hospitalo-Universitaire NeuroVasc, Paris, France.
AD  - Neurology (J.-C.B., G.T.), Groupe Hospitalier Universitaire-Paris Psychiatrie et 
      Neurosciences, Sainte-Anne Hospital, Paris, France.
FAU - Oppenheim, C
AU  - Oppenheim C
AUID- ORCID: 0000-0003-3410-0862
AD  - From the Institute of Psychiatry and Neuroscience of Paris (L.L., A.L.B., J.B., 
      W.B.H., C.P., O.N., J.-C.B., G.T., C. Oppenheim), Université Paris Cité, Institut 
      National de la Santé et de la Recherche Médicale U1266, Federation 
      Hospitalo-Universitaire NeuroVasc, Paris, France.
AD  - Departments of Neuroradiology (L.L., A.L.B., J.B., W.B.H., C.P., O.N., C. 
      Oppenheim).
CN  - PREDICT-RECANAL Collaborators
LA  - eng
PT  - Journal Article
DEP - 20221215
PL  - United States
TA  - AJNR Am J Neuroradiol
JT  - AJNR. American journal of neuroradiology
JID - 8003708
SB  - IM
MH  - Humans
MH  - Retrospective Studies
MH  - *Ischemic Stroke/complications
MH  - *Stroke/pathology
MH  - Magnetic Resonance Imaging
MH  - Thrombectomy
MH  - *Brain Ischemia/complications
MH  - Diffusion Magnetic Resonance Imaging/methods
PMC - PMC9835925
EDAT- 2022/12/16 06:00
MHDA- 2023/01/14 06:00
PMCR- 2024/01/01
CRDT- 2022/12/15 21:03
PHST- 2022/07/29 00:00 [received]
PHST- 2022/10/27 00:00 [accepted]
PHST- 2024/01/01 00:00 [pmc-release]
PHST- 2022/12/16 06:00 [pubmed]
PHST- 2023/01/14 06:00 [medline]
PHST- 2022/12/15 21:03 [entrez]
AID - ajnr.A7733 [pii]
AID - 22-00635 [pii]
AID - 10.3174/ajnr.A7733 [doi]
PST - ppublish
SO  - AJNR Am J Neuroradiol. 2023 Jan;44(1):26-32. doi: 10.3174/ajnr.A7733. Epub 2022 
      Dec 15.

PMID- 33673772
OWN - NLM
STAT- MEDLINE
DCOM- 20211210
LR  - 20211214
IS  - 0191-2917 (Print)
IS  - 0191-2917 (Linking)
VI  - 105
IP  - 9
DP  - 2021 Sep
TI  - Anthracnose Risk Establishment Based on Age-Related Susceptibility of Grape 
      Leaves, Flowers, and Berries to Infection by Elsinoë ampelina.
PG  - 2380-2388
LID - 10.1094/PDIS-09-20-2060-RE [doi]
AB  - Anthracnose is an important disease of grapevines caused by the fungus Elsinoë 
      ampelina. In recent years, there have been regular outbreaks in humid 
      grape-growing regions around the world. Young leaves and berries are reported to 
      be highly susceptible to E. ampelina, but detailed and seasonal development of 
      age-related susceptibility remains unclear. Experiments were conducted under 
      greenhouse and vineyard conditions by inoculating 1- to 19-day-old leaves, 
      flowers, and berries at different phenological stages of three grapevine 
      cultivars (Vandal-Cliche, Marquette, and Vidal). Leaf susceptibility was highest 
      when inoculated at 1 to 2 days old, and inoculated leaves were moderately 
      susceptible at 3 to 6 days old and almost resistant when older than 6 days. The 
      influence of leaf age on anthracnose relative severity was adequately described 
      by an exponential decay model. The susceptibility of the inflorescences was high 
      when inoculated from their initiation to the full flowering (50% fall of the 
      caps), and the inflorescences/flowers were moderately susceptible until veraison, 
      after which the berries were practically resistant. The flower/berry 
      susceptibility as a function of degree-days accumulated since 1 April was modeled 
      using a sigmoid model. Based on this model, 50% disease incidence is reached when 
      656, 543, and 550 degree days are accumulated for the cultivars Vandal-Cliche, 
      Marquette, and Vidal, respectively. These results suggest that the risk of 
      anthracnose development is high from bud-break to fruit set, and on newly emerged 
      leaves either early in the season or following pruning. More knowledge on 
      anthracnose epidemiology is needed, but these results could be used to improve 
      timing of fungicide applications and pruning activities.
FAU - Carisse, Odile
AU  - Carisse O
AUID- ORCID: 0000-0002-2714-013X
AD  - Saint-Jean-sur-Richelieu Research and Development Centre, Agriculture and 
      Agri-Food Canada, Saint-Jean-sur-Richelieu, QC, J3B 3E6, Canada.
FAU - Levasseur, Audrey
AU  - Levasseur A
AD  - Saint-Jean-sur-Richelieu Research and Development Centre, Agriculture and 
      Agri-Food Canada, Saint-Jean-sur-Richelieu, QC, J3B 3E6, Canada.
FAU - Provost, Caroline
AU  - Provost C
AD  - Centre de Recherche Agroalimentaire de Mirabel, Mirabel, QC, J7N 2X8, Canada.
LA  - eng
PT  - Journal Article
DEP - 20211012
PL  - United States
TA  - Plant Dis
JT  - Plant disease
JID - 9882809
RN  - Elsinoe ampelina
SB  - IM
MH  - Ascomycota
MH  - Flowers
MH  - Fruit
MH  - Plant Diseases
MH  - Plant Leaves
MH  - *Vitis
OTO - NOTNLM
OT  - disease management
OT  - fungi
OT  - ontogenic/resistance
OT  - small fruits
EDAT- 2021/03/07 06:00
MHDA- 2021/12/15 06:00
CRDT- 2021/03/06 05:27
PHST- 2021/03/07 06:00 [pubmed]
PHST- 2021/12/15 06:00 [medline]
PHST- 2021/03/06 05:27 [entrez]
AID - 10.1094/PDIS-09-20-2060-RE [doi]
PST - ppublish
SO  - Plant Dis. 2021 Sep;105(9):2380-2388. doi: 10.1094/PDIS-09-20-2060-RE. Epub 2021 
      Oct 12.

PMID- 32856560
OWN - NLM
STAT- MEDLINE
DCOM- 20210430
LR  - 20210829
IS  - 1943-4936 (Electronic)
IS  - 1040-6387 (Print)
IS  - 1040-6387 (Linking)
VI  - 33
IP  - 2
DP  - 2021 Mar
TI  - Porcine reproductive and respiratory syndrome virus whole-genome sequencing 
      efficacy with field clinical samples using a poly(A)-tail viral genome 
      purification method.
PG  - 216-226
LID - 10.1177/1040638720952411 [doi]
AB  - The genomic surveillance of porcine reproductive and respiratory syndrome virus 
      (PRRSV) is based on sequencing of the ORF5 gene of the virus, which covers only 
      4% of the entire viral genome. It is expected that PRRSV whole-genome sequencing 
      (WGS) will improve PRRSV genomic data and allow better understanding of clinical 
      discrepancies observed in the field when using ORF5 sequencing. Our main 
      objective was to implement an efficient method for WGS of PRRSV from clinical 
      samples. The viral genome was purified using a poly(A)-tail viral genome 
      purification method and sequenced using Illumina technology. We tested 149 
      PRRSV-positive samples: 80 sera, 33 lungs, 33 pools of tissues, 2 oral fluids, 
      and 1 processing fluid (i.e., castration liquid). Overall, WGS of 67.1% of 
      PRRSV-positive cases was successful. The viral load, in particular for tissues, 
      had a major impact on the PRRSV WGS success rate. Serum was the most efficient 
      type of sample to conduct PRRSV WGS poly(A)-tail assays, with a success rate of 
      76.3%, and this result can be explained by improved sequencing reads dispersion 
      matching throughout the entire viral genome. WGS was unsuccessful for all pools 
      of tissue and lung samples with Cq values > 26.5, whereas it could still be 
      successful with sera at Cq ≤ 34.1. Evaluation of results of highly qualified 
      personnel confirmed that laboratory skills could affect PRRSV WGS efficiency. 
      Oral fluid samples seem very promising and merit further investigation because, 
      with only 2 samples of low viral load (Cq = 28.8, 32.8), PRRSV WGS was 
      successful.
FAU - Gagnon, Carl A
AU  - Gagnon CA
AUID- ORCID: 0000-0003-4528-541X
AD  - Swine and Poultry Infectious Diseases Research Center and Molecular Diagnostic 
      Laboratory of the Service de diagnostic, Faculté de médecine vétérinaire, 
      Université de Montréal, St-Hyacinthe, Québec, Canada.
FAU - Lalonde, Christian
AU  - Lalonde C
AD  - Swine and Poultry Infectious Diseases Research Center, Faculté de médecine 
      vétérinaire, Université de Montréal, St-Hyacinthe, Québec, Canada.
FAU - Provost, Chantale
AU  - Provost C
AD  - Swine and Poultry Infectious Diseases Research Center and Molecular Diagnostic 
      Laboratory of the Service de diagnostic, Faculté de médecine vétérinaire, 
      Université de Montréal, St-Hyacinthe, Québec, Canada.
LA  - eng
PT  - Journal Article
DEP - 20200828
PL  - United States
TA  - J Vet Diagn Invest
JT  - Journal of veterinary diagnostic investigation : official publication of the 
      American Association of Veterinary Laboratory Diagnosticians, Inc
JID - 9011490
SB  - IM
MH  - Animals
MH  - Genome, Viral
MH  - High-Throughput Nucleotide Sequencing/methods/*veterinary
MH  - Porcine Reproductive and Respiratory Syndrome/*diagnosis
MH  - Porcine respiratory and reproductive syndrome virus/*isolation & purification
MH  - Sus scrofa
MH  - Swine
MH  - Viral Load/*veterinary
MH  - Whole Genome Sequencing/methods/*veterinary
PMC - PMC7953089
OTO - NOTNLM
OT  - MiSeq
OT  - animal viral disease
OT  - poly(A)-tails
OT  - porcine reproductive and respiratory syndrome virus
OT  - swine virus
OT  - whole-genome sequencing
COIS- Declaration of conflicting interests: The authors declared no potential conflicts 
      of interest with respect to the research, authorship, and/or publication of this 
      article.
EDAT- 2020/08/29 06:00
MHDA- 2021/05/01 06:00
CRDT- 2020/08/29 06:00
PHST- 2020/08/29 06:00 [pubmed]
PHST- 2021/05/01 06:00 [medline]
PHST- 2020/08/29 06:00 [entrez]
AID - 10.1177_1040638720952411 [pii]
AID - 10.1177/1040638720952411 [doi]
PST - ppublish
SO  - J Vet Diagn Invest. 2021 Mar;33(2):216-226. doi: 10.1177/1040638720952411. Epub 
      2020 Aug 28.

PMID- 31239470
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20200413
LR  - 20210110
IS  - 2045-2322 (Electronic)
IS  - 2045-2322 (Linking)
VI  - 9
IP  - 1
DP  - 2019 Jun 25
TI  - Winter storms accelerate the demise of sea ice in the Atlantic sector of the 
      Arctic Ocean.
PG  - 9222
LID - 10.1038/s41598-019-45574-5 [doi]
LID - 9222
AB  - A large retreat of sea-ice in the 'stormy' Atlantic Sector of the Arctic Ocean 
      has become evident through a series of record minima for the winter maximum 
      sea-ice extent since 2015. Results from the Norwegian young sea ICE (N-ICE2015) 
      expedition, a five-month-long (Jan-Jun) drifting ice station in first and second 
      year pack-ice north of Svalbard, showcase how sea-ice in this region is 
      frequently affected by passing winter storms. Here we synthesise the 
      interdisciplinary N-ICE2015 dataset, including independent observations of the 
      atmosphere, snow, sea-ice, ocean, and ecosystem. We build upon recent results and 
      illustrate the different mechanisms through which winter storms impact the 
      coupled Arctic sea-ice system. These short-lived and episodic synoptic-scale 
      events transport pulses of heat and moisture into the Arctic, which temporarily 
      reduce radiative cooling and henceforth ice growth. Cumulative snowfall from each 
      sequential storm deepens the snow pack and insulates the sea-ice, further 
      inhibiting ice growth throughout the remaining winter season. Strong winds 
      fracture the ice cover, enhance ocean-ice-atmosphere heat fluxes, and make the 
      ice more susceptible to lateral melt. In conclusion, the legacy of Arctic winter 
      storms for sea-ice and the ice-associated ecosystem in the Atlantic Sector lasts 
      far beyond their short lifespan.
FAU - Graham, Robert M
AU  - Graham RM
AUID- ORCID: 0000-0003-0008-1886
AD  - Norwegian Polar Institute, Fram Centre, Tromsø, Norway. Robert.Graham@npolar.no.
FAU - Itkin, Polona
AU  - Itkin P
AUID- ORCID: 0000-0002-4029-1936
AD  - Norwegian Polar Institute, Fram Centre, Tromsø, Norway. Polona.Itkin@uit.no.
FAU - Meyer, Amelie
AU  - Meyer A
AUID- ORCID: 0000-0003-0447-795X
AD  - Norwegian Polar Institute, Fram Centre, Tromsø, Norway.
AD  - ARC Centre of Excellence for Climate Extremes, IMAS University of Tasmania, 
      Hobart, Australia.
FAU - Sundfjord, Arild
AU  - Sundfjord A
AUID- ORCID: 0000-0002-6913-3368
AD  - Norwegian Polar Institute, Fram Centre, Tromsø, Norway.
FAU - Spreen, Gunnar
AU  - Spreen G
AUID- ORCID: 0000-0003-0165-8448
AD  - Institute of Environmental Physics, University of Bremen, Bergen, Germany.
FAU - Smedsrud, Lars H
AU  - Smedsrud LH
AUID- ORCID: 0000-0001-7391-0740
AD  - Geophysical Institute, University of Bergen, Bergen, Norway.
AD  - Bjerknes Centre for Climate Research, Bergen, Norway.
FAU - Liston, Glen E
AU  - Liston GE
AD  - Cooperative Institute for Research in the Atmosphere, Colorado State University, 
      Fort Collins, Colorado, USA.
FAU - Cheng, Bin
AU  - Cheng B
AD  - Finnish Meteorological Institute, Helsinki, Finland.
FAU - Cohen, Lana
AU  - Cohen L
AD  - Norwegian Polar Institute, Fram Centre, Tromsø, Norway.
FAU - Divine, Dmitry
AU  - Divine D
AD  - Norwegian Polar Institute, Fram Centre, Tromsø, Norway.
FAU - Fer, Ilker
AU  - Fer I
AUID- ORCID: 0000-0002-2427-2532
AD  - Bjerknes Centre for Climate Research, Bergen, Norway.
FAU - Fransson, Agneta
AU  - Fransson A
AD  - Norwegian Polar Institute, Fram Centre, Tromsø, Norway.
FAU - Gerland, Sebastian
AU  - Gerland S
AUID- ORCID: 0000-0002-2295-9867
AD  - Norwegian Polar Institute, Fram Centre, Tromsø, Norway.
FAU - Haapala, Jari
AU  - Haapala J
AD  - Finnish Meteorological Institute, Helsinki, Finland.
FAU - Hudson, Stephen R
AU  - Hudson SR
AD  - Norwegian Polar Institute, Fram Centre, Tromsø, Norway.
FAU - Johansson, A Malin
AU  - Johansson AM
AUID- ORCID: 0000-0003-0129-2239
AD  - UiT The Arctic University of Norway, Tromsø, Norway.
FAU - King, Jennifer
AU  - King J
AD  - Norwegian Polar Institute, Fram Centre, Tromsø, Norway.
FAU - Merkouriadi, Ioanna
AU  - Merkouriadi I
AD  - Norwegian Polar Institute, Fram Centre, Tromsø, Norway.
FAU - Peterson, Algot K
AU  - Peterson AK
AD  - Geophysical Institute, University of Bergen, Bergen, Norway.
AD  - Bjerknes Centre for Climate Research, Bergen, Norway.
FAU - Provost, Christine
AU  - Provost C
AD  - Laboratoire LOCEAN-IPSL, Sorbonne Universités, UPMC, Univ. Paris 6, 
      CNRS-IRD-MNHN, Paris, France.
FAU - Randelhoff, Achim
AU  - Randelhoff A
AUID- ORCID: 0000-0001-7947-9090
AD  - Norwegian Polar Institute, Fram Centre, Tromsø, Norway.
FAU - Rinke, Annette
AU  - Rinke A
AD  - Alfred Wegener Institute, Helmholtz Centre for Polar and Marine Research, 
      Potsdam, Germany.
FAU - Rösel, Anja
AU  - Rösel A
AD  - Norwegian Polar Institute, Fram Centre, Tromsø, Norway.
FAU - Sennéchael, Nathalie
AU  - Sennéchael N
AD  - Laboratoire LOCEAN-IPSL, Sorbonne Universités, UPMC, Univ. Paris 6, 
      CNRS-IRD-MNHN, Paris, France.
FAU - Walden, Von P
AU  - Walden VP
AD  - Washington State University, Department of Civil and Environmental Engineering, 
      Pullman, Washington, USA.
FAU - Duarte, Pedro
AU  - Duarte P
AD  - Norwegian Polar Institute, Fram Centre, Tromsø, Norway.
FAU - Assmy, Philipp
AU  - Assmy P
AD  - Norwegian Polar Institute, Fram Centre, Tromsø, Norway.
FAU - Steen, Harald
AU  - Steen H
AD  - Norwegian Polar Institute, Fram Centre, Tromsø, Norway.
FAU - Granskog, Mats A
AU  - Granskog MA
AUID- ORCID: 0000-0002-5035-4347
AD  - Norwegian Polar Institute, Fram Centre, Tromsø, Norway. Mats.Granskog@npolar.no.
LA  - eng
GR  - U17 CE002015/CE/NCIPC CDC HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20190625
PL  - England
TA  - Sci Rep
JT  - Scientific reports
JID - 101563288
SB  - IM
PMC - PMC6592951
COIS- The authors declare no competing interests.
EDAT- 2019/06/27 06:00
MHDA- 2019/06/27 06:01
CRDT- 2019/06/27 06:00
PHST- 2018/12/31 00:00 [received]
PHST- 2019/06/11 00:00 [accepted]
PHST- 2019/06/27 06:00 [entrez]
PHST- 2019/06/27 06:00 [pubmed]
PHST- 2019/06/27 06:01 [medline]
AID - 10.1038/s41598-019-45574-5 [pii]
AID - 45574 [pii]
AID - 10.1038/s41598-019-45574-5 [doi]
PST - epublish
SO  - Sci Rep. 2019 Jun 25;9(1):9222. doi: 10.1038/s41598-019-45574-5.

PMID- 34205087
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20210714
IS  - 2076-393X (Print)
IS  - 2076-393X (Electronic)
IS  - 2076-393X (Linking)
VI  - 9
IP  - 6
DP  - 2021 Jun 3
TI  - Comparison of Primary Virus Isolation in Pulmonary Alveolar Macrophages and Four 
      Different Continuous Cell Lines for Type 1 and Type 2 Porcine Reproductive and 
      Respiratory Syndrome Virus.
LID - 10.3390/vaccines9060594 [doi]
LID - 594
AB  - Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) has a highly 
      restricted cellular tropism. In vivo, the virus primarily infects tissue-specific 
      macrophages in the nose, lungs, tonsils, and pharyngeal lymphoid tissues. In 
      vitro however, the MARC-145 cell line is one of the few PRRSV susceptible cell 
      lines that are routinely used for in vitro propagation. Previously, several PRRSV 
      non-permissive cell lines were shown to become susceptible to PRRSV infection 
      upon expression of recombinant entry receptors (e.g., PK15(Sn-CD163), 
      PK15(S10-CD163)). In the present study, we examined the suitability of different 
      cell lines as a possible replacement of primary pulmonary alveolar macrophages 
      (PAM) cells for isolation and growth of PRRSV. The susceptibility of four 
      different cell lines (PK15(Sn-CD163), PK15(S10-CD163), MARC-145, and 
      MARC-145(Sn)) for the primary isolation of PRRSV from PCR positive sera (both 
      PRRSV1 and PRRSV2) was compared with that of PAM. To find possible correlations 
      between the cell tropism and the viral genotype, 54 field samples were sequenced, 
      and amino acid residues potentially associated with the cell tropism were 
      identified. Regarding the virus titers obtained with the five different cell 
      types, PAM gave the highest mean virus titers followed by PK15(Sn-CD163), 
      PK15(S10-CD163), MARC-145(Sn), and MARC-145. The titers in PK15(Sn-CD163) and 
      PK15(S10-CD163) cells were significantly correlated with virus titers in PAM for 
      both PRRSV1 (p < 0.001) and PRRSV2 (p < 0.001) compared with MARC-145(Sn) 
      (PRRSV1: p = 0.22 and PRRSV2: p = 0.03) and MARC-145 (PRRSV1: p = 0.04 and 
      PRRSV2: p = 0.12). Further, a possible correlation between cell tropism and viral 
      genotype was assessed using PRRSV whole genome sequences in a 
      Genome-Wide-Association Study (GWAS). The structural protein residues GP2:187L 
      and N:28R within PRRSV2 sequences were associated with their growth in MARC-145. 
      The GP5:78I residue for PRRSV2 and the Nsp11:155F residue for PRRSV1 was linked 
      to a higher replication on PAM. In conclusion, PK15(Sn-CD163) and PK15(S10-CD163) 
      cells are phenotypically closely related to the in vivo target macrophages and 
      are more suitable for virus isolation and titration than MARC-145/MARC-145(Sn) 
      cells. The residues of PRRSV proteins that are potentially related with cell 
      tropism will be further investigated in the future.
FAU - Xie, Jiexiong
AU  - Xie J
AUID- ORCID: 0000-0002-3374-6605
AD  - Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, 9820 
      Merelbeke, Belgium.
FAU - Vereecke, Nick
AU  - Vereecke N
AUID- ORCID: 0000-0001-5367-9756
AD  - Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, 9820 
      Merelbeke, Belgium.
AD  - PathoSense BV, 2500 Lier, Belgium.
FAU - Theuns, Sebastiaan
AU  - Theuns S
AD  - PathoSense BV, 2500 Lier, Belgium.
FAU - Oh, Dayoung
AU  - Oh D
AUID- ORCID: 0000-0002-1694-2620
AD  - Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, 9820 
      Merelbeke, Belgium.
FAU - Vanderheijden, Nathalie
AU  - Vanderheijden N
AD  - Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, 9820 
      Merelbeke, Belgium.
FAU - Trus, Ivan
AU  - Trus I
AUID- ORCID: 0000-0003-2849-5140
AD  - Vaccine and Infectious Disease Organization (VIDO)-International Vaccine Centre, 
      University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada.
FAU - Sauer, Jannes
AU  - Sauer J
AD  - PathoSense BV, 2500 Lier, Belgium.
FAU - Vyt, Philip
AU  - Vyt P
AD  - Dialab, Belsele, 9111 Sint-Niklaas, Belgium.
FAU - Bonckaert, Caroline
AU  - Bonckaert C
AD  - Animal Health Care Flanders (DGZ), 8820 Torhout, Belgium.
FAU - Lalonde, Christian
AU  - Lalonde C
AD  - Swine and Poultry Infectious Diseases Research Center (CRIPA)-Fonds de Recherche 
      du Québec, Faculté de Médecine Vétérinaire, Université de Montréal, St-Hyacinthe, 
      QC J2S 2M2, Canada.
FAU - Provost, Chantale
AU  - Provost C
AUID- ORCID: 0000-0002-6674-1157
AD  - Swine and Poultry Infectious Diseases Research Center (CRIPA)-Fonds de Recherche 
      du Québec, Faculté de Médecine Vétérinaire, Université de Montréal, St-Hyacinthe, 
      QC J2S 2M2, Canada.
FAU - Gagnon, Carl A
AU  - Gagnon CA
AUID- ORCID: 0000-0003-4528-541X
AD  - Swine and Poultry Infectious Diseases Research Center (CRIPA)-Fonds de Recherche 
      du Québec, Faculté de Médecine Vétérinaire, Université de Montréal, St-Hyacinthe, 
      QC J2S 2M2, Canada.
FAU - Nauwynck, Hans
AU  - Nauwynck H
AUID- ORCID: 0000-0001-5470-0713
AD  - Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, 9820 
      Merelbeke, Belgium.
AD  - PathoSense BV, 2500 Lier, Belgium.
LA  - eng
PT  - Journal Article
DEP - 20210603
PL  - Switzerland
TA  - Vaccines (Basel)
JT  - Vaccines
JID - 101629355
PMC - PMC8229515
OTO - NOTNLM
OT  - MARC-145
OT  - PK15S10-CD163
OT  - PK15Sn-CD163
OT  - PRRSV
OT  - macrophages
OT  - virus isolation/production
COIS- The authors declare no conflict of interest.
EDAT- 2021/07/03 06:00
MHDA- 2021/07/03 06:01
CRDT- 2021/07/02 01:23
PHST- 2021/04/28 00:00 [received]
PHST- 2021/05/23 00:00 [revised]
PHST- 2021/06/01 00:00 [accepted]
PHST- 2021/07/02 01:23 [entrez]
PHST- 2021/07/03 06:00 [pubmed]
PHST- 2021/07/03 06:01 [medline]
AID - vaccines9060594 [pii]
AID - vaccines-09-00594 [pii]
AID - 10.3390/vaccines9060594 [doi]
PST - epublish
SO  - Vaccines (Basel). 2021 Jun 3;9(6):594. doi: 10.3390/vaccines9060594.

PMID- 29606732
OWN - NLM
STAT- MEDLINE
DCOM- 20190416
LR  - 20190416
IS  - 0008-5286 (Print)
IS  - 0008-5286 (Linking)
VI  - 59
IP  - 4
DP  - 2018 Apr
TI  - First report of atypical porcine pestivirus in piglets with congenital tremor in 
      Canada.
PG  - 429-432
FAU - Dessureault, Fanny G
AU  - Dessureault FG
AD  - Complexe de diagnostic et d'épidémiosurveillance vétérinaires du Québec 
      (Dessureault), Centre de recherche en infectiologie porcine et avicole (Provost, 
      Gagnon), and Service de diagnostic (Gagnon), Faculté de médecine vétérinaire, 
      Université de Montréal, 3200 rue Sicotte, Saint-Hyacinthe, Québec J2S 2M2; Bureau 
      vétérinaire Martin Choinière DMV Inc., 5 avenue Pie X, Victoriaville, Québec G6P 
      8S7 (Choinière).
FAU - Choinière, Martin
AU  - Choinière M
AD  - Complexe de diagnostic et d'épidémiosurveillance vétérinaires du Québec 
      (Dessureault), Centre de recherche en infectiologie porcine et avicole (Provost, 
      Gagnon), and Service de diagnostic (Gagnon), Faculté de médecine vétérinaire, 
      Université de Montréal, 3200 rue Sicotte, Saint-Hyacinthe, Québec J2S 2M2; Bureau 
      vétérinaire Martin Choinière DMV Inc., 5 avenue Pie X, Victoriaville, Québec G6P 
      8S7 (Choinière).
FAU - Provost, Chantale
AU  - Provost C
AD  - Complexe de diagnostic et d'épidémiosurveillance vétérinaires du Québec 
      (Dessureault), Centre de recherche en infectiologie porcine et avicole (Provost, 
      Gagnon), and Service de diagnostic (Gagnon), Faculté de médecine vétérinaire, 
      Université de Montréal, 3200 rue Sicotte, Saint-Hyacinthe, Québec J2S 2M2; Bureau 
      vétérinaire Martin Choinière DMV Inc., 5 avenue Pie X, Victoriaville, Québec G6P 
      8S7 (Choinière).
FAU - Gagnon, Carl A
AU  - Gagnon CA
AD  - Complexe de diagnostic et d'épidémiosurveillance vétérinaires du Québec 
      (Dessureault), Centre de recherche en infectiologie porcine et avicole (Provost, 
      Gagnon), and Service de diagnostic (Gagnon), Faculté de médecine vétérinaire, 
      Université de Montréal, 3200 rue Sicotte, Saint-Hyacinthe, Québec J2S 2M2; Bureau 
      vétérinaire Martin Choinière DMV Inc., 5 avenue Pie X, Victoriaville, Québec G6P 
      8S7 (Choinière).
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - Canada
TA  - Can Vet J
JT  - The Canadian veterinary journal = La revue veterinaire canadienne
JID - 0004653
SB  - IM
MH  - Animals
MH  - Animals, Newborn
MH  - Canada
MH  - Pestivirus/*isolation & purification
MH  - Pestivirus Infections/congenital/pathology/*veterinary/virology
MH  - Sus scrofa
MH  - Swine
MH  - Swine Diseases/*congenital/virology
MH  - Tremor/congenital/pathology/*veterinary/virology
PMC - PMC5855290
EDAT- 2018/04/03 06:00
MHDA- 2019/04/17 06:00
CRDT- 2018/04/03 06:00
PHST- 2018/04/03 06:00 [entrez]
PHST- 2018/04/03 06:00 [pubmed]
PHST- 2019/04/17 06:00 [medline]
AID - cvj_04_429 [pii]
PST - ppublish
SO  - Can Vet J. 2018 Apr;59(4):429-432.

PMID- 34406414
OWN - NLM
STAT- MEDLINE
DCOM- 20210908
LR  - 20220819
IS  - 1525-3163 (Electronic)
IS  - 0021-8812 (Print)
IS  - 0021-8812 (Linking)
VI  - 99
IP  - 9
DP  - 2021 Sep 1
TI  - The administration of diets contaminated with low to intermediate doses of 
      deoxynivalenol and supplemented with antioxidants and binding agents slightly 
      affects the growth, antioxidant status, and vaccine response in weanling pigs.
LID - 10.1093/jas/skab238 [doi]
LID - skab238
AB  - This study aimed to evaluate the impact of grading levels of deoxynivalenol (DON) 
      in the diet of weaned pigs, as well as the effects of a supplementation with 
      antioxidants (AOX), hydrated sodium calcium aluminosilicates (HSCAS), and their 
      combination on the growth, AOX status, and immune and vaccine responses against 
      the porcine reproductive and respiratory syndrome virus (PRRSV) and porcine 
      circovirus type 2 (PCV2). At weaning, 336 piglets were allocated to six dietary 
      treatments according to a randomized complete block design. Treatments were as 
      follows: basal diet (CTRL); basal diet containing DON at 1.2 mg/kg (DON1.2); 
      basal diet containing DON at 2.4 mg/kg (DON2.4); DON2.4 diet + a mix of AOX which 
      included vitamins A and E at 20,000 IU and 200 IU/kg feed respectively, selenized 
      yeast at 0.3 mg/kg, and a grape seed extracts at 100 mg/kg feed (DON2.4 + AOX); 
      DON2.4 diet + the mix of AOX and the modified HSCAS mentioned above (DON2.4 + AOX 
      + HSCAS); DON2.4 + AOX + HSCAS. Pigs were vaccinated against PRRSV and PCV2 at 7 
      d; on 0, 14, and 35 d, growth performance was recorded, and blood samples were 
      collected in order to evaluate the oxidative status, inflammatory blood markers, 
      lymphocyte blastogenic response, and vaccine antibody response. Increasing intake 
      of DON resulted in a quadratic effect at 35 d in the lymphocyte proliferative 
      response to concanavalin A and PCV2 as well as in the anti-PRRSV antibody 
      response, whereas the catalase activity decreased in DON2.4 pigs compared with 
      the CTRL and DON1.2 groups (P ≤ 0.05). Compared with the DON2.4 diet, the AOX 
      supplementation slightly reduced gain to feed ratio (P = 0.026) and increased the 
      ferric reducing ability of plasma as well as α-tocopherol concentration (P < 
      0.05), whereas the association of AOX + HSCAS increased the anti-PRRSV IgG (P < 
      0.05). Furthermore, the HSCAS supplement reduced haptoglobin levels in serum at 
      14 d compared with the DON2.4 group; however, its concentration decreased in all 
      the experimental treatments from 14 to 35 d and particularly in the DON2.4 + AOX 
      pigs, whereas a different trend was evidenced in the DON2.4 + HSCAS group, where 
      over the same period haptoglobin concentration increased (P < 0.05). Overall, our 
      results show that the addition of AOX and HSCAS in the diet may alleviate the 
      negative effects due to DON contamination on the AOX status and immune response 
      of vaccinated weanling pigs.
CI  - © The Author(s) 2021. Published by Oxford University Press on behalf of the 
      American Society of Animal Science. All rights reserved. For permissions, please 
      e-mail: journals.permissions@oup.com.
FAU - Lo Verso, Luca
AU  - Lo Verso L
AUID- ORCID: 0000-0003-0925-8107
AD  - Department of Animal Science, Laval University, Quebec, QC G1V 0A6, Canada.
FAU - Dumont, Kristina
AU  - Dumont K
AD  - Department of Animal Science, Laval University, Quebec, QC G1V 0A6, Canada.
FAU - Lessard, Martin
AU  - Lessard M
AD  - Department of Animal Science, Laval University, Quebec, QC G1V 0A6, Canada.
AD  - The Swine and Poultry Infectious Diseases Research Centre (CRIPA), Faculté de 
      médecine vétérinaire, Université de Montréal, St-Hyacinthe, QC J2S 2M2, Canada.
AD  - Sherbrooke R & D Center, Agriculture and Agri-Food Canada (AAFC), Sherbrooke, QC 
      J1M 0C8, Canada.
FAU - Lauzon, Karoline
AU  - Lauzon K
AD  - Sherbrooke R & D Center, Agriculture and Agri-Food Canada (AAFC), Sherbrooke, QC 
      J1M 0C8, Canada.
FAU - Provost, Chantale
AU  - Provost C
AD  - The Swine and Poultry Infectious Diseases Research Centre (CRIPA), Faculté de 
      médecine vétérinaire, Université de Montréal, St-Hyacinthe, QC J2S 2M2, Canada.
AD  - Service de diagnostic, Faculté de médecine vétérinaire, Université de Montréal, 
      St-Hyacinthe, QC J2S 2M2, Canada.
FAU - Gagnon, Carl A
AU  - Gagnon CA
AD  - The Swine and Poultry Infectious Diseases Research Centre (CRIPA), Faculté de 
      médecine vétérinaire, Université de Montréal, St-Hyacinthe, QC J2S 2M2, Canada.
AD  - Service de diagnostic, Faculté de médecine vétérinaire, Université de Montréal, 
      St-Hyacinthe, QC J2S 2M2, Canada.
FAU - Chorfi, Younes
AU  - Chorfi Y
AD  - The Swine and Poultry Infectious Diseases Research Centre (CRIPA), Faculté de 
      médecine vétérinaire, Université de Montréal, St-Hyacinthe, QC J2S 2M2, Canada.
AD  - Service de diagnostic, Faculté de médecine vétérinaire, Université de Montréal, 
      St-Hyacinthe, QC J2S 2M2, Canada.
FAU - Guay, Frédéric
AU  - Guay F
AD  - Department of Animal Science, Laval University, Quebec, QC G1V 0A6, Canada.
AD  - The Swine and Poultry Infectious Diseases Research Centre (CRIPA), Faculté de 
      médecine vétérinaire, Université de Montréal, St-Hyacinthe, QC J2S 2M2, Canada.
LA  - eng
GR  - Quebec Ministry of Agriculture, Fisheries and Food/
PT  - Journal Article
PT  - Randomized Controlled Trial, Veterinary
PL  - United States
TA  - J Anim Sci
JT  - Journal of animal science
JID - 8003002
RN  - 0 (Antioxidants)
RN  - 0 (Trichothecenes)
RN  - 0 (Vaccines)
RN  - JT37HYP23V (deoxynivalenol)
SB  - IM
MH  - Animal Feed/analysis
MH  - Animals
MH  - *Antioxidants
MH  - Diet/veterinary
MH  - Dietary Supplements
MH  - Swine
MH  - Trichothecenes
MH  - *Vaccines
PMC - PMC8420677
OTO - NOTNLM
OT  - antioxidants
OT  - binding agents
OT  - deoxynivalenol
OT  - vaccine response
OT  - weanling pig
EDAT- 2021/08/19 06:00
MHDA- 2021/09/09 06:00
CRDT- 2021/08/18 12:28
PHST- 2021/06/18 00:00 [received]
PHST- 2021/08/17 00:00 [accepted]
PHST- 2021/08/19 06:00 [pubmed]
PHST- 2021/09/09 06:00 [medline]
PHST- 2021/08/18 12:28 [entrez]
AID - 6354170 [pii]
AID - skab238 [pii]
AID - 10.1093/jas/skab238 [doi]
PST - ppublish
SO  - J Anim Sci. 2021 Sep 1;99(9):skab238. doi: 10.1093/jas/skab238.

PMID- 30532293
OWN - NLM
STAT- MEDLINE
DCOM- 20191008
LR  - 20191008
IS  - 0008-5286 (Print)
IS  - 0008-5286 (Linking)
VI  - 59
IP  - 12
DP  - 2018 Dec
TI  - Canada: First report of Ureaplasma diversum, a bovine pathogen, in the 
      respiratory tract of swine in Canada.
PG  - 1333-1337
FAU - Burgher, Yaima
AU  - Burgher Y
AD  - Swine and poultry infectious diseases research center (CRIPA) (Burgher, Koszegi, 
      Provost, Gagnon), Molecular diagnostic laboratory (MDL), Service de diagnostic 
      (Grenier St-Saveur, Lafond-Lambert, Provost, Gagnon), Faculté de médecine 
      vétérinaire, Université de Montréal, 3200 rue Sicotte, Saint-Hyacinthe, Québec 
      J2S 2M2; Laboratoire de santé animale, Ministère de l'Agriculture, des Pêcheries 
      et de l'Alimentation du Québec (MAPAQ), 2650 rue Einstein, Ville de Québec, 
      Québec G1P 4S8 (Fournier).
FAU - Koszegi, Marika
AU  - Koszegi M
AD  - Swine and poultry infectious diseases research center (CRIPA) (Burgher, Koszegi, 
      Provost, Gagnon), Molecular diagnostic laboratory (MDL), Service de diagnostic 
      (Grenier St-Saveur, Lafond-Lambert, Provost, Gagnon), Faculté de médecine 
      vétérinaire, Université de Montréal, 3200 rue Sicotte, Saint-Hyacinthe, Québec 
      J2S 2M2; Laboratoire de santé animale, Ministère de l'Agriculture, des Pêcheries 
      et de l'Alimentation du Québec (MAPAQ), 2650 rue Einstein, Ville de Québec, 
      Québec G1P 4S8 (Fournier).
FAU - St-Sauveur, Valérie Grenier
AU  - St-Sauveur VG
AD  - Swine and poultry infectious diseases research center (CRIPA) (Burgher, Koszegi, 
      Provost, Gagnon), Molecular diagnostic laboratory (MDL), Service de diagnostic 
      (Grenier St-Saveur, Lafond-Lambert, Provost, Gagnon), Faculté de médecine 
      vétérinaire, Université de Montréal, 3200 rue Sicotte, Saint-Hyacinthe, Québec 
      J2S 2M2; Laboratoire de santé animale, Ministère de l'Agriculture, des Pêcheries 
      et de l'Alimentation du Québec (MAPAQ), 2650 rue Einstein, Ville de Québec, 
      Québec G1P 4S8 (Fournier).
FAU - Fournier, Dominique
AU  - Fournier D
AD  - Swine and poultry infectious diseases research center (CRIPA) (Burgher, Koszegi, 
      Provost, Gagnon), Molecular diagnostic laboratory (MDL), Service de diagnostic 
      (Grenier St-Saveur, Lafond-Lambert, Provost, Gagnon), Faculté de médecine 
      vétérinaire, Université de Montréal, 3200 rue Sicotte, Saint-Hyacinthe, Québec 
      J2S 2M2; Laboratoire de santé animale, Ministère de l'Agriculture, des Pêcheries 
      et de l'Alimentation du Québec (MAPAQ), 2650 rue Einstein, Ville de Québec, 
      Québec G1P 4S8 (Fournier).
FAU - Lafond-Lambert, Cynthia
AU  - Lafond-Lambert C
AD  - Swine and poultry infectious diseases research center (CRIPA) (Burgher, Koszegi, 
      Provost, Gagnon), Molecular diagnostic laboratory (MDL), Service de diagnostic 
      (Grenier St-Saveur, Lafond-Lambert, Provost, Gagnon), Faculté de médecine 
      vétérinaire, Université de Montréal, 3200 rue Sicotte, Saint-Hyacinthe, Québec 
      J2S 2M2; Laboratoire de santé animale, Ministère de l'Agriculture, des Pêcheries 
      et de l'Alimentation du Québec (MAPAQ), 2650 rue Einstein, Ville de Québec, 
      Québec G1P 4S8 (Fournier).
FAU - Provost, Chantale
AU  - Provost C
AD  - Swine and poultry infectious diseases research center (CRIPA) (Burgher, Koszegi, 
      Provost, Gagnon), Molecular diagnostic laboratory (MDL), Service de diagnostic 
      (Grenier St-Saveur, Lafond-Lambert, Provost, Gagnon), Faculté de médecine 
      vétérinaire, Université de Montréal, 3200 rue Sicotte, Saint-Hyacinthe, Québec 
      J2S 2M2; Laboratoire de santé animale, Ministère de l'Agriculture, des Pêcheries 
      et de l'Alimentation du Québec (MAPAQ), 2650 rue Einstein, Ville de Québec, 
      Québec G1P 4S8 (Fournier).
FAU - Gagnon, Carl A
AU  - Gagnon CA
AD  - Swine and poultry infectious diseases research center (CRIPA) (Burgher, Koszegi, 
      Provost, Gagnon), Molecular diagnostic laboratory (MDL), Service de diagnostic 
      (Grenier St-Saveur, Lafond-Lambert, Provost, Gagnon), Faculté de médecine 
      vétérinaire, Université de Montréal, 3200 rue Sicotte, Saint-Hyacinthe, Québec 
      J2S 2M2; Laboratoire de santé animale, Ministère de l'Agriculture, des Pêcheries 
      et de l'Alimentation du Québec (MAPAQ), 2650 rue Einstein, Ville de Québec, 
      Québec G1P 4S8 (Fournier).
LA  - eng
PT  - Journal Article
PL  - Canada
TA  - Can Vet J
JT  - The Canadian veterinary journal = La revue veterinaire canadienne
JID - 0004653
SB  - IM
MH  - Animals
MH  - Canada/epidemiology
MH  - Polymerase Chain Reaction/methods/veterinary
MH  - Respiratory System/microbiology
MH  - Swine
MH  - Swine Diseases/*microbiology
MH  - Ureaplasma/*isolation & purification
MH  - Ureaplasma Infections/*veterinary
PMC - PMC6237260
EDAT- 2018/12/12 06:00
MHDA- 2019/10/09 06:00
CRDT- 2018/12/12 06:00
PHST- 2018/12/12 06:00 [entrez]
PHST- 2018/12/12 06:00 [pubmed]
PHST- 2019/10/09 06:00 [medline]
AID - cvj_12_1333 [pii]
PST - ppublish
SO  - Can Vet J. 2018 Dec;59(12):1333-1337.

PMID- 32531851
OWN - NLM
STAT- MEDLINE
DCOM- 20201102
LR  - 20201102
IS  - 1600-0714 (Electronic)
IS  - 0904-2512 (Linking)
VI  - 49
IP  - 6
DP  - 2020 Jul
TI  - Interprofessional Collaboration in Dentistry: Role of physiotherapists to improve 
      care and outcomes for chronic pain conditions and sleep disorders.
PG  - 529-537
LID - 10.1111/jop.13068 [doi]
AB  - Physiotherapists can manage chronic pain patients by using technical 
      interventions such as mobility, strengthening, manual therapy, or flexibility in 
      a specific and functional manner, being a key component of a multidisciplinary 
      team. Dentists are involved in the management of different chronic pain 
      conditions such as temporomandibular disorders and sleep disorders such as 
      obstructive sleep apnea. However, they are frequently unaware of the benefits of 
      collaborating with physical therapists. In this review, the collaboration of 
      physical therapists and dentists will be explored when managing orofacial pain, 
      headaches, and sleep disorders. The physical therapist is important in the 
      management of these disorders and also in the screening of risk factors.
CI  - © 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
FAU - Herrero Babiloni, Alberto
AU  - Herrero Babiloni A
AUID- ORCID: 0000-0001-5588-5916
AD  - Sacre-Cœur Hospital, CIUSS du Nord-de-l'île-de-Montréal, Montreal, Canada.
AD  - Faculté de Medicine Dentaire, Université de Montréal, Montreal, Canada.
AD  - Division of Experimental Medicine, McGill University, Montreal, Canada.
FAU - Lam, Jacqueline T A T
AU  - Lam JTAT
AD  - School of Rehabilitation, Faculty of Medicine, Université de Montréal, Montreal, 
      Canada.
FAU - Exposto, Fernando G
AU  - Exposto FG
AD  - Section of Orofacial Pain and Jaw Function, Department of Dentistry, Aarhus 
      University, Aarhus, Denmark.
AD  - Scandinavian Center for Orofacial Neurosciences (SCON), Aarhus, Denmark.
FAU - Beetz, Gabrielle
AU  - Beetz G
AD  - Sacre-Cœur Hospital, CIUSS du Nord-de-l'île-de-Montréal, Montreal, Canada.
FAU - Provost, Catherine
AU  - Provost C
AD  - Sacre-Cœur Hospital, CIUSS du Nord-de-l'île-de-Montréal, Montreal, Canada.
FAU - Gagnon, Dany H
AU  - Gagnon DH
AD  - School of Rehabilitation, Faculty of Medicine, Université de Montréal, Montreal, 
      Canada.
FAU - Lavigne, Gilles J
AU  - Lavigne GJ
AD  - Sacre-Cœur Hospital, CIUSS du Nord-de-l'île-de-Montréal, Montreal, Canada.
AD  - Faculté de Medicine Dentaire, Université de Montréal, Montreal, Canada.
AD  - Division of Experimental Medicine, McGill University, Montreal, Canada.
LA  - eng
PT  - Journal Article
DEP - 20200628
PL  - Denmark
TA  - J Oral Pathol Med
JT  - Journal of oral pathology & medicine : official publication of the International 
      Association of Oral Pathologists and the American Academy of Oral Pathology
JID - 8911934
SB  - IM
MH  - *Chronic Pain/therapy
MH  - Dentistry
MH  - Facial Pain/therapy
MH  - Humans
MH  - Interprofessional Relations
MH  - *Physical Therapists
MH  - *Sleep Wake Disorders/therapy
OTO - NOTNLM
OT  - headache
OT  - multidisciplinary team
OT  - orofacial pain
OT  - physical therapy
OT  - sleep
OT  - temporomandibular joint disorders
EDAT- 2020/06/13 06:00
MHDA- 2020/11/03 06:00
CRDT- 2020/06/13 06:00
PHST- 2020/05/25 00:00 [received]
PHST- 2020/06/04 00:00 [accepted]
PHST- 2020/06/13 06:00 [pubmed]
PHST- 2020/11/03 06:00 [medline]
PHST- 2020/06/13 06:00 [entrez]
AID - 10.1111/jop.13068 [doi]
PST - ppublish
SO  - J Oral Pathol Med. 2020 Jul;49(6):529-537. doi: 10.1111/jop.13068. Epub 2020 Jun 
      28.

PMID- 32998356
OWN - NLM
STAT- MEDLINE
DCOM- 20210308
LR  - 20210308
IS  - 1999-4915 (Electronic)
IS  - 1999-4915 (Linking)
VI  - 12
IP  - 10
DP  - 2020 Sep 28
TI  - Chicken Astrovirus (CAstV) Molecular Studies Reveal Evidence of Multiple Past 
      Recombination Events in Sequences Originated from Clinical Samples of White Chick 
      Syndrome (WCS) in Western Canada.
LID - 10.3390/v12101096 [doi]
LID - 1096
AB  - In this study, we aimed to molecularly characterize 14 whole genome sequences of 
      chicken astrovirus (CAstV) isolated from samples obtained from white chick 
      syndrome (WCS) outbreaks in Western Canada during the period of 2014-2019. Genome 
      sequence comparisons showed all these sequences correspond to the novel Biv group 
      from which no confirmed representatives were published in GenBank. Molecular 
      recombination analyses using recombination detection software (i.e., RDP5 and 
      SimPlot) and phylogenetic analyses suggest multiple past recombination events in 
      open reading frame (ORF)1a, ORF1b, and ORF2. Our findings suggest that 
      recombination events and the accumulation of point mutations may have contributed 
      to the substantial genetic variation observed in CAstV and evidenced by the 
      current seven antigenic sub-clusters hitherto described. This is the first paper 
      that describes recombination events in CAstV following analysis of complete CAstV 
      sequences originated in Canada.
FAU - Palomino-Tapia, Victor
AU  - Palomino-Tapia V
AUID- ORCID: 0000-0002-1367-7403
AD  - Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, 
      University of Calgary, Health Research Innovation Center 2C53, 3330 Hospital 
      Drive NW, Calgary, AB T2N 4N1, Canada.
FAU - Mitevski, Darko
AU  - Mitevski D
AD  - Poultry Health Services, 1-4 East Lake Ave NE, Airdrie, AB T4A 2G8, Canada.
FAU - Inglis, Tom
AU  - Inglis T
AD  - The Institute of Applied Poultry Technologies, 201-151 East Lake Blvd, Airdrie, 
      AB T4A 2G1, Canada.
FAU - van der Meer, Frank
AU  - van der Meer F
AD  - Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, 
      University of Calgary, Health Research Innovation Center 2C53, 3330 Hospital 
      Drive NW, Calgary, AB T2N 4N1, Canada.
FAU - Martin, Emily
AU  - Martin E
AD  - Animal Health Laboratory, University of Guelph, Guelph, ON N1H 6R8, Canada.
FAU - Brash, Marina
AU  - Brash M
AD  - Animal Health Laboratory, University of Guelph, Guelph, ON N1H 6R8, Canada.
FAU - Provost, Chantale
AU  - Provost C
AUID- ORCID: 0000-0002-6674-1157
AD  - Swine and poultry infectious diseases research center (CRIPA Fonds de Recherche 
      du Quebec), Molecular Diagnostic Laboratory, Faculty of veterinary medicine, 
      University of Montreal, 3200 Sicotte, Saint-Hyacinthe, QC J2S 2M2, Canada.
FAU - Gagnon, Carl A
AU  - Gagnon CA
AUID- ORCID: 0000-0003-4528-541X
AD  - Swine and poultry infectious diseases research center (CRIPA Fonds de Recherche 
      du Quebec), Molecular Diagnostic Laboratory, Faculty of veterinary medicine, 
      University of Montreal, 3200 Sicotte, Saint-Hyacinthe, QC J2S 2M2, Canada.
FAU - Abdul-Careem, Mohamed Faizal
AU  - Abdul-Careem MF
AD  - Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, 
      University of Calgary, Health Research Innovation Center 2C53, 3330 Hospital 
      Drive NW, Calgary, AB T2N 4N1, Canada.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20200928
PL  - Switzerland
TA  - Viruses
JT  - Viruses
JID - 101509722
SB  - IM
MH  - Animals
MH  - Astroviridae Infections/epidemiology/pathology/*veterinary/*virology
MH  - Avastrovirus/classification/*genetics
MH  - Base Sequence
MH  - Canada/epidemiology
MH  - Chickens/*virology
MH  - Genome, Viral
MH  - Genotype
MH  - Liver/pathology
MH  - Molecular Epidemiology
MH  - Open Reading Frames
MH  - Phylogeny
MH  - Poultry Diseases/epidemiology/pathology/*virology
MH  - *Recombination, Genetic
PMC - PMC7600043
OTO - NOTNLM
OT  - chicken astrovirus
OT  - molecular epidemiology
OT  - recombination
OT  - runting-stunting syndrome
OT  - white chick syndrome
OT  - whole genome sequencing
COIS- The authors declare no conflict of interest.
EDAT- 2020/10/02 06:00
MHDA- 2021/03/09 06:00
CRDT- 2020/10/01 01:00
PHST- 2020/09/12 00:00 [received]
PHST- 2020/09/22 00:00 [revised]
PHST- 2020/09/25 00:00 [accepted]
PHST- 2020/10/01 01:00 [entrez]
PHST- 2020/10/02 06:00 [pubmed]
PHST- 2021/03/09 06:00 [medline]
AID - v12101096 [pii]
AID - viruses-12-01096 [pii]
AID - 10.3390/v12101096 [doi]
PST - epublish
SO  - Viruses. 2020 Sep 28;12(10):1096. doi: 10.3390/v12101096.

PMID- 31814632
OWN - NLM
STAT- MEDLINE
DCOM- 20200701
LR  - 20200701
IS  - 0008-5286 (Print)
IS  - 0008-5286 (Linking)
VI  - 60
IP  - 12
DP  - 2019 Dec
TI  - First reported outbreak of Duck atadenovirus A tracheobronchitis in 3-week-old 
      ducklings in Québec including whole genome sequence of the virus.
PG  - 1285-1288
FAU - Chénier, Sonia
AU  - Chénier S
AD  - Laboratoire de santé animale de St-Hyacinthe, Ministère de l'Agriculture, des 
      Pêcheries et de l'Alimentation du Québec (MAPAQ), 3220 Sicotte, St-Hyacinthe, 
      Québec J2S 7X9 (Chénier); Services vétérinaires Michel Desroches, 260, rue 
      Principale, St-Cléophas-de-Brandon, Québec J0K 2A0 (Desroches); Molecular 
      diagnostic laboratory (MDL) and Swine and Poultry Infectious Diseases Research 
      Center (CRIPA), Faculté de médecine vétérinaire (FMV) Université de Montréal, 
      3200 Sicotte, St-Hyacinthe, Québec J2S 2M2 (Provost, Bournival, St-Sauveur, 
      Koszegi, Gagnon).
FAU - Desroches, Michel
AU  - Desroches M
AD  - Laboratoire de santé animale de St-Hyacinthe, Ministère de l'Agriculture, des 
      Pêcheries et de l'Alimentation du Québec (MAPAQ), 3220 Sicotte, St-Hyacinthe, 
      Québec J2S 7X9 (Chénier); Services vétérinaires Michel Desroches, 260, rue 
      Principale, St-Cléophas-de-Brandon, Québec J0K 2A0 (Desroches); Molecular 
      diagnostic laboratory (MDL) and Swine and Poultry Infectious Diseases Research 
      Center (CRIPA), Faculté de médecine vétérinaire (FMV) Université de Montréal, 
      3200 Sicotte, St-Hyacinthe, Québec J2S 2M2 (Provost, Bournival, St-Sauveur, 
      Koszegi, Gagnon).
FAU - Provost, Chantale
AU  - Provost C
AD  - Laboratoire de santé animale de St-Hyacinthe, Ministère de l'Agriculture, des 
      Pêcheries et de l'Alimentation du Québec (MAPAQ), 3220 Sicotte, St-Hyacinthe, 
      Québec J2S 7X9 (Chénier); Services vétérinaires Michel Desroches, 260, rue 
      Principale, St-Cléophas-de-Brandon, Québec J0K 2A0 (Desroches); Molecular 
      diagnostic laboratory (MDL) and Swine and Poultry Infectious Diseases Research 
      Center (CRIPA), Faculté de médecine vétérinaire (FMV) Université de Montréal, 
      3200 Sicotte, St-Hyacinthe, Québec J2S 2M2 (Provost, Bournival, St-Sauveur, 
      Koszegi, Gagnon).
FAU - Bournival, Véronique
AU  - Bournival V
AD  - Laboratoire de santé animale de St-Hyacinthe, Ministère de l'Agriculture, des 
      Pêcheries et de l'Alimentation du Québec (MAPAQ), 3220 Sicotte, St-Hyacinthe, 
      Québec J2S 7X9 (Chénier); Services vétérinaires Michel Desroches, 260, rue 
      Principale, St-Cléophas-de-Brandon, Québec J0K 2A0 (Desroches); Molecular 
      diagnostic laboratory (MDL) and Swine and Poultry Infectious Diseases Research 
      Center (CRIPA), Faculté de médecine vétérinaire (FMV) Université de Montréal, 
      3200 Sicotte, St-Hyacinthe, Québec J2S 2M2 (Provost, Bournival, St-Sauveur, 
      Koszegi, Gagnon).
FAU - St-Sauveur, Valérie Grenier
AU  - St-Sauveur VG
AD  - Laboratoire de santé animale de St-Hyacinthe, Ministère de l'Agriculture, des 
      Pêcheries et de l'Alimentation du Québec (MAPAQ), 3220 Sicotte, St-Hyacinthe, 
      Québec J2S 7X9 (Chénier); Services vétérinaires Michel Desroches, 260, rue 
      Principale, St-Cléophas-de-Brandon, Québec J0K 2A0 (Desroches); Molecular 
      diagnostic laboratory (MDL) and Swine and Poultry Infectious Diseases Research 
      Center (CRIPA), Faculté de médecine vétérinaire (FMV) Université de Montréal, 
      3200 Sicotte, St-Hyacinthe, Québec J2S 2M2 (Provost, Bournival, St-Sauveur, 
      Koszegi, Gagnon).
FAU - Koszegi, Marika
AU  - Koszegi M
AD  - Laboratoire de santé animale de St-Hyacinthe, Ministère de l'Agriculture, des 
      Pêcheries et de l'Alimentation du Québec (MAPAQ), 3220 Sicotte, St-Hyacinthe, 
      Québec J2S 7X9 (Chénier); Services vétérinaires Michel Desroches, 260, rue 
      Principale, St-Cléophas-de-Brandon, Québec J0K 2A0 (Desroches); Molecular 
      diagnostic laboratory (MDL) and Swine and Poultry Infectious Diseases Research 
      Center (CRIPA), Faculté de médecine vétérinaire (FMV) Université de Montréal, 
      3200 Sicotte, St-Hyacinthe, Québec J2S 2M2 (Provost, Bournival, St-Sauveur, 
      Koszegi, Gagnon).
FAU - Gagnon, Carl A
AU  - Gagnon CA
AD  - Laboratoire de santé animale de St-Hyacinthe, Ministère de l'Agriculture, des 
      Pêcheries et de l'Alimentation du Québec (MAPAQ), 3220 Sicotte, St-Hyacinthe, 
      Québec J2S 7X9 (Chénier); Services vétérinaires Michel Desroches, 260, rue 
      Principale, St-Cléophas-de-Brandon, Québec J0K 2A0 (Desroches); Molecular 
      diagnostic laboratory (MDL) and Swine and Poultry Infectious Diseases Research 
      Center (CRIPA), Faculté de médecine vétérinaire (FMV) Université de Montréal, 
      3200 Sicotte, St-Hyacinthe, Québec J2S 2M2 (Provost, Bournival, St-Sauveur, 
      Koszegi, Gagnon).
LA  - eng
PT  - Journal Article
PL  - Canada
TA  - Can Vet J
JT  - The Canadian veterinary journal = La revue veterinaire canadienne
JID - 0004653
SB  - IM
MH  - Animals
MH  - *Atadenovirus
MH  - Disease Outbreaks
MH  - Ducks
MH  - *Poultry Diseases
MH  - Quebec
PMC - PMC6855221
EDAT- 2019/12/10 06:00
MHDA- 2020/07/02 06:00
CRDT- 2019/12/10 06:00
PHST- 2019/12/10 06:00 [entrez]
PHST- 2019/12/10 06:00 [pubmed]
PHST- 2020/07/02 06:00 [medline]
AID - cvj_12_1285 [pii]
PST - ppublish
SO  - Can Vet J. 2019 Dec;60(12):1285-1288.

PMID- 33198373
OWN - NLM
STAT- MEDLINE
DCOM- 20210303
LR  - 20210303
IS  - 1999-4915 (Electronic)
IS  - 1999-4915 (Linking)
VI  - 12
IP  - 11
DP  - 2020 Nov 12
TI  - Analysis of Whole-Genome Sequences of Infectious laryngotracheitis Virus Isolates 
      from Poultry Flocks in Canada: Evidence of Recombination.
LID - 10.3390/v12111302 [doi]
LID - 1302
AB  - Infectious laryngotracheitis virus (ILTV) is a herpes virus that causes an acute 
      respiratory disease of poultry known as infectious laryngotracheitis (ILT). 
      Chicken embryo origin (CEO) and tissue culture origin (TCO) live attenuated 
      vaccines are routinely used for the control of ILT. However, vaccine virus is 
      known to revert to virulence, and it has been recently shown that ILT field viral 
      strains can undergo recombination with vaccinal ILTV and such recombinant ILT 
      viruses possess greater transmission and pathogenicity potential. Based on 
      complete or partial genes of the ILTV genome, few studies genotyped ILTV strains 
      circulating in Canada, and so far, information is scarce on whole-genome 
      sequencing or the presence of recombination in Canadian ILTV isolates. The 
      objective of this study was to genetically characterize the 14 ILTV isolates that 
      originated from three provinces in Canada (Alberta, British Columbia and Quebec). 
      To this end, a phylogenetic analysis of 50 ILTV complete genome sequences, 
      including 14 sequences of Canadian origin, was carried out. Additional 
      phylogenetic analysis of the unique long, unique short and inverted repeat 
      regions of the ILTV genome was also performed. We observed that 71%, 21% and 7% 
      of the ILTV isolates were categorized as CEO revertant, wild-type and TCO 
      vaccine-related, respectively. The sequences were also analyzed for potential 
      recombination events, which included evidence in the British Columbia ILTV 
      isolate. This event involved two ILTV vaccine (CEO) strains as parental strains. 
      Recombination analysis also identified that one ILTV isolate from Alberta as a 
      potential parental strain for a United States origin ILTV isolate. The positions 
      of the possible recombination breakpoints were identified. These results indicate 
      that the ILTV wild-type strains can recombine with vaccinal strains complicating 
      vaccine-mediated control of ILT. Further studies on the pathogenicity of these 
      ILTV strains, including the recombinant ILTV isolate are currently ongoing.
FAU - Perez Contreras, Ana
AU  - Perez Contreras A
AD  - Faculty of Veterinary Medicine, University of Calgary, Health Research Innovation 
      Center 2C53, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada.
FAU - van der Meer, Frank
AU  - van der Meer F
AD  - Faculty of Veterinary Medicine, University of Calgary, Health Research Innovation 
      Center 2C53, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada.
FAU - Checkley, Sylvia
AU  - Checkley S
AUID- ORCID: 0000-0002-9118-2721
AD  - Faculty of Veterinary Medicine, University of Calgary, Health Research Innovation 
      Center 2C53, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada.
FAU - Joseph, Tomy
AU  - Joseph T
AD  - Animal Health Centre, Ministry of Agriculture, Abbotsford, BC V3G 2M3, Canada.
FAU - King, Robin
AU  - King R
AD  - Agri Food Laboratories, Alberta Agriculture and Forestry, AB T6H 4P2, Canada.
FAU - Ravi, Madhu
AU  - Ravi M
AD  - Animal Health and Assurance, Alberta Agriculture and Forestry, AB T6H 4P2, 
      Canada.
FAU - Peters, Delores
AU  - Peters D
AD  - Animal Health and Assurance, Alberta Agriculture and Forestry, AB T6H 4P2, 
      Canada.
FAU - Fonseca, Kevin
AU  - Fonseca K
AD  - Provincial Laboratory for Public Health, Calgary, AB T2N 4W4, Canada.
FAU - Gagnon, Carl A
AU  - Gagnon CA
AUID- ORCID: 0000-0003-4528-541X
AD  - Swine and poultry Infectious Diseases Research Center (CRIPA-Fonds de Recherche 
      du Québec), Faculté de Médecine Vétérinaire, Université de Montréal, 3200 rue 
      Sicotte, Saint-Hyacinthe, QC J2S 2M2, Canada.
FAU - Provost, Chantale
AU  - Provost C
AUID- ORCID: 0000-0002-6674-1157
AD  - Swine and poultry Infectious Diseases Research Center (CRIPA-Fonds de Recherche 
      du Québec), Faculté de Médecine Vétérinaire, Université de Montréal, 3200 rue 
      Sicotte, Saint-Hyacinthe, QC J2S 2M2, Canada.
FAU - Ojkic, Davor
AU  - Ojkic D
AD  - Laboratory, University of Guelph, Guelph, ON N1G 2W1, Canada.
FAU - Abdul-Careem, Mohamed Faizal
AU  - Abdul-Careem MF
AD  - Faculty of Veterinary Medicine, University of Calgary, Health Research Innovation 
      Center 2C53, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20201112
PL  - Switzerland
TA  - Viruses
JT  - Viruses
JID - 101509722
RN  - 0 (DNA, Viral)
RN  - 0 (Viral Vaccines)
SB  - IM
MH  - Animals
MH  - Canada/epidemiology
MH  - DNA, Viral
MH  - *Genome, Viral
MH  - *Genomics/methods
MH  - Herpesvirus 1, Gallid/isolation & purification/*physiology
MH  - Humans
MH  - Infant
MH  - Mutation
MH  - Phylogeny
MH  - Poultry Diseases/*epidemiology/prevention & control/transmission/*virology
MH  - Recombination, Genetic
MH  - Viral Vaccines/immunology
MH  - Whole Genome Sequencing
PMC - PMC7696358
OTO - NOTNLM
OT  - herpesvirus
OT  - molecular characterization
OT  - mutation
OT  - phylogenetic analysis
OT  - poultry
OT  - recombination
OT  - vaccine
COIS- The authors declare no conflict of interest.
EDAT- 2020/11/18 06:00
MHDA- 2021/03/04 06:00
CRDT- 2020/11/17 01:06
PHST- 2020/09/03 00:00 [received]
PHST- 2020/10/30 00:00 [revised]
PHST- 2020/11/10 00:00 [accepted]
PHST- 2020/11/17 01:06 [entrez]
PHST- 2020/11/18 06:00 [pubmed]
PHST- 2021/03/04 06:00 [medline]
AID - v12111302 [pii]
AID - viruses-12-01302 [pii]
AID - 10.3390/v12111302 [doi]
PST - epublish
SO  - Viruses. 2020 Nov 12;12(11):1302. doi: 10.3390/v12111302.

PMID- 32332783
OWN - NLM
STAT- MEDLINE
DCOM- 20201214
LR  - 20210424
IS  - 2045-2322 (Electronic)
IS  - 2045-2322 (Linking)
VI  - 10
IP  - 1
DP  - 2020 Apr 24
TI  - Neuroligin-1 is altered in the hippocampus of Alzheimer's disease patients and 
      mouse models, and modulates the toxicity of amyloid-beta oligomers.
PG  - 6956
LID - 10.1038/s41598-020-63255-6 [doi]
LID - 6956
AB  - Synapse loss occurs early and correlates with cognitive decline in Alzheimer's 
      disease (AD). Synaptotoxicity is driven, at least in part, by amyloid-beta 
      oligomers (Aβo), but the exact synaptic components targeted by Aβo remain to be 
      identified. We here tested the hypotheses that the post-synaptic protein 
      Neuroligin-1 (NLGN1) is affected early in the process of neurodegeneration in the 
      hippocampus, and specifically by Aβo, and that it can modulate Aβo toxicity. We 
      found that hippocampal NLGN1 was decreased in patients with AD in comparison to 
      patients with mild cognitive impairment and control subjects. Female 3xTg-AD mice 
      also showed a decreased NLGN1 level in the hippocampus at an early age (i.e., 4 
      months). We observed that chronic hippocampal Aβo injections initially increased 
      the expression of one specific Nlgn1 transcript, which was followed by a clear 
      decrease. Lastly, the absence of NLGN1 decreased neuronal counts in the dentate 
      gyrus, which was not the case in wild-type animals, and worsens impairment in 
      spatial learning following chronic hippocampal Aβo injections. Our findings 
      support that NLGN1 is impacted early during neurodegenerative processes, and that 
      Aβo contributes to this effect. Moreover, our results suggest that the presence 
      of NLGN1 favors the cognitive prognosis during Aβo-driven neurodegeneration.
FAU - Dufort-Gervais, Julien
AU  - Dufort-Gervais J
AD  - Department of Pharmacology and Physiology, Université de Montréal, Montréal, 
      Québec, Canada.
AD  - Center for Advanced Research in Sleep Medicine, Hôpital du Sacré-Coeur de 
      Montréal (Recherche CIUSSS-NIM), Montréal, Québec, Canada.
FAU - Provost, Chloé
AU  - Provost C
AD  - Center for Advanced Research in Sleep Medicine, Hôpital du Sacré-Coeur de 
      Montréal (Recherche CIUSSS-NIM), Montréal, Québec, Canada.
FAU - Charbonneau, Laurence
AU  - Charbonneau L
AD  - Department of Neuroscience, Université de Montréal, Montréal, Québec, Canada.
FAU - Norris, Christopher M
AU  - Norris CM
AD  - Department of Molecular and Biomedical Pharmacology, Sanders-Brown Center on 
      Aging, University of Kentucky, Lexington, KY, USA.
FAU - Calon, Frédéric
AU  - Calon F
AD  - Neuroscience Unit, Research Center - CHU de Québec, Québec, QC, Canada.
AD  - Faculty of Pharmacy, Université Laval, Québec, QC, Canada.
FAU - Mongrain, Valérie
AU  - Mongrain V
AUID- ORCID: 0000-0002-6242-9166
AD  - Center for Advanced Research in Sleep Medicine, Hôpital du Sacré-Coeur de 
      Montréal (Recherche CIUSSS-NIM), Montréal, Québec, Canada. 
      valerie.mongrain@umontreal.ca.
AD  - Department of Neuroscience, Université de Montréal, Montréal, Québec, Canada. 
      valerie.mongrain@umontreal.ca.
FAU - Brouillette, Jonathan
AU  - Brouillette J
AD  - Department of Pharmacology and Physiology, Université de Montréal, Montréal, 
      Québec, Canada. jonathan.brouillette@umontreal.ca.
AD  - Center for Advanced Research in Sleep Medicine, Hôpital du Sacré-Coeur de 
      Montréal (Recherche CIUSSS-NIM), Montréal, Québec, Canada. 
      jonathan.brouillette@umontreal.ca.
LA  - eng
GR  - RF1 AG027297/AG/NIA NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20200424
PL  - England
TA  - Sci Rep
JT  - Scientific reports
JID - 101563288
RN  - 0 (Amyloid beta-Peptides)
RN  - 0 (Cell Adhesion Molecules, Neuronal)
RN  - 0 (neuroligin 1)
SB  - IM
MH  - Aging/genetics/physiology
MH  - Alzheimer Disease/*metabolism/pathology
MH  - Amyloid beta-Peptides/genetics/metabolism
MH  - Animals
MH  - Blotting, Western
MH  - Cell Adhesion Molecules, Neuronal/genetics/*metabolism
MH  - Cell Survival/genetics/physiology
MH  - Cells, Cultured
MH  - Female
MH  - Hippocampus/*metabolism
MH  - Humans
MH  - Male
MH  - Mice
MH  - Mice, Inbred C57BL
MH  - Mice, Knockout
MH  - Morris Water Maze Test
PMC - PMC7181681
COIS- The authors declare no competing interests.
EDAT- 2020/04/26 06:00
MHDA- 2020/12/15 06:00
CRDT- 2020/04/26 06:00
PHST- 2019/12/10 00:00 [received]
PHST- 2020/03/27 00:00 [accepted]
PHST- 2020/04/26 06:00 [entrez]
PHST- 2020/04/26 06:00 [pubmed]
PHST- 2020/12/15 06:00 [medline]
AID - 10.1038/s41598-020-63255-6 [pii]
AID - 63255 [pii]
AID - 10.1038/s41598-020-63255-6 [doi]
PST - epublish
SO  - Sci Rep. 2020 Apr 24;10(1):6956. doi: 10.1038/s41598-020-63255-6.

PMID- 32196498
OWN - NLM
STAT- MEDLINE
DCOM- 20200514
LR  - 20200514
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 15
IP  - 3
DP  - 2020
TI  - Moderate to severe acute pain disturbs motor cortex intracortical inhibition and 
      facilitation in orthopedic trauma patients: A TMS study.
PG  - e0226452
LID - 10.1371/journal.pone.0226452 [doi]
LID - e0226452
AB  - OBJECTIVE: Primary motor (M1) cortical excitability alterations are involved in 
      the development and maintenance of chronic pain. Less is known about M1-cortical 
      excitability implications in the acute phase of an orthopedic trauma. This study 
      aims to assess acute M1-cortical excitability in patients with an isolated upper 
      limb fracture (IULF) in relation to pain intensity. METHODS: Eighty-four (56 IULF 
      patients <14 days post-trauma and 28 healthy controls). IULF patients were 
      divided into two subgroups according to pain intensity (mild versus moderate to 
      severe pain). A single transcranial magnetic stimulation (TMS) session was 
      performed over M1 to compare groups on resting motor threshold (rMT), 
      short-intracortical inhibition (SICI), intracortical facilitation (ICF), and 
      long-interval cortical inhibition (LICI). RESULTS: Reduced SICI and ICF were 
      found in IULF patients with moderate to severe pain, whereas mild pain was not 
      associated with M1 alterations. Age, sex, and time since the accident had no 
      influence on TMS measures. DISCUSSION: These findings show altered M1 in the 
      context of acute moderate to severe pain, suggesting early signs of altered 
      GABAergic inhibitory and glutamatergic facilitatory activities.
FAU - Jodoin, Marianne
AU  - Jodoin M
AD  - Hôpital Sacré-Cœur de Montréal (HSCM), Montreal, QC, Canada.
AD  - Département de psychologie, de l'Université de Montréal, Montreal, QC, Canada.
FAU - Rouleau, Dominique M
AU  - Rouleau DM
AD  - Hôpital Sacré-Cœur de Montréal (HSCM), Montreal, QC, Canada.
AD  - Département de chirurgie, de l'Université de Montréal, Montreal, QC, Canada.
FAU - Bellemare, Audrey
AU  - Bellemare A
AD  - Hôpital Sacré-Cœur de Montréal (HSCM), Montreal, QC, Canada.
AD  - Département de psychologie, de l'Université de Montréal, Montreal, QC, Canada.
FAU - Provost, Catherine
AU  - Provost C
AD  - Hôpital Sacré-Cœur de Montréal (HSCM), Montreal, QC, Canada.
FAU - Larson-Dupuis, Camille
AU  - Larson-Dupuis C
AD  - Hôpital Sacré-Cœur de Montréal (HSCM), Montreal, QC, Canada.
AD  - Département de psychologie, de l'Université de Montréal, Montreal, QC, Canada.
FAU - Sandman, Émilie
AU  - Sandman É
AD  - Hôpital Sacré-Cœur de Montréal (HSCM), Montreal, QC, Canada.
AD  - Département de chirurgie, de l'Université de Montréal, Montreal, QC, Canada.
FAU - Laflamme, Georges-Yves
AU  - Laflamme GY
AD  - Hôpital Sacré-Cœur de Montréal (HSCM), Montreal, QC, Canada.
AD  - Département de chirurgie, de l'Université de Montréal, Montreal, QC, Canada.
FAU - Benoit, Benoit
AU  - Benoit B
AD  - Hôpital Sacré-Cœur de Montréal (HSCM), Montreal, QC, Canada.
AD  - Département de chirurgie, de l'Université de Montréal, Montreal, QC, Canada.
FAU - Leduc, Stéphane
AU  - Leduc S
AD  - Hôpital Sacré-Cœur de Montréal (HSCM), Montreal, QC, Canada.
AD  - Département de chirurgie, de l'Université de Montréal, Montreal, QC, Canada.
FAU - Levesque, Martine
AU  - Levesque M
AD  - Hôpital Sacré-Cœur de Montréal (HSCM), Montreal, QC, Canada.
AD  - Hôpital Fleury, Montreal, QC, Canada.
FAU - Gosselin, Nadia
AU  - Gosselin N
AD  - Hôpital Sacré-Cœur de Montréal (HSCM), Montreal, QC, Canada.
AD  - Département de psychologie, de l'Université de Montréal, Montreal, QC, Canada.
FAU - De Beaumont, Louis
AU  - De Beaumont L
AUID- ORCID: 0000-0003-4753-3499
AD  - Hôpital Sacré-Cœur de Montréal (HSCM), Montreal, QC, Canada.
AD  - Département de chirurgie, de l'Université de Montréal, Montreal, QC, Canada.
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20200320
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
SB  - IM
MH  - *Acute Pain/physiopathology/therapy
MH  - Adolescent
MH  - Adult
MH  - *Cortical Excitability
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Motor Cortex/*physiopathology
MH  - *Neural Inhibition
MH  - *Transcranial Magnetic Stimulation
MH  - *Wounds and Injuries/physiopathology/therapy
PMC - PMC7083311
COIS- The authors have declared that no competing interests exist.
EDAT- 2020/03/21 06:00
MHDA- 2020/05/15 06:00
CRDT- 2020/03/21 06:00
PHST- 2019/11/25 00:00 [received]
PHST- 2020/03/04 00:00 [accepted]
PHST- 2020/03/21 06:00 [entrez]
PHST- 2020/03/21 06:00 [pubmed]
PHST- 2020/05/15 06:00 [medline]
AID - PONE-D-19-32702 [pii]
AID - 10.1371/journal.pone.0226452 [doi]
PST - epublish
SO  - PLoS One. 2020 Mar 20;15(3):e0226452. doi: 10.1371/journal.pone.0226452. 
      eCollection 2020.

PMID- 32251995
OWN - NLM
STAT- MEDLINE
DCOM- 20210713
LR  - 20210713
IS  - 1872-9614 (Electronic)
IS  - 0969-8051 (Linking)
VI  - 84-85
DP  - 2020 May-Jun
TI  - A comparative study of peptide-based imaging agents [(68)Ga]Ga-PSMA-11, 
      [(68)Ga]Ga-AMBA, [(68)Ga]Ga-NODAGA-RGD and [(68)Ga]Ga-DOTA-NT-20.3 in preclinical 
      prostate tumour models.
PG  - 88-95
LID - S0969-8051(19)30600-6 [pii]
LID - 10.1016/j.nucmedbio.2020.03.005 [doi]
AB  - INTRODUCTION: Peptide-based imaging agents targeting prostate-specific membrane 
      antigen (PSMA) have revolutionized the evaluation of biochemical recurrence of 
      prostate cancer (PCa) but lacks sensitivity at very low serum prostate specific 
      antigen (PSA) levels. Once recurrence is suspected, other positron emission 
      tomography (PET) radiotracers could be of interest to discriminate between local 
      and distant relapse. We studied [(18)F]fluorodeoxyglucose ([(18)F]FDG) targeting 
      glucose metabolism, [(18)F]fluorocholine ([(18)F]FCH) targeting membrane 
      metabolism and peptide-based imaging agents [(68)Ga]Ga-PSMA-11, [(68)Ga]Ga-AMBA, 
      [(68)Ga]Ga-NODAGA-RGD and [(68)Ga]Ga-DOTA-NT-20.3 targeting PSMA, gastrin 
      releasing peptide receptor (GRPr), αvβ3 integrin and neurotensin type 1 receptor 
      (NTSR1) respectively, in different PCa tumour models. METHODS: Mice were 
      xenografted with 22Rv1, an androgen-receptor (AR)-positive, PCa cell line that 
      expresses PSMA and PC3, an AR-negative one that does not express PSMA. PET 
      imaging using the different radiotracers was performed sequentially and the 
      uptake characteristics compared to one other. NTSR1 and PSMA expression levels 
      were analysed in tumours by immunohistochemistry. RESULTS: [(18)F]FDG displayed 
      low but sufficient uptake to visualize PC3 and 22Rv1 derived tumours. We also 
      observed a low efficacy of [(18)F]FCH PET imaging and a low [(68)Ga]Ga-NODAGA-RGD 
      tumour uptake in those tumours. As expected, an elevated tumour uptake was 
      obtained for [(68)Ga]Ga-PSMA-11 in 22Rv1 derived tumour although no uptake was 
      measured in the androgen independent cell line PC3, derived from a bone 
      metastasis of a high-grade PCa. Moreover, in PC3 cell line, we obtained good 
      tumour uptake, high tumour-to-background contrast using [(68)Ga]Ga-AMBA and 
      [(68)Ga]Ga-DOTA-NT-20.3. Immunohistochemistry analysis confirmed high NTSR1 
      expression in PC3 derived tumours and conversely high PSMA expression in 22Rv1 
      derived tumours. CONCLUSION: PET imaging using [(68)Ga]Ga-AMBA and 
      [(68)Ga]Ga-DOTA-NT-20.3 demonstrates that GRPr and NTSR1 could represent viable 
      alternative targets for diagnostic or therapeutic applications in PCa with 
      limited PSMA expression levels. More preclinical and clinical studies will follow 
      to explore this potential. ADVANCES IN KNOWLEDGE AND IMPLICATIONS FOR PATIENT: 
      Peptide-based imaging agents targeting PSMA represent a major progress in the 
      evaluation of biochemical recurrence of PCa but sometimes yield false negative 
      results in some lesions. Continuing efforts have thus been made to evaluate other 
      radiotracers. Our preclinical results suggest that [(68)Ga]labelled bombesin and 
      neurotensin analogues could serve as alternative PET radiopharmaceuticals for 
      diagnostic or therapy in cases of PSMA-negative PCa.
CI  - Copyright © 2020 Elsevier Inc. All rights reserved.
FAU - Zhang-Yin, Jules
AU  - Zhang-Yin J
AD  - Sorbonne Université, Nuclear Medicine Department AP-HP, Hôpital Tenon, Paris; 
      Sorbonne Université, UMS28 Phénotypage du Petit Animal, Laboratoire d'Imagerie 
      Moléculaire Positonique (LIMP), Paris, France; Sorbonne Université, GRC n°5, 
      ONCOTYPE-URO, AP-HP, Hôpital Tenon, Paris, France. Electronic address: 
      jules.zhang-yin@aphp.fr.
FAU - Provost, Claire
AU  - Provost C
AD  - Sorbonne Université, UMS28 Phénotypage du Petit Animal, Laboratoire d'Imagerie 
      Moléculaire Positonique (LIMP), Paris, France.
FAU - Cancel-Tassin, Géraldine
AU  - Cancel-Tassin G
AD  - Sorbonne Université, GRC n°5, ONCOTYPE-URO, AP-HP, Hôpital Tenon, Paris, France; 
      CeRePP, Sorbonne Université, AP-HP, Hôpital Tenon, Paris, France.
FAU - Rusu, Timofei
AU  - Rusu T
AD  - Sorbonne Université, Nuclear Medicine Department AP-HP, Hôpital Tenon, Paris; 
      Sorbonne Université, UMS28 Phénotypage du Petit Animal, Laboratoire d'Imagerie 
      Moléculaire Positonique (LIMP), Paris, France.
FAU - Penent, Mallaurie
AU  - Penent M
AD  - Sorbonne Université, UMS28 Phénotypage du Petit Animal, Laboratoire d'Imagerie 
      Moléculaire Positonique (LIMP), Paris, France.
FAU - Radulescu, Camelia
AU  - Radulescu C
AD  - Pathology Department, Hôpital Foch, Paris, France.
FAU - Comperat, Eva
AU  - Comperat E
AD  - Sorbonne Université, GRC n°5, ONCOTYPE-URO, AP-HP, Hôpital Tenon, Paris, France; 
      CeRePP, Sorbonne Université, AP-HP, Hôpital Tenon, Paris, France.
FAU - Cussenot, Olivier
AU  - Cussenot O
AD  - Sorbonne Université, GRC n°5, ONCOTYPE-URO, AP-HP, Hôpital Tenon, Paris, France; 
      CeRePP, Sorbonne Université, AP-HP, Hôpital Tenon, Paris, France.
FAU - Montravers, Françoise
AU  - Montravers F
AD  - Sorbonne Université, Nuclear Medicine Department AP-HP, Hôpital Tenon, Paris.
FAU - Renard-Penna, Raphaële
AU  - Renard-Penna R
AD  - Sorbonne Université, GRC n°5, ONCOTYPE-URO, AP-HP, Hôpital Tenon, Paris, France; 
      CeRePP, Sorbonne Université, AP-HP, Hôpital Tenon, Paris, France.
FAU - Talbot, Jean-Noël
AU  - Talbot JN
AD  - Sorbonne Université, Nuclear Medicine Department AP-HP, Hôpital Tenon, Paris.
FAU - Prignon, Aurélie
AU  - Prignon A
AD  - Sorbonne Université, UMS28 Phénotypage du Petit Animal, Laboratoire d'Imagerie 
      Moléculaire Positonique (LIMP), Paris, France. Electronic address: 
      aurelie.prignon@sorbonne-universite.fr.
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20200330
PL  - United States
TA  - Nucl Med Biol
JT  - Nuclear medicine and biology
JID - 9304420
RN  - 0 (Antigens, Surface)
RN  - 0 (Gallium Radioisotopes)
RN  - 0 (Heterocyclic Compounds, 1-Ring)
RN  - 0 (Oligopeptides)
RN  - 0 (Receptors, Neurotensin)
RN  - 0 (neurotensin type 1 receptor)
RN  - 1HTE449DGZ (1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid)
RN  - 78VO7F77PN (arginyl-glycyl-aspartic acid)
RN  - 98B30EPP5S (Gallium-68)
RN  - EC 3.4.17.21 (FOLH1 protein, human)
RN  - EC 3.4.17.21 (Glutamate Carboxypeptidase II)
SB  - IM
MH  - Animals
MH  - Antigens, Surface/metabolism
MH  - Cell Transformation, Neoplastic
MH  - *Gallium Radioisotopes
MH  - Gene Expression Regulation, Neoplastic
MH  - Glutamate Carboxypeptidase II/metabolism
MH  - Heterocyclic Compounds, 1-Ring/*chemistry
MH  - Humans
MH  - Male
MH  - Mice
MH  - Neoplasm Grading
MH  - Neoplasm Metastasis
MH  - Oligopeptides/*chemistry
MH  - PC-3 Cells
MH  - Prostatic Neoplasms/*diagnostic imaging
MH  - Receptors, Neurotensin/metabolism
OTO - NOTNLM
OT  - GRPr
OT  - NTSR1
OT  - PET
OT  - PSMA
OT  - Prostate cancer
COIS- Declaration of competing interest The authors declare that they have no conflict 
      of interest.
EDAT- 2020/04/07 06:00
MHDA- 2021/07/14 06:00
CRDT- 2020/04/07 06:00
PHST- 2020/01/01 00:00 [received]
PHST- 2020/03/20 00:00 [revised]
PHST- 2020/03/24 00:00 [accepted]
PHST- 2020/04/07 06:00 [pubmed]
PHST- 2021/07/14 06:00 [medline]
PHST- 2020/04/07 06:00 [entrez]
AID - S0969-8051(19)30600-6 [pii]
AID - 10.1016/j.nucmedbio.2020.03.005 [doi]
PST - ppublish
SO  - Nucl Med Biol. 2020 May-Jun;84-85:88-95. doi: 10.1016/j.nucmedbio.2020.03.005. 
      Epub 2020 Mar 30.

PMID- 31355795
OWN - NLM
STAT- MEDLINE
DCOM- 20200610
LR  - 20200610
IS  - 1940-087X (Electronic)
IS  - 1940-087X (Linking)
IP  - 149
DP  - 2019 Jul 12
TI  - A Novel and Translational Rat Model of Concussion Combining Force and Rotation 
      with In Vivo Cerebral Microdialysis.
LID - 10.3791/59585 [doi]
AB  - Persistent cognitive and motor symptoms are known consequences of 
      concussions/mild traumatic brain injury (mTBIs) that can be partly attributable 
      to altered neurotransmission. Indeed, cerebral microdialysis studies in rodents 
      have demonstrated an excessive extracellular glutamate release in the hippocampus 
      within the first 10 min following trauma. Microdialysis offers the clear 
      advantage of in vivo neurotransmitter continuous sampling while not having to 
      sacrifice the animal. In addition to the aforementioned technique, a closed head 
      injury model that exerts rapid acceleration and deceleration of the head and 
      torso is needed, as such a factor is not available in many other animal models. 
      The Wayne State weight-drop model mimics this essential component of human 
      craniocerebral trauma, allowing the induction of an impact on the head of an 
      unrestrained rodent with a falling weight. Our novel and translational rat model 
      combines cerebral microdialysis with the Wayne State weight-drop model to study, 
      in lightly anesthetized and unrestrained adult rats, the acute changes in 
      extracellular neurotransmitter levels following concussion. In this protocol, the 
      microdialysis probe was inserted inside the hippocampus as region of interest, 
      and was left inserted in the brain at impact. There is a high density of 
      terminals and receptors in the hippocampus, making it a relevant region to 
      document altered neurotransmission following concussion. When applied to adult 
      Sprague-Dawley rats, our combined model induced increases in hippocampal 
      extracellular glutamate concentrations within the first 10 min, consistent with 
      the previously reported post-concussion symptomology. This combined weight-drop 
      model provides a reliable tool for researchers to study early therapeutic 
      responses to concussions in addition to repetitive brain injury, since this 
      protocol induces a closed-head mild trauma.
FAU - Massé, Ian O
AU  - Massé IO
AD  - Research Center, Hôpital du Sacré-Cœur de Montréal; ian.masse.im@gmail.com.
FAU - Moquin, Luc
AU  - Moquin L
AD  - Research Center, Douglas Institute.
FAU - Provost, Chloé
AU  - Provost C
AD  - Research Center, Hôpital du Sacré-Cœur de Montréal.
FAU - Guay, Samuel
AU  - Guay S
AD  - Research Center, Hôpital du Sacré-Cœur de Montréal.
FAU - Gratton, Alain
AU  - Gratton A
AD  - Research Center, Douglas Institute.
FAU - De Beaumont, Louis
AU  - De Beaumont L
AD  - Research Center, Hôpital du Sacré-Cœur de Montréal.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Video-Audio Media
DEP - 20190712
PL  - United States
TA  - J Vis Exp
JT  - Journal of visualized experiments : JoVE
JID - 101313252
SB  - IM
MH  - Animals
MH  - Brain/*pathology
MH  - Brain Concussion/diagnosis/*therapy
MH  - Brain Injuries/*diagnosis/*therapy
MH  - Disease Models, Animal
MH  - Humans
MH  - Male
MH  - Microdialysis/*methods
MH  - Rats
MH  - Rats, Sprague-Dawley
MH  - Rotation
EDAT- 2019/07/30 06:00
MHDA- 2020/06/11 06:00
CRDT- 2019/07/30 06:00
PHST- 2019/07/30 06:00 [entrez]
PHST- 2019/07/30 06:00 [pubmed]
PHST- 2020/06/11 06:00 [medline]
AID - 10.3791/59585 [doi]
PST - epublish
SO  - J Vis Exp. 2019 Jul 12;(149). doi: 10.3791/59585.

PMID- 30730762
OWN - NLM
STAT- MEDLINE
DCOM- 20191104
LR  - 20220408
IS  - 1205-7541 (Electronic)
IS  - 0008-4212 (Linking)
VI  - 97
IP  - 6
DP  - 2019 Jun
TI  - Angiotensin II induces apoptosis of human right and left ventricular endocardial 
      endothelial cells by activating the AT(2) receptor (1).
PG  - 581-588
LID - 10.1139/cjpp-2018-0592 [doi]
AB  - Endocardial endothelial cells (EECs) form a monolayer lining the ventricular 
      cavities. Studies from our laboratory and the literature have shown differences 
      between EECs isolated from the right and left ventricles (EECRs and EECLs, 
      respectively). Angiotensin II (Ang II) was shown to induce apoptosis of different 
      cell types mainly via AT(1) receptor activation. In this study, we verified 
      whether Ang II induces apoptosis of human EECRs and EECLs (hEECRs and hEECLs, 
      respectively) and via which type of receptor. Using the annexin V labeling and in 
      situ TUNEL assays, our results showed that Ang II induced apoptosis of both 
      hEECRs and hEECLs in a concentration-dependent manner. Our results using specific 
      AT(1) and AT(2) receptor antagonists showed that the Ang-II-induced apoptosis in 
      both hEECRs and hEECLs is mediated mainly via the AT(2) receptor. However, AT(1) 
      receptor blockade partially prevented Ang-II-induced apoptosis, particularly in 
      hEECRs. Hence, our results suggest that mainly AT(2) receptors mediate 
      Ang-II-induced apoptosis of hEECRs and hEECLs. The damage of EECs would affect 
      their function as a physical barrier between the blood and cardiomyocytes, thus 
      affecting cardiomyocyte functions.
FAU - Jacques, Danielle
AU  - Jacques D
AD  - Department of Anatomy and Cell Biology, Faculty of Medicine, University of 
      Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
FAU - Provost, Chantale
AU  - Provost C
AD  - Department of Anatomy and Cell Biology, Faculty of Medicine, University of 
      Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
AD  - Department of Anatomy and Cell Biology, Faculty of Medicine, University of 
      Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
FAU - Normand, Alexandre
AU  - Normand A
AD  - Department of Anatomy and Cell Biology, Faculty of Medicine, University of 
      Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
AD  - Department of Anatomy and Cell Biology, Faculty of Medicine, University of 
      Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
FAU - Abou Abdallah, Nadia
AU  - Abou Abdallah N
AD  - Department of Anatomy and Cell Biology, Faculty of Medicine, University of 
      Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
AD  - Department of Anatomy and Cell Biology, Faculty of Medicine, University of 
      Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
FAU - Al-Khoury, Johny
AU  - Al-Khoury J
AD  - Department of Anatomy and Cell Biology, Faculty of Medicine, University of 
      Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
AD  - Department of Anatomy and Cell Biology, Faculty of Medicine, University of 
      Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
FAU - Bkaily, Ghassan
AU  - Bkaily G
AD  - Department of Anatomy and Cell Biology, Faculty of Medicine, University of 
      Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
LA  - eng
PT  - Journal Article
DEP - 20190207
PL  - Canada
TA  - Can J Physiol Pharmacol
JT  - Canadian journal of physiology and pharmacology
JID - 0372712
RN  - 0 (Receptor, Angiotensin, Type 2)
RN  - 11128-99-7 (Angiotensin II)
SB  - IM
MH  - Angiotensin II/*pharmacology
MH  - Apoptosis/*drug effects
MH  - Dose-Response Relationship, Drug
MH  - Endothelial Cells/*cytology/drug effects/*metabolism
MH  - Heart Ventricles/*cytology/drug effects
MH  - Humans
MH  - Receptor, Angiotensin, Type 2/*metabolism
MH  - Time Factors
OTO - NOTNLM
OT  - AT receptor
OT  - angiotensin II
OT  - angiotensin II receptor antagonists
OT  - angiotensine II
OT  - antagonistes des récepteurs de l’angiotensine II
OT  - apoptose
OT  - apoptosis
OT  - cellules endothéliales endocardiques humaines
OT  - human endocardial endothelial cells
OT  - récepteur AT
EDAT- 2019/02/08 06:00
MHDA- 2019/11/05 06:00
CRDT- 2019/02/08 06:00
PHST- 2019/02/08 06:00 [pubmed]
PHST- 2019/11/05 06:00 [medline]
PHST- 2019/02/08 06:00 [entrez]
AID - 10.1139/cjpp-2018-0592 [doi]
PST - ppublish
SO  - Can J Physiol Pharmacol. 2019 Jun;97(6):581-588. doi: 10.1139/cjpp-2018-0592. 
      Epub 2019 Feb 7.

PMID- 31013092
OWN - NLM
STAT- MEDLINE
DCOM- 20200316
LR  - 20200316
IS  - 1543-8392 (Electronic)
IS  - 1543-8384 (Linking)
VI  - 16
IP  - 6
DP  - 2019 Jun 3
TI  - Preclinical Evaluation of (68)Ga-DOTA-NT-20.3: A Promising PET Imaging Probe To 
      Discriminate Human Pancreatic Ductal Adenocarcinoma from Pancreatitis.
PG  - 2776-2784
LID - 10.1021/acs.molpharmaceut.9b00283 [doi]
AB  - Neurotensin receptor 1 (NTSR1) is overexpressed in human pancreatic ductal 
      adenocarcinoma (PDAC). Specific noninvasive positron-emission tomography (PET) 
      imaging probes may improve the diagnostic accuracy and the monitoring of therapy 
      for patients with PDAC. Here, we report the use of the (68)Ga-labeled neurotensin 
      (NTS) analogue DOTA-NT-20.3 to image human PDAC in animal models and to 
      discriminate tumors from pancreatitis. In addition to the preclinical study, two 
      tissue microarray slides, constructed by small core biopsies (2-5) from standard 
      paraffin-embedded tumor tissues, were used to confirm the high (78%) positivity 
      rate of NTSR1 expression in human PDAC. PET imaging, biodistribution, blocking, 
      and histology studies were performed in subcutaneous AsPC-1 pancreatic 
      tumor-bearing mice. (68)Ga-DOTA-NT-20.3 PET images showed rapid tumor uptake and 
      high contrast between the tumor and background with a fast blood clearance and a 
      moderate accumulation in the kidneys. Ex vivo biodistribution showed low uptake 
      in normal pancreas (0.22% IA/g) and in the remaining organs at 1 h postinjection, 
      kidney retention (5.38 ± 0.54% IA/g), and fast clearance from blood and confirmed 
      high uptake in tumors (5.28 ± 0.93% IA/g), leading to a tumor-to-blood ratio 
      value of 6 at 1 h postinjection. The significant decrease of tumor uptake in a 
      blocking study demonstrated the specificity of (68)Ga-DOTA-N-T20.3 to target 
      NTSR1 in vivo. PET imaging was also conducted in an orthotopic xenograft model 
      that allows tumors to grow in their native microenvironment and in an 
      experimental pancreatitis model generated by caerulein injections. As opposed to 
      2-[(18)F]fluoro-deoxyglucose, (68)Ga-DOTA-NT-20.3 distinguishes PDAC from 
      pancreatitis. Thus, (68)Ga-DOTA-NT-20.3 is a promising PET imaging probe for 
      imaging PDAC in humans.
FAU - Prignon, Aurélie
AU  - Prignon A
AUID- ORCID: 0000-0002-3963-863X
AD  - Sorbonne Université, UMS28 Phénotypage du Petit Animal, Laboratoire d'Imagerie 
      Moléculaire Positonique (LIMP) , Paris 75020 , France.
FAU - Provost, Claire
AU  - Provost C
AD  - Sorbonne Université, UMS28 Phénotypage du Petit Animal, Laboratoire d'Imagerie 
      Moléculaire Positonique (LIMP) , Paris 75020 , France.
FAU - Alshoukr, Faisal
AU  - Alshoukr F
AD  - Nuclear Medicine Department , CHR de Metz-Thionville , Thionville 57100 , France.
FAU - Wendum, Dominique
AU  - Wendum D
AD  - Sorbonne Université, Pathology Department Saint-Antoine Hospital AP-HP , Paris 
      75012 , France.
FAU - Couvelard, Anne
AU  - Couvelard A
AD  - University of Paris, Pathology Department Bichat Hospital AP-HP , Paris 75006 , 
      France.
FAU - Barbet, Jacques
AU  - Barbet J
AD  - GIP Arronax , Saint-Herblain 44800 , France.
FAU - Forgez, Patricia
AU  - Forgez P
AD  - Inserm UMRS 1007, Paris Descartes University , Paris 75006 , France.
FAU - Talbot, Jean-Noël
AU  - Talbot JN
AD  - Sorbonne Université, UMS28 Phénotypage du Petit Animal, Laboratoire d'Imagerie 
      Moléculaire Positonique (LIMP) , Paris 75020 , France.
AD  - Sorbonne Université, Nuclear Medicine Department Tenon Hospital AP-HP , Paris 
      75020 , France.
FAU - Gruaz-Guyon, Anne
AU  - Gruaz-Guyon A
AD  - Sorbonne Université, UMS28 Phénotypage du Petit Animal, Laboratoire d'Imagerie 
      Moléculaire Positonique (LIMP) , Paris 75020 , France.
LA  - eng
PT  - Journal Article
DEP - 20190503
PL  - United States
TA  - Mol Pharm
JT  - Molecular pharmaceutics
JID - 101197791
RN  - 0 (Gallium Radioisotopes)
RN  - Pancreatic Carcinoma
SB  - IM
MH  - Animals
MH  - Carcinoma, Pancreatic Ductal/*diagnostic imaging
MH  - Diagnostic Imaging/*methods
MH  - Gallium Radioisotopes/*analysis
MH  - Humans
MH  - Male
MH  - Mice
MH  - Pancreatic Neoplasms/diagnostic imaging
MH  - Positron-Emission Tomography/*methods
OTO - NOTNLM
OT  - gallium-68
OT  - neurotensin receptor
OT  - pancreatic ductal adenocarcinoma
OT  - positron emission tomography (PET) imaging
EDAT- 2019/04/24 06:00
MHDA- 2020/03/17 06:00
CRDT- 2019/04/24 06:00
PHST- 2019/04/24 06:00 [pubmed]
PHST- 2020/03/17 06:00 [medline]
PHST- 2019/04/24 06:00 [entrez]
AID - 10.1021/acs.molpharmaceut.9b00283 [doi]
PST - ppublish
SO  - Mol Pharm. 2019 Jun 3;16(6):2776-2784. doi: 10.1021/acs.molpharmaceut.9b00283. 
      Epub 2019 May 3.

PMID- 31926510
OWN - NLM
STAT- MEDLINE
DCOM- 20200205
LR  - 20200205
IS  - 1042-7260 (Print)
IS  - 1042-7260 (Linking)
VI  - 50
IP  - 4
DP  - 2020 Jan 9
TI  - WHOLE GENOME SEQUENCING OF AN AVIPOXVIRUS ASSOCIATED WITH INFECTIONS IN A GROUP 
      OF AVIARY-HOUSED SNOW BUNTINGS (PLECTROPHENAX NIVALIS).
PG  - 803-812
LID - 10.1638/2018-0102 [doi]
AB  - Avipoxvirus infections have been reported in both free-ranging and domestic birds 
      worldwide. Fowlpox and canarypox viruses belong to the genus Avipoxvirus among 
      the virus family Poxviridae. They cause cutaneous lesions with proliferative 
      growths on the unfeathered parts of the skin and/or diphtheritic lesions 
      generally associated with necrosis in the upper respiratory and digestive tracts. 
      In this study, a poxvirus has been identified in wild-caught snow buntings 
      (Plectrophenax nivalis) housed in an outdoor aviary in the region of Rimouski, 
      Quebec. During the falls and winters of 2015 and 2016, eight snow buntings 
      affected by this infection were examined. Macroscopic and microscopic lesions 
      observed were characteristic of an avipoxvirus infection. Electron microscopy 
      imaging of an ultrathin section of the histopathological lesions of two birds 
      confirmed the presence of the poxvirus. Afterward, the presence of the poxvirus 
      was confirmed in three birds by a specific polymerase chain reaction assay that 
      amplified a segment of the gene encoding the fowlpox virus 4b core protein. A 
      576-nucleotide amplicon was obtained from one of them and sequenced. The analyses 
      revealed a 99% homology to other previously described avipoxviruses. Using 
      high-throughput sequencing, almost the entire viral genome of this avipoxvirus 
      was revealed and found to possess a 359,853-nucleotide sequence in length. 
      Bioinformatic analyses revealed that the virus was genetically related to 
      canarypox virus. To our knowledge, this is the first confirmed case and full 
      description of a poxviral infection in this species. This episode suggests a high 
      susceptibility of this northern species of passerine to avipoxviruses circulating 
      in southeastern Canada during the summer months. Even if the source of the viral 
      infections remains undetermined, transmission by local biological vectors is 
      suspected. Management of poxviral infections in snow buntings housed outdoors in 
      southeastern Canada could rely on the control of biting insects.
FAU - Le Net, Rozenn
AU  - Le Net R
AD  - Centre québécois sur la santé des animaux sauvages/Canadian Wildlife Health 
      Cooperative, Faculté de médecine vétérinaire, Université de Montréal, 3200 rue 
      Sicotte, Québec J2S 2M2, Canada.
FAU - Provost, Chantale
AU  - Provost C
AD  - Centre de recherche en Infectiologie Porcine et Avicole (CRIPA), Laboratoire de 
      diagnostic virologique vétérinaire et de diagnostic moléculaire, Faculté de 
      médecine vétérinaire, Université de Montréal, 3200 rue Sicotte, Saint-Hyacinthe, 
      Québec J2S 2M2, Canada (Provost, Lalonde, and Gagnon).
FAU - Lalonde, Christian
AU  - Lalonde C
AD  - Centre de recherche en Infectiologie Porcine et Avicole (CRIPA), Laboratoire de 
      diagnostic virologique vétérinaire et de diagnostic moléculaire, Faculté de 
      médecine vétérinaire, Université de Montréal, 3200 rue Sicotte, Saint-Hyacinthe, 
      Québec J2S 2M2, Canada.
FAU - Régimbald, Lyette
AU  - Régimbald L
AD  - Département de biologie, chimie et géographie, Université du Québec à Rimouski, 
      300 allée des Ursulines, Rimouski, Québec G5L 3A1, Canada.
FAU - Vézina, Francois
AU  - Vézina F
AD  - Département de biologie, chimie et géographie, Université du Québec à Rimouski, 
      300 allée des Ursulines, Rimouski, Québec G5L 3A1, Canada.
FAU - Gagnon, Carl A
AU  - Gagnon CA
AD  - Centre de recherche en Infectiologie Porcine et Avicole (CRIPA), Laboratoire de 
      diagnostic virologique vétérinaire et de diagnostic moléculaire, Faculté de 
      médecine vétérinaire, Université de Montréal, 3200 rue Sicotte, Saint-Hyacinthe, 
      Québec J2S 2M2, Canada, carl.a.gagnon@umontreal.ca.
FAU - Lair, Stéphane
AU  - Lair S
AD  - Centre québécois sur la santé des animaux sauvages/Canadian Wildlife Health 
      Cooperative, Faculté de médecine vétérinaire, Université de Montréal, 3200 rue 
      Sicotte, Québec J2S 2M2, Canada, stephane.lair@umontreal.ca.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Zoo Wildl Med
JT  - Journal of zoo and wildlife medicine : official publication of the American 
      Association of Zoo Veterinarians
JID - 8915208
SB  - IM
MH  - Animals
MH  - Avipoxvirus/*genetics
MH  - Bird Diseases/pathology/*virology
MH  - Female
MH  - *Genome, Viral
MH  - Male
MH  - *Passeriformes
MH  - Phylogeny
MH  - Poxviridae Infections/*veterinary/virology
MH  - *Whole Genome Sequencing
OTO - NOTNLM
OT  - Avipoxvirus
OT  - Plectrophenax nivalis
OT  - canarypox
OT  - pathology
OT  - pox
OT  - snow bunting
OT  - whole genome sequencing
EDAT- 2020/01/13 06:00
MHDA- 2020/02/06 06:00
CRDT- 2020/01/13 06:00
PHST- 2019/06/30 00:00 [accepted]
PHST- 2020/01/13 06:00 [entrez]
PHST- 2020/01/13 06:00 [pubmed]
PHST- 2020/02/06 06:00 [medline]
AID - 10.1638/2018-0102 [doi]
PST - ppublish
SO  - J Zoo Wildl Med. 2020 Jan 9;50(4):803-812. doi: 10.1638/2018-0102.

PMID- 32817228
OWN - NLM
STAT- MEDLINE
DCOM- 20210623
LR  - 20210623
IS  - 1098-660X (Electronic)
IS  - 0095-1137 (Print)
IS  - 0095-1137 (Linking)
VI  - 58
IP  - 11
DP  - 2020 Oct 21
TI  - Whole-Genome Sequencing of Porcine Reproductive and Respiratory Syndrome Virus 
      from Field Clinical Samples Improves the Genomic Surveillance of the Virus.
LID - 10.1128/JCM.00097-20 [doi]
LID - e00097-20
AB  - Porcine reproductive and respiratory syndrome virus (PRRSV) is a major economic 
      concern worldwide. There are currently large data sets available about the ORF5 
      gene of the virus, with thousands of sequences available, but little data are 
      currently available on the full-length genome of PRRSV. We hypothesized that 
      whole-genome sequencing (WGS) of the PRRSV genome would allow better 
      epidemiological monitoring than ORF5 gene sequencing. PRRSV PCR-positive serum, 
      oral fluid, and tissue clinical samples submitted to the diagnostic laboratory 
      for routine surveillance or diagnosis of PRRSV infection in Québec, Canada, swine 
      herds were used. The PRRSV reverse transcription-quantitative PCR Cq values of 
      the processed samples varied between 11.5 and 34.34. PRRSV strain genomes were 
      isolated using a poly (A)-tail method and were sequenced with a MiSeq Illumina 
      sequencer. Ninety-two full-length PRRSV genomes were obtained from 88 clinical 
      samples out of 132 tested samples, resulting in a PRRSV WGS success rate of 
      66.67%. Three important deletions in ORF1a were found in most wild-type (i.e., 
      not vaccine-like) strains. The importance of these deletions remains 
      undetermined. Two different full-length PRRSV genomes were found in four 
      different samples (three serum samples and one pool of tissues), suggesting a 
      4.55% PRRSV strain coinfection prevalence in swine. Moreover, six PRRSV whole 
      genomes (6.52% of PRRSV strains) were found to cluster differently than they did 
      under the ORF5 classification method. Overall, WGS of PRRSV enables better strain 
      classification and/or interpretation of results in 9.10% of clinical samples than 
      ORF5 sequencing, as well as allowing interesting research avenues.
CI  - Copyright © 2020 American Society for Microbiology.
FAU - Lalonde, Christian
AU  - Lalonde C
AD  - Swine and Poultry Infectious Diseases Research Center (CRIPA), Université de 
      Montréal, Saint-Hyacinthe, Québec, Canada.
FAU - Provost, Chantale
AU  - Provost C
AUID- ORCID: 0000-0002-6674-1157
AD  - Swine and Poultry Infectious Diseases Research Center (CRIPA), Université de 
      Montréal, Saint-Hyacinthe, Québec, Canada.
AD  - Molecular Diagnostic Laboratory (MDL), Faculté de Médecine Vétérinaire, 
      Université de Montréal, Saint-Hyacinthe, Québec, Canada.
FAU - Gagnon, Carl A
AU  - Gagnon CA
AUID- ORCID: 0000-0003-4528-541X
AD  - Swine and Poultry Infectious Diseases Research Center (CRIPA), Université de 
      Montréal, Saint-Hyacinthe, Québec, Canada carl.a.gagnon@umontreal.ca.
AD  - Molecular Diagnostic Laboratory (MDL), Faculté de Médecine Vétérinaire, 
      Université de Montréal, Saint-Hyacinthe, Québec, Canada.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20201021
PL  - United States
TA  - J Clin Microbiol
JT  - Journal of clinical microbiology
JID - 7505564
SB  - IM
MH  - Animals
MH  - Canada
MH  - Genomics
MH  - Phylogeny
MH  - *Porcine Reproductive and Respiratory Syndrome/epidemiology
MH  - *Porcine respiratory and reproductive syndrome virus/genetics
MH  - Quebec/epidemiology
MH  - Swine
PMC - PMC7587098
OTO - NOTNLM
OT  - NGS
OT  - PRRSV
OT  - WGS
OT  - animal viral disease
OT  - classification
OT  - coinfection
OT  - next-generation sequencing
OT  - porcine reproductive and respiratory syndrome virus
OT  - recombinant
OT  - swine virus
OT  - whole-genome sequencing
EDAT- 2020/08/21 06:00
MHDA- 2021/06/24 06:00
CRDT- 2020/08/21 06:00
PHST- 2020/01/16 00:00 [received]
PHST- 2020/08/04 00:00 [accepted]
PHST- 2020/08/21 06:00 [pubmed]
PHST- 2021/06/24 06:00 [medline]
PHST- 2020/08/21 06:00 [entrez]
AID - JCM.00097-20 [pii]
AID - 00097-20 [pii]
AID - 10.1128/JCM.00097-20 [doi]
PST - epublish
SO  - J Clin Microbiol. 2020 Oct 21;58(11):e00097-20. doi: 10.1128/JCM.00097-20. Print 
      2020 Oct 21.

PMID- 31906705
OWN - NLM
STAT- MEDLINE
DCOM- 20201006
LR  - 20201006
IS  - 1940-4034 (Electronic)
IS  - 1074-2484 (Linking)
VI  - 25
IP  - 3
DP  - 2020 May
TI  - Cilostazol Mediates Immune Responses and Affects Angiogenesis During the Acute 
      Phase of Hind Limb Ischemia in a Mouse Model.
PG  - 273-285
LID - 10.1177/1074248419897852 [doi]
AB  - BACKGROUND: Cilostazol is a drug of choice for the treatment of intermittent 
      claudication that also affects innate and adaptive immune cells. The purpose of 
      our study was the evaluation of cilostazol's impact on the immune and angiogenic 
      response in murine models of hind limb ischemia. METHODS: We used 108 
      immunodeficient NOD.CB17-Prkdcscid/J mice and 108 wild-type CB17 mice. At day 0 
      (D0), all animals underwent hind limb ischemia. Half of them in both groups 
      received daily cilostazol starting at D0 and for the next 7 postoperative days, 
      while the rest of them served as controls, receiving vehicle. Interleukin (IL) 2, 
      IL-4, IL-6, IL-10, IL-17A, tumor necrosis factor α (TNF-α), and interferon γ 
      (IFN-γ) serum concentrations were measured by flow cytometry on postsurgery days 
      D1, D3, D5, and D7. On D7, both groups underwent positron emission tomography 
      scan with (68)Ga-RGD. Mice were euthanatized and gastrocnemius muscles were 
      obtained for histological evaluation. RESULTS: There was a statistically 
      significant augmentation (P < .05) in IL-4, IL-10, IL-6, and IFN-γ concentrations 
      in treated CB17 animals, while IL-2 was significantly suppressed. Significant 
      difference was detected between the CiBisch and Bisch groups on D1 and D7 (P < 
      .05) in CD31 staining. In treated NOD.CB17 animals, TNF-α, IL-6, and IFN-γ 
      presented significant augmentation, while (68)Ga-NODAGA-RGDfK uptake and CD31 
      expression were found significantly lower for both legs in comparison to the 
      control. CONCLUSION: Cilostazol seems to significantly increase angiogenesis in 
      wild-type animals during the first postoperational week. It also influences 
      immune cells, altering the type of immune response by promoting anti-inflammatory 
      cytokine production in wild-type animals, while it helps toward inflammation 
      regression in immunodeficient animals.
FAU - Paronis, Efthymios
AU  - Paronis E
AUID- ORCID: 0000-0002-5861-8589
AD  - Center of Clinical, Experimental Surgery & Translational Research, Biomedical 
      Research Foundation, Academy of Athens (BRFAA), Athens, Greece.
AD  - Vascular Surgery Department, School of Medicine, National and Kapodistrian 
      University of Athens, Attikon Teaching Hospital, Athens, Greece.
AD  - Section of Animal and Human Physiology, Department of Biology, National and 
      Kapodistrian University of Athens, Panepistimiopolis, Ilissia, Athens, Greece.
FAU - Katsimpoulas, Michalis
AU  - Katsimpoulas M
AD  - Center of Clinical, Experimental Surgery & Translational Research, Biomedical 
      Research Foundation, Academy of Athens (BRFAA), Athens, Greece.
FAU - Kadoglou, Nikolaos P E
AU  - Kadoglou NPE
AD  - Center for Statistics in Medicine-Botnar Research Centre, University of Oxford, 
      Oxford, United Kingdom.
FAU - Provost, Claire
AU  - Provost C
AD  - Sorbonne University, UMS28, plateforme LIMP, Laboratoire d'Imagerie Moléculaire 
      Positonique, Hopital Tenon, Paris, France.
FAU - Stasinopoulou, Marianna
AU  - Stasinopoulou M
AD  - Center of Clinical, Experimental Surgery & Translational Research, Biomedical 
      Research Foundation, Academy of Athens (BRFAA), Athens, Greece.
FAU - Spyropoulos, Christos
AU  - Spyropoulos C
AD  - Institute of Energy, Safety and Environmental Technologies, National Center for 
      Scientific Research "Demokritos," Athens, Greece.
FAU - Poulaki, Elpida
AU  - Poulaki E
AD  - First Department of Pathology, School of Medicine, National and Kapodistrian 
      University of Athens, Athens, Greece.
FAU - Prignon, Aurelie
AU  - Prignon A
AD  - Sorbonne University, UMS28, plateforme LIMP, Laboratoire d'Imagerie Moléculaire 
      Positonique, Hopital Tenon, Paris, France.
FAU - Kakisis, Ioannis
AU  - Kakisis I
AD  - Vascular Surgery Department, School of Medicine, National and Kapodistrian 
      University of Athens, Attikon Teaching Hospital, Athens, Greece.
FAU - Kostomitsopoulos, Nikolaos G
AU  - Kostomitsopoulos NG
AD  - Center of Clinical, Experimental Surgery & Translational Research, Biomedical 
      Research Foundation, Academy of Athens (BRFAA), Athens, Greece.
FAU - Bouziotis, Penelope
AU  - Bouziotis P
AD  - Radiochemical Studies Laboratory, Institute of Nuclear & Radiological Sciences & 
      Technology, Energy & Safety, National Center for Scientific Research 
      "Demokritos," Athens, Greece.
FAU - Kostopoulos, Ioannis V
AU  - Kostopoulos IV
AD  - Section of Animal and Human Physiology, Department of Biology, National and 
      Kapodistrian University of Athens, Panepistimiopolis, Ilissia, Athens, Greece.
FAU - Tsitsilonis, Ourania
AU  - Tsitsilonis O
AD  - Section of Animal and Human Physiology, Department of Biology, National and 
      Kapodistrian University of Athens, Panepistimiopolis, Ilissia, Athens, Greece.
FAU - Lazaris, Andreas
AU  - Lazaris A
AD  - Vascular Surgery Department, School of Medicine, National and Kapodistrian 
      University of Athens, Attikon Teaching Hospital, Athens, Greece.
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20200107
PL  - United States
TA  - J Cardiovasc Pharmacol Ther
JT  - Journal of cardiovascular pharmacology and therapeutics
JID - 9602617
RN  - 0 (Angiogenesis Inducing Agents)
RN  - 0 (Cytokines)
RN  - 0 (Inflammation Mediators)
RN  - N7Z035406B (Cilostazol)
SB  - IM
MH  - Angiogenesis Inducing Agents/*pharmacology
MH  - Animals
MH  - Cilostazol/*pharmacology
MH  - Cytokines/blood
MH  - Disease Models, Animal
MH  - Hindlimb
MH  - Immunity, Innate/*drug effects
MH  - Immunocompromised Host
MH  - Inflammation Mediators/blood
MH  - Ischemia/*drug therapy/immunology/metabolism/physiopathology
MH  - Male
MH  - Mice, Inbred NOD
MH  - Mice, SCID
MH  - Muscle, Skeletal/*blood supply
MH  - Neovascularization, Physiologic/*drug effects
MH  - Signal Transduction
OTO - NOTNLM
OT  - angiogenesis
OT  - cilostazol
OT  - cytokine profile
OT  - mouse model
OT  - peripheral ischemia
EDAT- 2020/01/08 06:00
MHDA- 2020/10/07 06:00
CRDT- 2020/01/08 06:00
PHST- 2020/01/08 06:00 [pubmed]
PHST- 2020/10/07 06:00 [medline]
PHST- 2020/01/08 06:00 [entrez]
AID - 10.1177/1074248419897852 [doi]
PST - ppublish
SO  - J Cardiovasc Pharmacol Ther. 2020 May;25(3):273-285. doi: 
      10.1177/1074248419897852. Epub 2020 Jan 7.

PMID- 32986537
OWN - NLM
STAT- MEDLINE
DCOM- 20201103
LR  - 20201103
IS  - 0191-2917 (Print)
IS  - 0191-2917 (Linking)
VI  - 104
IP  - 11
DP  - 2020 Nov
TI  - Influence of Leaf Wetness Duration and Temperature on Infection of Grape Leaves 
      by Elsinoë ampelina under Controlled and Vineyard Conditions.
PG  - 2817-2822
LID - 10.1094/PDIS-02-20-0262-RE [doi]
AB  - On susceptible varieties, indirect damage to vines infected by Elsinoë ampelina 
      range from reduced vigor to complete defoliation while, on berries, damage ranges 
      from reduced quality to complete yield loss. Limited knowledge about the 
      relationship between weather conditions and infection makes anthracnose 
      management difficult and favors routine application of fungicides. The influence 
      of leaf wetness duration and temperature on infection of grape leaves by E. 
      ampelina was studied under both controlled and vineyard conditions. For the 
      controlled conditions experiments, the five youngest leaves of potted vines 
      (Vidal) were inoculated with a conidia suspension and exposed to combinations of 
      six leaf wetness durations (from 0 to 24 h) and six constant temperatures (from 5 
      to 30°C). A week after each preset infection period, the percent leaf area 
      diseased (PLAD) was assessed. At 5°C, regardless of the leaf wetness duration, no 
      disease developed. At 10 and at 15 to 30°C, the minimum leaf wetness durations 
      were 4 and 6 h, respectively. Above the minimum wetness duration, at temperatures 
      from 10 to 30°C, PLAD increased linearly, with increasing leaf wetness up to 12 
      h, and then at a lower rate from 12 to 24 h. The optimal temperature for 
      infection was 25°C. Relative infection was modeled as a function of both 
      temperature and wetness duration using a Richards model (R(2) = 0.93). The 
      predictive capacity of the model was evaluated with data collected in 
      experimental vineyard plots exposed to natural wetness durations or artificial 
      wetness durations created using sprinklers. In total, 264 vineyard infection 
      events were used to validate the controlled experiments model. There was a linear 
      relationship between the risk of infection estimated with the model and the 
      observed severity of anthracnose (R(2) = 90); however, the model underestimated 
      disease severity. A risk chart was constructed using the model corrected for 
      vineyard observations and three levels of risk, with light, moderate, and severe 
      risks corresponding to ≤5, >5% to ≤25, and >25% leaf area diseased, respectively. 
      Overall, 93.9% of 132 independent observations were correctly classified, with 
      100, 29.4, and 9.4% of the light, moderate, and severe risks, respectively.
FAU - Carisse, Odile
AU  - Carisse O
AUID- ORCID: 0000-0002-2714-013X
AD  - Saint-Jean-sur-Richelieu Research and Development Centre, Agriculture and 
      Agri-Food Canada, Saint-Jean-sur-Richelieu, QC, J3B 3E6, Canada.
FAU - Levasseur, Audrey
AU  - Levasseur A
AD  - Saint-Jean-sur-Richelieu Research and Development Centre, Agriculture and 
      Agri-Food Canada, Saint-Jean-sur-Richelieu, QC, J3B 3E6, Canada.
FAU - Provost, Caroline
AU  - Provost C
AD  - Centre de recherche agroalimentaire de Mirabel, Mirabel, QC, J7N 2X8, Canada.
LA  - eng
PT  - Journal Article
DEP - 20200928
PL  - United States
TA  - Plant Dis
JT  - Plant disease
JID - 9882809
RN  - 059QF0KO0R (Water)
SB  - IM
MH  - Farms
MH  - Humans
MH  - *Infections
MH  - Plant Diseases
MH  - Plant Leaves
MH  - Temperature
MH  - *Vitis
MH  - Water
OTO - NOTNLM
OT  - climate/weather effects
OT  - epidemiology
OT  - fruit
OT  - fungi
OT  - small fruits
EDAT- 2020/09/29 06:00
MHDA- 2020/11/04 06:00
CRDT- 2020/09/28 17:11
PHST- 2020/09/29 06:00 [pubmed]
PHST- 2020/11/04 06:00 [medline]
PHST- 2020/09/28 17:11 [entrez]
AID - 10.1094/PDIS-02-20-0262-RE [doi]
PST - ppublish
SO  - Plant Dis. 2020 Nov;104(11):2817-2822. doi: 10.1094/PDIS-02-20-0262-RE. Epub 2020 
      Sep 28.

PMID- 30771758
OWN - NLM
STAT- Publisher
LR  - 20191120
IS  - 1547-5646 (Electronic)
IS  - 1547-5646 (Linking)
DP  - 2019 Feb 15
TI  - The occipitoatlantal capsular ligaments are the primary stabilizers of the 
      occipitoatlantal joint in the craniocervical junction: a finite element analysis.
PG  - 1-9
LID - 2018.10.SPINE181102 [pii]
LID - 10.3171/2018.10.SPINE181102 [doi]
AB  - OBJECTIVEThere is contradictory evidence regarding the relative contribution of 
      the key stabilizing ligaments of the occipitoatlantal (OA) joint. Cadaveric 
      studies are limited by the nature and the number of injury scenarios that can be 
      tested to identify OA stabilizing ligaments. Finite element (FE) analysis can 
      overcome these limitations and provide valuable data in this area. The authors 
      completed an FE analysis of 5 subject-specific craniocervical junction (CCJ) 
      models to investigate the biomechanics of the OA joint and identify the 
      ligamentous structures essential for stability.METHODSIsolated and combined 
      injury scenarios were simulated under physiological loads for 5 validated CCJ FE 
      models to assess the relative role of key ligamentous structures on OA joint 
      stability. Each model was tested in flexion-extension, axial rotation, and 
      lateral bending in various injury scenarios. Isolated ligamentous injury 
      scenarios consisted of either decreasing the stiffness of the OA capsular 
      ligaments (OACLs) or completely removing the transverse ligament (TL), tectorial 
      membrane (TM), or alar ligaments (ALs). Combination scenarios were also 
      evaluated.RESULTSAn isolated OACL injury resulted in the largest percentage 
      increase in all ranges of motion (ROMs) at the OA joint compared with the other 
      isolated injuries. Flexion, extension, lateral bending, and axial rotation 
      significantly increased by 12.4% ± 7.4%, 11.1% ± 10.3%, 83.6% ± 14.4%, and 81.9% 
      ± 9.4%, respectively (p ≤ 0.05 for all). Among combination injuries, OACL+TM+TL 
      injury resulted in the most consistent significant increases in ROM for both the 
      OA joint and the CCJ during all loading scenarios. OACL+AL injury caused the most 
      significant percentage increase for OA joint axial rotation.CONCLUSIONSThese 
      results demonstrate that the OACLs are the key stabilizing ligamentous structures 
      of the OA joint. Injury of these primary stabilizing ligaments is necessary to 
      cause OA instability. Isolated injuries of TL, TM, or AL are unlikely to result 
      in appreciable instability at the OA joint.
FAU - Phuntsok, Rinchen
AU  - Phuntsok R
AD  - 1Department of Bioengineering, and Scientific Computing and Imaging Institute, 
      University of Utah; and.
FAU - Ellis, Benjamin J
AU  - Ellis BJ
AD  - 1Department of Bioengineering, and Scientific Computing and Imaging Institute, 
      University of Utah; and.
FAU - Herron, Michael R
AU  - Herron MR
AD  - 1Department of Bioengineering, and Scientific Computing and Imaging Institute, 
      University of Utah; and.
FAU - Provost, Chase W
AU  - Provost CW
AD  - 1Department of Bioengineering, and Scientific Computing and Imaging Institute, 
      University of Utah; and.
FAU - Dailey, Andrew T
AU  - Dailey AT
AD  - 2Department of Neurosurgery, Division of Pediatric Neurosurgery, University of 
      Utah, Primary Children's Hospital, Salt Lake City, Utah.
FAU - Brockmeyer, Douglas L
AU  - Brockmeyer DL
AD  - 2Department of Neurosurgery, Division of Pediatric Neurosurgery, University of 
      Utah, Primary Children's Hospital, Salt Lake City, Utah.
LA  - eng
PT  - Journal Article
DEP - 20190215
PL  - United States
TA  - J Neurosurg Spine
JT  - Journal of neurosurgery. Spine
JID - 101223545
OTO - NOTNLM
OT  - AA = atlantoaxial
OT  - AACL = AA capsular ligament
OT  - AL = alar ligament
OT  - AOD = atlantooccipital dislocation
OT  - CCI = condylar–C1 interval
OT  - CCJ = craniocervical junction
OT  - FE = finite element
OT  - FEM = FE method
OT  - OA = occipitoatlantal
OT  - OACL = OA capsular ligament
OT  - Oc = occiput
OT  - ROM = range of motion
OT  - TL = transverse ligament
OT  - TM = tectorial membrane
OT  - alar ligaments
OT  - biomechanics
OT  - cervical spine
OT  - craniocervical junction
OT  - finite element analysis
OT  - instability
OT  - occipitoatlantal capsular ligaments
OT  - occipitoatlantal joint
OT  - range of motion
OT  - tectorial membrane
OT  - transverse ligament
EDAT- 2019/02/17 06:00
MHDA- 2019/02/17 06:00
CRDT- 2019/02/17 06:00
PHST- 2018/09/07 00:00 [received]
PHST- 2018/10/04 00:00 [accepted]
PHST- 2019/02/17 06:00 [entrez]
PHST- 2019/02/17 06:00 [pubmed]
PHST- 2019/02/17 06:00 [medline]
AID - 2018.10.SPINE181102 [pii]
AID - 10.3171/2018.10.SPINE181102 [doi]
PST - aheadofprint
SO  - J Neurosurg Spine. 2019 Feb 15:1-9. doi: 10.3171/2018.10.SPINE181102.

PMID- 29948641
OWN - NLM
STAT- MEDLINE
DCOM- 20190801
LR  - 20200306
IS  - 1860-2002 (Electronic)
IS  - 1536-1632 (Linking)
VI  - 21
IP  - 2
DP  - 2019 Apr
TI  - [(68)Ga]RGD Versus [(18)F]FDG PET Imaging in Monitoring Treatment Response of a 
      Mouse Model of Human Glioblastoma Tumor with Bevacizumab and/or Temozolomide.
PG  - 297-305
LID - 10.1007/s11307-018-1224-9 [doi]
AB  - PURPOSE: The aim of this study was to evaluate positron emission tomography (PET) 
      imaging with [(68)Ga]NODAGA-c(RGDfK) ([(68)Ga]RGD), in comparison with 
      2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG), for early monitoring of the 
      efficacy of an antiangiogenic agent associated or not with chemotherapy, in a 
      mouse model of glioblastoma (GB). PROCEDURES: Mice bearing U87MG human GB cells 
      line were parted into five groups of five mice each. One group was imaged at 
      baseline before the treatment phase; another group was treated with bevacizumab 
      (BVZ), another group with temozolomide (TMZ), another group with both agents, and 
      the last one was the control group. Tumors growth and biological properties were 
      evaluated by caliper measurements and PET imaging at three time points (baseline, 
      during treatment t1 = 4-6 days and t2 = 10-12 days). At the end of the study, 
      tumors were counted and analyzed by immunohistochemistry (CD31 to evaluate 
      microvessel density). RESULTS: The tumor volume assessed by caliper measurements 
      was significantly greater at t1 in the control group than in the TMZ + 
      BVZ-treated group or in the BVZ-treated group. At t2, tumor volume of all treated 
      groups was significantly smaller than that of the control group. [(18)F]FDG PET 
      failed to reflect this efficacy of treatment. In contrast, at t1, the [(68)Ga]RGD 
      tumor uptake was concordant with tumor growth in controls and in treated groups. 
      At t2, a significant increase in tumor uptake of [(68)Ga]RGD vs. t1 was only 
      observed in the TMZ-treated group, reflecting a lack of angiogenesis inhibition, 
      whereas TMZ + BVZ resulted in a dramatic tumor arrest, reduction in microvessel 
      density and stable tumor [(68)Ga]RGD uptake. CONCLUSIONS: [(68)Ga]RGD is a useful 
      PET agent for in vivo angiogenesis imaging and can be useful for monitoring 
      antiangiogenic treatment associated or not with chemotherapy.
FAU - Provost, Claire
AU  - Provost C
AUID- ORCID: 0000-0002-4390-4486
AD  - Laboratoire d'Imagerie Moléculaire Positonique (LIMP), UMS 28, UPMC - Sorbonne 
      Universités, Paris, France. claire.provost@upmc.fr.
FAU - Rozenblum-Beddok, Laura
AU  - Rozenblum-Beddok L
AD  - Laboratoire d'Imagerie Moléculaire Positonique (LIMP), UMS 28, UPMC - Sorbonne 
      Universités, Paris, France.
AD  - Service de Médecine Nucléaire et Radiopharmacie, Hôpital Tenon, AP-HP, Paris, 
      France.
FAU - Nataf, Valérie
AU  - Nataf V
AD  - Laboratoire d'Imagerie Moléculaire Positonique (LIMP), UMS 28, UPMC - Sorbonne 
      Universités, Paris, France.
AD  - Service de Médecine Nucléaire et Radiopharmacie, Hôpital Tenon, AP-HP, Paris, 
      France.
FAU - Merabtene, Fatiha
AU  - Merabtene F
AD  - Plateforme d'Histomorphologie Service d'Anatomie Pathologique, Hôpital Saint 
      Antoine, AP-HP, Paris, France.
FAU - Prignon, Aurélie
AU  - Prignon A
AD  - Laboratoire d'Imagerie Moléculaire Positonique (LIMP), UMS 28, UPMC - Sorbonne 
      Universités, Paris, France.
FAU - Talbot, Jean-Noël
AU  - Talbot JN
AD  - Laboratoire d'Imagerie Moléculaire Positonique (LIMP), UMS 28, UPMC - Sorbonne 
      Universités, Paris, France.
AD  - Service de Médecine Nucléaire et Radiopharmacie, Hôpital Tenon, AP-HP, Paris, 
      France.
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Mol Imaging Biol
JT  - Molecular imaging and biology
JID - 101125610
RN  - 0 (Gallium Radioisotopes)
RN  - 0 (Oligopeptides)
RN  - 0Z5B2CJX4D (Fluorodeoxyglucose F18)
RN  - 2S9ZZM9Q9V (Bevacizumab)
RN  - 78VO7F77PN (arginyl-glycyl-aspartic acid)
RN  - 98B30EPP5S (Gallium-68)
RN  - YF1K15M17Y (Temozolomide)
MH  - Animals
MH  - Bevacizumab/*therapeutic use
MH  - Brain Neoplasms/diagnostic imaging/*drug therapy/pathology
MH  - Cell Line, Tumor
MH  - Cell Proliferation
MH  - Disease Models, Animal
MH  - Fluorodeoxyglucose F18/*chemistry
MH  - Gallium Radioisotopes/*chemistry
MH  - Glioblastoma/*diagnostic imaging/*drug therapy/pathology
MH  - Humans
MH  - Mice
MH  - Oligopeptides/chemistry
MH  - *Positron-Emission Tomography
MH  - Temozolomide/*therapeutic use
MH  - Tissue Distribution
MH  - Treatment Outcome
MH  - Tumor Burden
OTO - NOTNLM
OT  - Angiogenesis
OT  - Bevacizumab
OT  - Integrins αvβ3
OT  - PET
OT  - Temozolomide
OT  - [18F]FDG
OT  - [68Ga]RGD
EDAT- 2018/06/28 06:00
MHDA- 2019/08/02 06:00
CRDT- 2018/06/28 06:00
PHST- 2018/06/28 06:00 [pubmed]
PHST- 2019/08/02 06:00 [medline]
PHST- 2018/06/28 06:00 [entrez]
AID - 10.1007/s11307-018-1224-9 [pii]
AID - 10.1007/s11307-018-1224-9 [doi]
PST - ppublish
SO  - Mol Imaging Biol. 2019 Apr;21(2):297-305. doi: 10.1007/s11307-018-1224-9.

PMID- 29721204
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20191120
IS  - 1949-2553 (Electronic)
IS  - 1949-2553 (Linking)
VI  - 9
IP  - 27
DP  - 2018 Apr 10
TI  - Comparison and evaluation of two RGD peptides labelled with (68)Ga or (18)F for 
      PET imaging of angiogenesis in animal models of human glioblastoma or lung 
      carcinoma.
PG  - 19307-19316
LID - 10.18632/oncotarget.25028 [doi]
AB  - The aim of this study was to evaluate two RGD radiotracers radiolabelled with 
      fluorine-18 or gallium-68, in detecting angiogenesis in grafted human tumours and 
      monitoring their treatment with the anti-angiogenic agent bevacizumab. Sixteen 
      mice bearing an U87MG tumour in one flank and a contralateral A549 tumour were 
      treated with intravenous injections of bevacizumab twice a week for 3 weeks. PET 
      images with (18)F-RGD-K5 and (68)Ga-RGD were acquired before treatment 
      (baseline), after three bevacizumab injections (t1) and after seven bevacizumab 
      injections (t2). In A549 tumours, the treatment stopped the tumour growth, with a 
      tumour volume measured by calliper remaining between 0.28 and 0.40 cm(3). The 
      decrease in tumour uptake of both RGD tracers was non-significant. Therefore it 
      was not possible to predict this efficacy on tumour growth based on RGD PET 
      results, whereas ex vivo measurements showed a significantly lower tumour uptake 
      of both tracers in mice sacrificed at t2 vs. at baseline. In U87MG tumours, the 
      uptake measured on PET decreased during treatment, reflecting the partial 
      therapeutic effect observed on tumour volume, consisting in a decrease in the 
      slope of tumour growth. Using (18)F-RGD-K5, this decrease in tumour SUVmax became 
      significant at t1, whereas it was also observed with the (68)Ga-RGD tracer, but 
      only at t2. (18)F-RGD-K5 appeared more efficient than (68)Ga-RGD in the 
      visualisation and follow-up of U87MG tumours. The comparison of those results 
      with those of immunohistochemistry at baseline and at t2 favoured the hypothesis 
      that tumour RGD uptake reflects other cancer properties than just its angiogenic 
      capacity.
FAU - Provost, Claire
AU  - Provost C
AD  - Laboratoire d'Imagerie Moléculaire Positonique (LIMP), UMS 28, Sorbonne 
      Université, Paris, France.
AD  - PETNET Solutions SAS, Siemens Healthineers, Lisses, France.
FAU - Prignon, Aurélie
AU  - Prignon A
AD  - Laboratoire d'Imagerie Moléculaire Positonique (LIMP), UMS 28, Sorbonne 
      Université, Paris, France.
FAU - Rozenblum-Beddok, Laura
AU  - Rozenblum-Beddok L
AD  - Laboratoire d'Imagerie Moléculaire Positonique (LIMP), UMS 28, Sorbonne 
      Université, Paris, France.
AD  - Service de Médecine Nucléaire et Radiopharmacie, Hôpital Tenon, AP-HP Paris, 
      France.
FAU - Bruyer, Quentin
AU  - Bruyer Q
AD  - PETNET Solutions SAS, Siemens Healthineers, Lisses, France.
FAU - Dumont, Sylvie
AU  - Dumont S
AD  - Plateforme d'Histomorphologie Service d'Anatomie Pathologique, Hôpital Saint 
      Antoine, AP-HP, Paris, France.
FAU - Merabtene, Fatiha
AU  - Merabtene F
AD  - Plateforme d'Histomorphologie Service d'Anatomie Pathologique, Hôpital Saint 
      Antoine, AP-HP, Paris, France.
FAU - Nataf, Valérie
AU  - Nataf V
AD  - Service de Médecine Nucléaire et Radiopharmacie, Hôpital Tenon, AP-HP Paris, 
      France.
FAU - Bouteiller, Cédric
AU  - Bouteiller C
AD  - PETNET Solutions SAS, Siemens Healthineers, Lisses, France.
FAU - Talbot, Jean-Noël
AU  - Talbot JN
AD  - Laboratoire d'Imagerie Moléculaire Positonique (LIMP), UMS 28, Sorbonne 
      Université, Paris, France.
AD  - Service de Médecine Nucléaire et Radiopharmacie, Hôpital Tenon, AP-HP Paris, 
      France.
LA  - eng
PT  - Journal Article
DEP - 20180410
PL  - United States
TA  - Oncotarget
JT  - Oncotarget
JID - 101532965
PMC - PMC5922398
OTO - NOTNLM
OT  - 18F-RGD-K5
OT  - 68Ga-RGD
OT  - angiogenesis
OT  - integrins αvβ3
OT  - preclinical PET
COIS- CONFLICTS OF INTEREST The authors declare that they have no competing interests.
EDAT- 2018/05/04 06:00
MHDA- 2018/05/04 06:01
CRDT- 2018/05/04 06:00
PHST- 2017/10/15 00:00 [received]
PHST- 2018/03/19 00:00 [accepted]
PHST- 2018/05/04 06:00 [entrez]
PHST- 2018/05/04 06:00 [pubmed]
PHST- 2018/05/04 06:01 [medline]
AID - 25028 [pii]
AID - 10.18632/oncotarget.25028 [doi]
PST - epublish
SO  - Oncotarget. 2018 Apr 10;9(27):19307-19316. doi: 10.18632/oncotarget.25028. 
      eCollection 2018 Apr 10.
